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Thesis abstract 
 
Cells are in constant and dynamic interactions with the extracellular 
environment. They receive several inputs involved in the regulation of cell 
behaviour. Fibronectin, an abundant protein of the ECM, contains multiple 
binding domains and binds to cell receptors, growth factors and other ECM 
proteins. FN undergoes conformational changes through cell-generated 
contractile forces which consequently affects cell response.  Tissue 
engineering aims at engineering biomaterials that recreate the in vivo ECM. In 
addition to biomaterials, stem cells have emerged as a promising source due to 
their inherent differentiation potential.  
 
In this work, the role of poly acrylates in controlling human mesenchymal stem 
cell behaviour (hMSCs) was explored. Particularly, a series of copolymers with 
specific ratio of ethyl(acrylate), EA, and methyl(acrylate), MA, were used. It is 
known that poly(ethyl)acrylate, PEA, triggers a network-like conformation of FN 
upon adsorption, whereas poly(methyl)acrylate, PMA, elicits a globular 
conformation. It was found that a different degree of FN organisation can be 
obtained dependent on the EA/MA ratio, with the network being more 
connected with increased EA ratio. This differential conformation was shown to 
affect the availability of critical binding sites. This system was further used to 
study hMSCs response in terms of adhesion and osteogenic differentiation. All 
surfaces support cell growth and focal adhesion formation. However, increased 
cell size and spreading was promoted on surfaces with higher EA 
concentration. Next, the potential of the surfaces after sequential adsorption of 
FN and the growth factor BMP-2 to drive osteogenic commitment was explored. 
Enhanced expression of the osteogenic markers RUNX2 and OCN was found 
with higher concentration of EA whereas the opposite was observed with ALP 
expression. Another part of this work involved investigating cell migration on 
PEA and PMA. Higher cell speed was found on PEA where FN adopts a more 
extended conformation. Moreover, the protein composition of focal adhesions 
was evaluated by proteomic analysis.  
 
The findings of this work give further insights into how the surface with well-
defined chemical properties can modulate FN conformation and how these 
changes affect cellular processes.  
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1.1 Introduction  
Regenerative medicine is a multidisciplinary field that aims to replace, restore 
and improve the function of injured and diseased tissues. Tissue engineering 
(TE) is an important component of regenerative medicine and its goal is to 
develop biological substitutes of tissues1. Current approaches of TE require a 
suitable cell source, engineered biomaterials and the delivery of biomolecules. 
This field has contributed to understanding the mechanisms that regulate major 
cell functions as well as cell-biomaterials interactions2. Essentially, the 
objective of TE is to deconstruct the complexity of the in vivo environment and 
to recapitulate the cell physiological environment.  
 
1.2 Extracellular matrix 
The extracellular matrix (ECM) is the cell native environment and it is a three-
dimensional non-cellular heterogeneous network composed of a meshwork of 
proteoglycans, glycoproteins and soluble growth factors3, 4. The ECM serves 
multiple and fundamental functions. It provides structural support to the cells 
and thus it defines the shape of organs and tissues. Deregulation of ECM 
components and biophysical properties are associated with the development of 
pathologies, such as skin diseases, fibrosis and cancer5. ECM is a rather 
dynamic entity that undergoes constant remodelling and its composition and 
topology is tissue-specific. It is also a source of signals and growth factors that 
allow cells to carry out important processes for their proliferation and survival6. 
All cell types synthesize and secrete matrix proteins, a process which is highly 
regulated.  
  
1.3 Cell adhesion 
Cells sense the biochemical and physical cues coming from the ECM and they 
are then converted to biochemical signals which regulate cell processes such 
as differentiation and survival. Signal transduction is mediated via cell adhesion 
receptors known as integrins formed at the sites of cell-ECM interactions. 
These complexes are physically bound to specific amino acid sequences of 
ECM proteins, such as fibronectin (FN), vitronectin (VN), collagen and laminin 
and mechanically link the actin cytoskeleton to the ECM7. Transduction of 
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external signals via integrins results in changes in ECM architecture and 
instigate signalling pathways important for cell response8.  
 
1.3.1 Integrins 
Integrins are bidirectional cell surfaces receptors and mediate divalent cation-
dependent interactions with components of the ECM. They are heterodimeric 
type I transmembrane receptors and are composed of non-covalently bound α 
and β glycoprotein subunits. Each receptor recognises specific ECM ligands 
with different affinities7. Integrin structure and function have been extensively 
studied since their discovery and classification in the 1980s9. In mammals, 
there are 18 α subunits and 8 β subunits which are composed of several 
domains and are assembled into 24 different receptors. Each subunit consists 
of a large extracellular domain, a spanning transmembrane helix and a short 
cytoplasmic domain. The solved crystal structure of the extracellular domain of 
αvβ3 integrin has given important insights into the structural conformations 
integrins obtain upon ligand binding10. Half of the α subunits contain an extra 
domain known as inserted αI domain and is the major ligand binding site. For 
the integrins that lack the αI domain, such as αvβ3, αIIββ3 and α5β1, ligand 
binding occurs at the largest interface between the two subunits and the βI 
domain which is homologous to αI11, 12.   
 
Most integrins are not constitutively active. Their regulation is achieved through 
tight temporal and spatial control of their affinity for ECM ligands. Three distinct 
integrin structures associated with ligand affinity have been described; bent 
with a closed headpiece, extended with a closed headpiece, and extended 
with an open headpiece. Conversion from low-affinity to high-affinity state is 
induced by both extracellular and intracellular signals13. Low-affinity integrins, 
represented by a bend and inverted V-like conformation10, 14, indicate the 
inactive state of integrins which does not favour the recognition and binding of 
ligands. Activation of integrins is triggered by the binding of small ligand 
molecules (Mg2+, Mn2+ and Ca2+). This leads to rapid conformation changes 
characterised by a more open and extended configuration14. These changes 
have been shown to alter the structure of metal ion-dependent adhesion sites 
(MIDAS) in αI and βI domains and the adjacent site to MIDAS (AMIDAS)12. 
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Conformational changes and integrin clustering are required for the 
transmission of outside-in signalling. However, it is still not clear how signals 
are transmitted across the plasma membrane through the transmembrane 
domain. Recent studies showed that association of the α and β subunit 
transmembrane domains results in the stabilisation of the inactive integrin 
state. The separation of the transmembrane domain, induced by binding of the 
β subunit cytoplasmic domain to intracellular molecules, contribute to the high-
affinity conformation and integrin activation15-17 (Figure 1.1).  
 
 
Figure 1.1 Schematic representation of integrin activation. Integrin 
structure, activation and interactions18. 
 
1.3.2 Focal adhesions 
Conformational changes induced by ligand binding result in the assembly of an 
intracellular multiprotein structure. The activating step is followed by binding of 
the anchoring protein talin which interacts with the intracellular β subunit of 
integrins via the N-terminal while the C-terminal binds to actin19. Talin also 
contributes to the upright conformation of integrins. Expression of talin in talin 
knockout cells rescued integrin activation and cell spreading20. In addition, 
disruption of talin in endothelial cells impaired organization into vessels, leading 
to embryonic death at gastrulation21. Kindlin, another anchoring protein, co-
operates with talin and is essential for integrin activation4. Lack of either talin or 
kindlin failed to activate β1 integrins22.  
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Binding of talin to kindlin elicits the recruitment of various proteins in the 
cytoplasmic tail resulting in the assembly of focal adhesions (FAs). One of the 
best characterised protein is vinculin which is considered a mechanosensitive 
protein. Constitutively active forms of vinculin were shown to induce an 
increase in the size of FAs as well a reduced rate of turnover23.  In contrast, 
loss of intracellular tension caused by blebbistatin promoted rapid dissociation 
of vinculin from FAs24. Vinculin binds to talin via its N-terminal and triggers the 
clustering of activated integrins and actin complexes. By binding to actin via its 
C-terminal, vinculin act as a molecular clutch and is essential in development 
of stable focal adhesion complexes25. Talin-vinculin interactions are regulated 
by conformational changes. Vinculin also reinforces the link between talin and 
actin. Suppression of vinculin binding to talin results in the inactivation of the 
actin-binding domain of talin and in the formation of unstable short-lived focal 
complexes20. 
 
The first adhesion structure is formed away from the leading edge between 
lamellipodia (membrane extensions formed at the cell front26)  and the lamella 
(structures found behind the lamellipodia26) and are short-lived nascent 
adhesions (NAs) (> 1 µm length)27. These focal points transmit traction forces 
and they undergo rapid disassembly. Some of them grow in size and develop 
into longer mature FAs in the lamellum (1.0–10 µm2). These structures contain 
multiple proteins such as vinculin, talin and paxillin. FAs are tightly attached to 
the ECM and to the cytoskeleton via F-actin. They thus contribute to cell 
response to chemical and physical features coming from the ECM and to signal 
transmission. For example, fibroblasts seeded on rigid surfaces displayed large 
and uniformly oriented FAs28, 29.  
 
Mechanotransduction via FAs is transimitted by a non-receptor tyrosine kinase 
known as focal adhesion kinase (FAK). Upon integrin clustering, FAK is 
activated by autophosphorylation on the Y397. This triggers the binding of Src 
to the autophosphorylated sites leading to an increase in Src–FAK activation30. 
Src is another non-receptor tyrosine kinase and phosphorylates other sites of 
FAK31 and other FA proteins such as paxillin30. Previous studies suggest that 
the FAK-Src are involved in the control of FA dynamics which subsequently has 
an impact on downstream signalling pathways32.  
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1.4 Fibronectin 
FN is one of the most abundant components of the ECM and is widely involved 
in physiological events such as development and tissue regeneration. FN 
knockout mice fail to develop beyond embryonic day 10 or 1133. It can also 
influence pathological conditions such as tumour metastasis34. Within the ECM, 
FN is organised into a network of elongated fibrils which can be stretched in a 
cell-mediated process35. FN is encoded by a single gene, however various 
isoforms are generated by alternative splicing3. FN is synthesised by a variety 
of cells and two main forms have been described; plasma FN, predominantly 
secreted by hepatocytes, and cellular FN36.  
 
FN is a dimeric protein and consists of two subunits of ~250 kDa covalently 
linked by disulphide bonds at their C-terminus37. Each dimer contains multiple 
recognition domains that mediate interactions with other ECM proteins, such as 
collagen, heparin and fibrin, FN molecules, glycosaminoglycans (GAGs) and 
cell surface receptors38 . There are three types of FN repeating units; type I, 
type II and type III 39. Each module consists of 12 type I repeats, 2 type II 
repeats and 15-17 type III repeats (Figure 1.2). The structure of type I and type 
II repeats is stabilised by pairs of intramolecular disulphide bridges, whereas 
type III repeats are 7-stranded β-barrel structures which are stabilised by 
hydrogen bonds and Van der Waals forces40. Due to the lack of disulphate 
bonds, type III repeats are flexible and can undergo conformation changes 
under mechanical or chemical stimuli41.  
 
 
Figure 1.2. FN subunit and its molecular recognition sites. Each dimer 
consists of three types of domains; type I, type II and type III. 
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FN has been associated with a wide range of cellular processes. It contributes 
to the homeostasis of the ECM as well as to the stability and assembly of other 
ECM components. In addition, it is required for the deposition of other ECM 
proteins such as collagen. In a study where FN null cells were used, FN 
polymerisation was found to be a prerequisite for the deposition of collagen I 
and thrombosponin-142. Furthermore, using Förster resonance energy transfer 
(FRET) labelled FN, it was found that collagen I fibres interact preferentially 
with more relaxed FN. Once collagen I is assembled, it restrict the ability of 
fibroblasts to further stretch and mechanically unfold FN fibres43.  
 
1.4.1 Fibronectin matrix assembly 
FN can be categorised into soluble plasma and insoluble cellular molecules. FN 
can be found in different conformations which in turn affect the protein 
biological function. Consequently, a critical event in FN biological activity is the 
assembly of FN molecules into interconnected fibres which ultimately result in a 
fibrillar network. This is a cell-dependent process and occurs in an elaborate 
step-wise way which is not yet fully understood. The dimeric protein is secreted 
in a soluble and compact form. In this form, FN is inactive and its activation is 
required for matrix assembly. The initial step involves binding to cell surface 
receptors such as syndecans and integrins. Cell attachment is mediated 
primarily through binding of α5β1 integrin to the RGD (arginine-glycine-
aspartate) sequence located in the FNIII10 repeat and to the adjacent PHSRN 
(Pro-His-Ser-Arg-Asn) synergy domain located in a loop in FNIII9 repeat39, 44-46. 
An RGD-independent assembly of FN has been also reported to occur through 
binding of α4β1 integrin to the alternatively spliced V region near the C terminus 
of FN47. 
 
Cell attachment to FN supports actin stress fibre formation and enhances cell 
contractility via the activation of small guanosine triphosphatase (GTPase) 
Rho48. This event leads to an increase in the concentration of integrin-bound 
FN which is organised into short fibrils. In addition, actin-myosin interactions 
generate forces sufficient to extent FN molecules. Such conformational 
changes lead to protein unravelling and the exposure of cryptic binding sites 
which allowing FN molecule to interact laterally and promote the formation of 
thicker fibrils. It has been suggested that unfolding of the FNIII10 repeat 
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contributes to FN fibrillogenesis49. The compact form of FN is maintained by 
intramolecular association of several binding sites such as binding of FNIII2-3 
and FNIII12-14 repeats50. Disruption of these interactions promote fibrillogenesis 
and allow intermolecular interactions. Further unfolding of type III repeats have 
been proposed to contribute to fibril extensibility51. Other binding domains 
contribute to this process too. The FNIII1-2 repeat has been shown to regulate 
fibrillogenesis via binding to FN. Blocking of FNIII152 or deletion of the FNIII1-2 
site significantly reduced matrix assembly53. For example, the FNIII1-5 site at N-
terminal binds directly to other binding regions across FN. Additionally, covalent 
interactions of the subunits are also required involving a pair of the C-terminal 
bonds 39, 54.  
 
1.4.2 Fibronectin activity 
Cells interact with FN via integrins which recognise and bind to its multiple 
domains. Integrin binding is a highly regulated process and a specific pattern of 
binding can direct cell behaviour. The major cell binding site recognised by 
numerous integrins is the RGD sequence which is incorporated into many 
adhesive ECM proteins55. The RGD sequence is recognised by the five αV 
integrins, two β1 integrins (α5, α8) and αIIbβ356 and it has described as the 
minimal adhesive motif. Adjacent to RGD site, FN harbours the synergy domain 
PHRSN which binds α5β1 and αIIbβ3 integrins but not αv-class integrins57. In 
vitro studies have demonstrated that the PHSRN domain contributes to the 
binding affinity of the α5β1 to FN58 and to the overall increase in cell 
adhesion59. These two sequences can mimic the adhesive properties of native 
FN60.  
 
A large body of evidence suggests that FN conformational state affects integrin 
binding. Both the RGD and PHRSN are required for the binding of the α5β1 
integrin which assumes an open conformation upon binding61. Other integrins 
engage FN through RGD including αIIbβ3, αVβ3, αVβ6, αVβ1 and α8β162.  The 
spatial organisation of the RGD and PHSRN sites have critical implication in 
the affinity of integrin binding. They are separated by about 32 Å when FN is 
relaxed. Under tension, the FNIII10 repeat unfolds resulting essentially in 
translocation of the RGD from the PHSRN site from 32 Å to approximately 55 
Å63. It has been shown that when they are in closer proximity, the binding of 
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α5β1 integrin is enhanced. In contrast, a stretched state of FN results in a 
decrease in the binding affinity. Further evidence to support the effect of RGD-
PHSRN distance in integrin binding is shown when the FNIII9 repeat was 
stabilised by a Leu-Pro mutation resulting in an increased affinity of α5β164. 
Another study reported decreased binding of the integrin subunits α3 and α5 on 
FNIII10 compared to increased binding found on the FNIII9-10 repeat. In contrast, 
binding of the av integrins was not affected by the lack of synergy domain65. 
Altering the binding of integrins to FN has been shown to affect cell phenotype. 
Garcia et al. demonstrated that the levels of bound α5β1 could regulate the 
switch between the proliferation and differentiation of murine myoblasts66. In 
another study, cells bound to substrates through α5β1 exert higher forces than if 
they were bound through αvβ367. In another study, blocking of α5β1 had an 
effect only on highly affine substrates where FN fragments presented both the 
RGD and PHSRN domain. In contrast, full-length FN and fragments containing 
only the RGD site sustained cell growth64.  
 
Aside from FN-integrin interactions, FN binds various growth factors including 
transforming growth factor beta (TGF)-β168 and hepatocyte growth 
factor (HGF)69 via growth factor binding domains. More specifically, the FNIII12-
14 is known as a binding site for several GFs. Martino et al. reported high affinity 
of platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), TGF-β, 
and neurotrophin families to engineered FNIII12-14 fragments70. Furthermore, 
VEGF has been shown to bind to this site. When the lysine and arginine of 
repeats 13 and 14 were mutated to serine, the binding of vascular endothelial 
growth factor (VEGF) was abolished. Interestingly, in the same study it was 
also demonstrated that the VEGF biological activity required the synergy of 
both cell-binding and VEGF-binding domains to promote the VEGF activity71.  
 
1.5 Stem cells 
Stem cells are characterised by prolonged self-renewal capacity and the ability 
to differentiate and commit to one or more cell lineages. Due to their inherent 
differentiation potential, they have long been recognised as an ideal cell source 
in developing cell-based therapies for the regeneration of injured or diseased 
tissues. Strategies combing the use of appropriate materials and stem cells are 
promising in treating several conditions72.  
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Stem cells reside in a specialised microenvironment, the niche, in which cells 
remain in a quiescent state or are activated in response to specific stimuli and 
differentiate73. Stem cells are broadly divided into embryonic stem cells (ESC), 
adult stem cells (ASC) and induced pluripotent stem cells (iPSCs). ESCs were 
first isolated from mice 74, 75 and are derived from the inner cell mass of the 
blastocyst. They are pluripotent cells since they can differentiate into all 
somatic germ layers (mesoderm, endoderm and ectoderm) 76, 77. ASCs are 
isolated from various tissues like bone marrow, adipose tissue, dental pulp and 
brain tissue. Their self-renewal capacity is similar to ESCs. However, their 
differentiation potential is more restricted and they give rise to a tissue-specific 
cell type78. More recently, the development of a new class of stem cells, iPSCs 
has been reported. iPSCs were first established by Takahashi and Yamada 
and they were obtained from genetically reprogramming adult cells into a de-
differentiated state. They are characterised by over expression of four key 
transcription factors; Oct3/4, Sox2, c-Myc, and Klf4 which were inserted into the 
nuclei of mouse fibroblasts by using a retroviral vector79. iPSCs exhibit similar 
characteristics to ESCs and have attracted much interest recently as a cell 
source because they do not have the limitations ESCs present. They also 
represent a promising source of autologous pluripotent stem cells obtained 
from adult tissues.  
 
1.5.1 Mesenchymal stem cells 
Mesenchymal stem cells (MSCs) are a population of ASCs. They were first 
isolated by Friedenstein from bone marrow, but since then they have been 
identified in several tissues of the body such as adipose and dermis tissue, 
umbilical cord, pancreas and muscles. Their regenerative potential was first 
indicated by Cohnheim who hypothesised that MSCs can contribute to wound 
healing by migrating through the blood stream to sites of injuries and 
differentiate into functional cells80. MSCs are fibroblastic multipotent stromal 
stem cells characterised by the ability to differentiate into cells of the 
mesodermal lineage (Figure 1.3)81. According to the International Society for 
Cellular Therapy (ISCT), MSCs meet the following criteria: they adhere to 
plastic, they express the markers CD105, CD73, CD90 and they lack the 
expression of CD45, CD34, CD14or CD11b, CD79a or CD19, HLA-DR, and 
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they can differentiate into osteoblasts, adipocytes, and chondrocytes82. It 
should be noted that MSC characterisation has been updated in 201683. MSCs 
are a potential cell source in stem cell-bases therapies due to their potent 
immunomodulatory properties84 and their intrinsic ability to differentiate into 
multiple cell linages.  
 
 
Figure 1.3. MSCs differentiation. The differentiation potential of MSCs into 
osteoblastic, chondrogenic, myogenic, smooth muscle, and neurogenic 
differentiation85. 
 
1.6 Stem cell differentiation  
Stem cells are found in numerous mammalian tissues and throughout life they 
produce a variety of functionally specialized mature cells while they maintain 
their renewal capacity. MSC differentiation is a two-step process; however, the 
exact mechanism is not fully understood86. It requires the switch of MSCs to 
lineage-specific progenitors and the subsequent maturation which indicates the 
progression from progenitor cells to specific cell types. This switch from 
renewal to committed state requires the cross-talk of a complex network of 
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signalling pathways. It is well known that the mitogen-activated protein kinases 
(MAPKs) play a fundamental role in converting diverse extracellular signals into 
cellular responses including cell proliferation, differentiation and apoptosis.  For 
example, MAPK-mediated integrin signalling is required for maintaining the 
stemness of epidermal SCs87.   
 
MAPKs are protein Ser/Thr kinases and typical MAPKs include at least four 
distinctly regulated groups: the extracellular-regulated kinases 1/2 (ERK1/2), c-
Jun N-terminal kinases 1-3 (JNK1-3), p38 proteins (p38α/β/γ/δ) and ERK5 and 
are activated by specific MAPKs. There are additional MAPKs such as ERK3/4, 
ERK7/8, and nemo-like kinase (NLK); however, their enzymatic activity is 
incompletely understood88. The most studied are the ERK1/2, JNKs, and p38 
isoforms MAPKs. Essentially they consist of a linear array of three kinases 
(Figure 1.4).  
 
 
Figure 1.4. The MAPK signalling pathway. Redrawn and adapted89. 
 
They are activated by a wide variety of extracellular stimuli such as GFs, 
cytokines, mitogens, and stress. MAP3Ks are often phosphorylated as a result 
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of their interaction with a small (guanosine triphosphate) GTP-binding protein. 
This is followed by the phosphorylation of Ser/Thr residues on MAP2Ks which 
in turn activate MAPKs through phosphorylation on Thr and Tyr residues. 
MAPKs translocate directly into the nucleus or activate additional kinases in the 
cytoplasm90-92.  
 
1.6.1 ERK pathway 
The ERK cascade, comprising of Raf, MEK and ERK, is the most extensively 
investigated. Signal transduction is initiated when an extracellular signal binds 
to a cell specific receptor tyrosine kinase (RTK). Upon binding, the inactive 
monomers dimerise promoting autophosphorylation of Tyr residues in the 
intracellular domain and activation93. The phosphorylated residues act as 
binding sites for proteins containing Src homology 2 (SH2) or phosphotyrosine 
binding (PTB) domains, including the adaptor proteins Shc and the growth 
factor receptor-bound protein 2 (Grbp2). Grbp2 or Shc interact with the son of 
sevenless (SOS) which is recruited from the cytosol to the plasma membrane. 
SOS contributes to the exchange of guanosine diphosphate (GDP) bound to 
Ras by (GTP) 94, 95. This event positively regulates Ras which in turn activates 
Raf. All Raf members can activate MEK1/2 which subsequently activates 
ERK1/2 through phosphorylation on the threonine/tyrosine residues96. This 
event results in the phosphorylation of a wide range of targets, such as 
nuclear transcription factors. Cell response is determined by the activation of 
a specific set of factors97.  
 
The control of ERK pathway is subjected to both positive and negative 
regulatory events which ultimately affect its biological activity. For example, 
stimulation of PC-12 cells with nerve growth factor (NGF) or epidermal 
growth factor (EGF) resulted in neuronal differentiation or proliferation 
respectively. These results were associated with the transient MAP2K 
activation by EGF as opposed to the sustained activation by NGF98. ERK is 
subjected to spatial regulation as well which enhances the complexity of this 
pathway. The subcellular localisation of activated ERK can affect its 
signalling activity99. 
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ERK signalling is involved in cell cycle progression100, 101 and proliferation102. It 
has been also suggested that FAK-mediated activation of ERK promotes cell 
survival103. Another work has shown that FN stimulated ERK pathway via 
FAK/Src activation104. Integrin-ECM interactions have been shown to 
regulate the phosphorylation and activation of the ERK pathway. For 
example, diminished ERK activation was shown when endothelial cells were 
treated with integrin αvβ3 antagonists105. ERK signaling is also involved in the 
pluripotency maintenance and in regulation of stem cell differentiation. It has 
been reported that inhibition of ERK activity obstructed the differentiation of 
ESCs106. However, other studies showed that ERK activation may be 
dispensable for propagation of undifferentiated mouse ESCs107.  
 
1.7 Osteogenic differentiation of MSCs 
MSCs are a promising cell source for cell-based TE strategies. In particular, the 
osteogenic capacity of MSCs in vitro has been the focus of a large body of 
research. Bone formation by osteoblasts and resorption by osteoclasts is a 
dynamic and highly regulated process which ultimately leads to the formation of 
bone tissue. Osteoclasts are derived from hematopoietic stem cell precursors 
(HSCs) along the myeloid differentiation lineage. Osteoblasts originate from 
bone marrow MSCs108.  
 
The progression of MSCs towards osteogenic differentiation is divided in vitro 
into three stages. The initial stage which lasts from 1 to 4 days is characterised 
by cell proliferation and expression of osteoblast markers. This is followed  by 
loss of cell expansion from days 5 to 14 and the synthesis of ECM, mainly 
collagen type I109. ECM maturation follows, marked by an increase in alkaline 
phosphate activity (ALP). ALP is a metalloenzyme expressed in many tissues 
such as kidney, bone and liver and is considered an early osteoblast marker. 
By using antisense RNA approaches, knockout mice and small interfering 
RNAs (siRNAs), absence of osteoblasts was indicated as well as defects and 
inhibition of matrix mineralisation110-112. In the third stage from days 14 to 28, 
the level of ALP decreases and an upregulation in osteocalcin (OCN) and 
osteopontin (OPN) expression follows. This event leads to the deposition of 
calcium and phosphate. OCN is the most abundant noncollagenous bone 
matrix-bound protein and is produced by osteoblasts. It has been suggested 
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that OCN binds to the hydroxyapatite (HA) mineral component of bone 113. 
However, its precise function in bone formation is not fully understood. OPN is 
a soluble protein and can function extracellularly through interactions with 
various integrins. Its increased expression in MSCs has been implicated in 
numerous processes including osteogenic differentiation114   
 
Recently the role of integrins in osteogenic differentiation has been 
demonstrated in several studies. Martino et al. showed that the binding affinity 
of α5β1 to FN fragments containing both the RGD and PHSRN sequence 
influenced the osteogenic differentiation of human MSCs (hMSCs)64. Other 
studies have shown that this cell receptor upregulated the expression of 
osteogenic markers. Increased expression of the α5 subunit has been found in 
undifferentiated dental bud stem cells (DBSCs) and formed a complex with β1 
when cells differentiated115.  
 
1.7.1 RUNX2 
RUNX2, also known as Cbfa1, is a major regulator of osteoblast differentiation. 
RUNX2 is a Runt-related transcription factor and contains the DNA binding 
domain runt. Its critical role in osteoblast differentiation and mineralisation 
during bone formation has been demonstrated in several studies. RUNX2 
deficient mice were characterised by absence of ossification 116, 117. Moreover, 
accelerated bone repair in a critical-sized defects was demonstrated when 
Runx2-modified MSCs were used118, while enhanced bone accumulation was 
found in developing mice upon ERK-MAPK activation through changes in the 
RUNX2 posphorylation119.  In addition, upregulation of RUNX2 induced MSC 
differentiation into immature osteoblasts while it inhibits adipogenic 
differentiation120. 
 
During osteoblast differentiation, most signalling pathways already discussed 
are targeted at RUNX2. Activation of MAPK resulted in increased RUNX2 
phosphorylation121, while introduction of specific mutations at RUNX2 
phosphorylation sites led to inhibited MAPK activation and to reduced 
osteoblast-specific gene expression122. Similarly, ERK1/2 activation was shown 
to control RUNX2 activation which resulted in osteoblast differentiation123. FAK-
mediated activation of ERK1/2 and p38 phosphorylated RUNX2 inducing 
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increased osteogenic differentiation of immature osteoblast-like cells124. 
RUNX2 has been also shown to upregulate the expression of osteogenic 
marker genes such as ALP, OCN and OPN125. However, downregulation of 
RUNX2 expression is required for differentiation into mature osteoblasts 
underlying its role in directing pluripotent mesenchymal cells to the osteoblast 
lineage126.  
 
1.7.2 Osteogenesis and integrins 
The role of cell adhesion in guiding stem cell fate has gained significant 
interest. FAK has been shown to phosphorylate and activate ERK1/2 
contributing to bone formation127 or expression of RUNX2 in hMSCs128. 
Inhibition of FAK disrupted the activation of MAPK pathway causing decreased 
expression of osteogenic differentiation markers129. The integrins αvβ3 and α5β1 
have been implicated in stem cell osteogenic differentiation too; however, their 
role is not fully understood. In vivo and in vitro expression of β1 and β5 subunits 
in osteoblasts from human bone has been reported130, 131. In addition, 
interaction with increased specificity of α5β1 integrin with FN fragments resulted 
in upregulated ALP activity and osteogenic gene expression in MSCs64. In line 
with these results, upregulated osteoblast gene expression and osteogenic 
differentiation of MSC was observed in vitro and in vivo with induced 
expression of α5β1 integrin132. Improved osseointegration was also reported 
when titanium implants specific to α5β1 integrin were implanted in rats133. 
Similarly, decreased levels of α5β1 were associated with bone loss134.  
 
The role of αvβ3 in osteogenesis remains controversial. Blocking antibodies 
against αvβ3 and RGD-containing peptides had a negative impact on bone 
resorption135, 136. In addition, osteogenic differentiation of hMSCs was promoted 
on monolayers functionalized with an RGD peptide with high affinity with the 
αvβ3 integrin137. In contrast, decreased osteoblastic differentiation has been 
reported in a murine osteoblastic cell line overexpressing αvβ3138. Blocking αvβ3 
binding also increased the ratio of ALP positive MSCs139. Other integrins have 
been implicated in bone formation as well. Administration of a peptidomimetic 
ligand of activated α4β1 conjugated with a bone seeking component and ectopic 
expression of α4β1 on MSCs increased MSC bone homing140, 141. In addition, 
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knocking down the α2 and α11 subunits in hMSCs cultured on collagen I 
inhibited the deposition of mineralized matrix142. 
 
1.8 Bone morphogenetic proteins 
Growth factors (GFs) are proteins which regulate fundamental cell functions 
such cell proliferation and embryonic development. GFs are secreted by cells 
into the ECM and bind to specific receptors on the cell surface in order to exert 
their biological functions in an autocrine, paracrine or endocrine way. Bone 
morphogenetic proteins (BMPs) belong to the TGF-β superfamily and around 
20 BMP ligands have been identified. At the cellular level, BMPs regulate many 
processes like apoptosis, differentiation and migration143, 144.  They are dimeric 
molecules and are synthesised as inactive peptide precursors. They consist of 
an N-terminal signal peptide, a non-conserved prodomain for folding and 
secretion, and a mature peptide located at the C-terminal145. They can be 
divided into four categories according to their structural homology and function: 
1) BMPs -2 and -4 2) BMP -5, -6, -7, -8a, and -8b; 3) BMP -9, -10, and 4) BMP 
-12, -13 and -14146. Different members affect MSCs differentiation in a dose-
dependent way. For instance, low doses of BMP-2 induced adipogenic 
differentiation of embryonic stem cells whereas chondrogenic and osteogenic 
differentiation was triggered at higher doses147.  
Name Main function 
BMP1 Induces cartilage formation. 
BMP2 Plays a role in bone and cartilage formation. Also involved in 
osteoblast differentiation. 
BMP4 Induces bone and cartilage formation. Also involved in tooth 
development, limp formation and fracture repair.  
BMP5 Induces cartilage formation. 
BMP6 Involved in the regulation of bone and cartilage formation. Also 
involved in the regulation of the number of HSCs. 
BMP7 Induces bone and cartilage formation. Plays a role in renal and 
kidney development. 
BMP8a Play a role in the development of the reproductive system.  
BMP8b Involved in thermogenesis in brown adipose tissue.  
BMP9 Involved in angiogenesis.  
BMP10 Plays a role in maintaining cardiac growth. 
BMP11 Involved in skeletal patterning during development. 
BMP12 Involved in the joint and ligament formation. 
BMP13 Inhibits bone formation. 
BMP14 Involved bone and joint formation. 
Table 1.1. Biological role of BMP members.  
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The osteoinductive activity of bone morphogenetic proteins 2 (BMP-2) was first 
characterised in 1960s148 and since then several growth factors have been 
used to induce bone formation. Even though BMPs were initially identified as 
components which induce ectopic bone formation, some BMPs act as inhibitors 
of bone formation or they contribute to the maintenance of several tissues. For 
example, BMP-3 is a negative regulator of bone density, and BMP-13 is a 
strong inhibitor of bone formation149. BMP-4 and BMP-7 have been reported to 
stimulate adipogenesis150, 151.BMP-2, BMP-4, BMP-7 and BMP-9 are the most 
well-known osteoinductive BMPs 152, 153. BMP-2 and its involvement in 
osteogenic differentiation is the focus of a large body of research. Katagiri et al. 
demonstrated that BMP-2 inhibited myotube formation of C2C12 cells and 
initiated the production of osteogenic markers154. Another study showed that 
transduction of MSCs with BMP-2 enhanced osteogenesis155. Currently, BMP-2 
has become the most powerful osteoinductive growth factor. Recombinant 
BMP-2 in combination with a collagen sponge is used for the treatment of open 
long cone fractures156 
 
1.8.1 BMP/TGF-β pathway 
The TGF-β superfamily contains more than 30 members, including BMPs, 
TGF-βs, activins, and other factors157. The BMP/TGF-β signalling pathway is 
widely involved in cell proliferation, differentiation, and apoptosis. It also has a 
dual role in regulating cell differentiation. For example, BMP-2 has been 
identified as a regulator of both osteogenic and adipogenic differentiation of 
MSCs and ESCs147, 158. Similarly, a study analysing 14 types of BMPs 
demonstrated that most BMPs exhibited distinct abilities to regulate expression 
of makers of four common lineages derived from MSCs16.  
 
The BMP/TGF-β pathway transmits signals into the cytoplasm via the activation 
of two types of serine/threonine kinase receptors. BMPs start signalling through 
the receptors BMPRI and BMPRII, which consist of a short extracellular 
domain, a single transmembrane domain, and an intracellular domain with 
serine/threonine kinase activity. There are seven BMPRIs for the TGF-β 
ligands, three of which bind BMPs: BMPRIA, BMPRIB, and type IA activin 
receptor. There are also four BMPRIIs for the TGF-β ligands, three of which 
interact with BMPs: BMPRIIB, ACTRIIA, and ACTIIB receptors159. Initially, 
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ligands bind with high affinity to BMPRI followed by heterodimerisation with 
BMPRII. This allows BMPRII to phosphorylate and activate the kinase activity 
of BMPRI160. The way the heteromeric complex is formed may vary and 
depends on the type of BMP. BMPRI organises into a receptor complex with 
BMPRII or recruits BMPRII. For example, either BMP2 or BMP4 preferentially 
interacts with BMPRI receptors and recruit the BMPRII receptors161. However, 
BMP6 and BMP7 bind BMPRII receptors and recruit type I receptors162. 
Depending on the oligomerisation pattern for signal transduction, a different 
pathways might be activated163.The signal transduction is mediated via both the 
canonical mothers against decapentaplegic homolog (Smad)-dependent 
pathways and non-canonical Smad-independent signaling pathways (Figure 
1.5). 
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Figure 1.5. TGF-β canonical and non-canonical signalling pathway. Redrawn 
and adapted157. 
 
1.8.2 Canonical pathway  
The canonical pathway is triggered when BMP/TGF-βs bind to the 
corresponding surface receptor kinase which is activated through 
oligomerisaition and phosphorylation. Signals are transmitted via the human 
Smad proteins. Smads are intracellular proteins and they generally consist of 
three distinct domains: an N-terminal mad-homology 1 (MH1) domain that 
carries nuclear localization signal and a DNA-binding region, a C-terminal MH2 
domain that binds to BMPRI to mediate Smad-dependent transcriptional 
activity, and a proline-rich linker domain that separates the MH1 and MH2 
domains164, 165. Activation of the type I receptor results in the phosphorylation 
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of the receptor-regulated cytoplasmic Smads proteins (R-Smad) at the C-
terminal serine residues. R-Smads regulate TGF-β signalling in a pathway-
specific manner. SMAD 2 and 3 are phosphorylated by TGF-β whereas Smad 
1, 5 and 8 are usually activated by BMPs166, 167. This event is followed by 
disassociation of phosphorylated R-Smad from the BMPRs and it subsequently 
interacts with the co-mediator Smad (C-Smad), Smad4 forming a complex. The 
complex translocates to the nucleus where it binds to specific promoters and 
regulates the transcription of target gene expression168. Smads can control cell 
response in various ways. For example, FN coated surfaces immobilised with 
BMP-2 triggered the phosphorylation of Smad1/5 resulting in increased cell 
migration169. 
 
1.8.3 Noncanonical pathway 
Besides Smad-mediated transcription, TFG-β/BMP-2 pathway activates other 
non-canonical signalling pathways. The non-canonical pathway includes mainly 
molecules which belong to MAPK family; ERK, JNK and p38 MAPK kinase 
pathways170. For example, rapid activation of ERK through TFG-β was reported 
in epithelial171 and in breast cancer cells172. Noncanonical pathways have been 
shown to transmit signals in a Smad-dependent way173. However, other studies 
suggest a Smad-independent signalling as well. For example, Smad-
independent JNK activation has been documented174.  
 
BMP/TGF-β pathway is involved in RUNX2 regulation. More specifically, BMP-
2 has been shown to upregulate RUNX2 via Smads 1,3, and 5175, 176. By 
introducing mutations on RUNX2, it was found that the activated SMAD 
complex interacts with the C-terminal of RUNX2 inducing the expression of 
osteogenic genes177. Similar results were found in other studies suggesting that 
the formation of RUNX2-SMAD interactions are essential in signal transduction 
that modulate osteogenic differentiation175, 178.  
 
1.9 Biomaterials 
TE attempts to mimic the physical, chemical and topographical properties of the 
ECM in order to direct a desired cell response in a controlled environment. A 
myriad of biomaterials has been used in vivo for biomedical applications. 
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Biomaterials are designed not only to interact with the surrounding environment 
but also to provide informative signals and allow cells to interact with them, thus 
guiding their fate179. Despite their diversity, they have to fulfil certain 
requirements. Biomaterials are designed to be biocompatible and 
biodegradable and their properties are specific to the tissue of interest180. 
 
There is a wide range of biomaterials depending on the applications they are 
used for and the cell type. Broadly, they can be classified as synthetic (such as 
poly(L-lactic acid (PLLA), poly(glycolic acid) (PGA), poly(caprolactone) (PCL)), 
and natural (such as collagen, gelatin, fibrin, chitosan)181, 182. They can be also 
classified based on their structure and function, for example they can be porous 
scaffolds or they might be used for drug delivery183, 184. Natural polymers were 
the first biodegradable materials to be used in clinical applications due to their 
improved interactions with cells. Common synthetic polymers present 
advantages too due to their manufacturing process and their reproducibility. 
However, they might lack the chemical or topographical cues which cells 
recognise and respond to.  
 
Even though the ECM is a highly complex structure, several strategies, such as 
surface modification, are implemented to recapitulate its characteristics. For 
example, the RGD and GFOGER (Gly-Phe-Hyp-Gly-Glu-Arg) adhesion motif 
have been used extensively to coat biomaterial surfaces and enhance their 
bioactivity185. In such systems, the ligand type, its concentration and spatial 
distribution are highly defined and can control cell response. For example, 
varying the spacing of the RGD ligand affects integrin clustering and cell 
spreading186 as well as lineage commitment of MSCs187. 
 
1.9.1 Surface properties  
In order to further investigate the clinical potential of stem cells, a plethora of 
biomaterials has been used. Based on their composition and structure, 
biomaterials can provide physical and chemical signals to recreate a 
physiological niche. It is well established that manipulation of the topography, 
chemistry, stiffness and dimensionality of the substrate can instruct stem cell 
fate decisions. Using microfabrication technologies, surfaces with various 
topographies in terms of size, type and distribution, have been produced to 
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induce specific cell responses in vitro. It is well documented that micro- and 
nanoscale feature can affect cell adhesion and differentiation. For example, 
substrates with micrometre-scale islands of ECM with defined shape and size 
induced cells to selectively adhere on these regions and adopt their 
geometry188. Moreover, the use of nanopits at a specific arrangement was 
shown to maintain multipotency of MSC189 or to induce an increase in the 
expression of osteogenic markers in MSCs indicating osteogenic 
differentiation190, 191. In another study, MSC differentiation towards specific 
lineages depended on the size of groove/ridge structures192. It has been also 
demonstrated that MSC differentiation can be influenced by the mechanical 
properties of the underlying matrix. Engler et al. showed that hMSCs undergo 
osteogenic differentiation when plated onto stiff matrices whereas softer 
matrices generated neuronal and myogenic differentiation193. Similarly, MSC 
commitment towards chondrogenic or adipogenic differentiation could be 
controlled by varying the stiffness of polymer surfaces without exogenous 
growth factor194. 
 
Taking into consideration that stem cells reside in a 3D environment in vivo, 
studies have explored their behaviour in a more physiological-like context. For 
example, MSCs were embedded into synthetic 3D matrices in order to 
characterise their osteogenic commitment in relation to various stiffness. Such 
variations however were not followed by changes in cell morphology as 
observed in 2D studies195. Chemical modification of biomaterials has been 
investigated as well. Self-assembled monolayers (SAMs) with well-defined 
chemistries changed the structure and activity of adsorbed FN196 and induced 
osteogenic differentiation of immature osteoblast-like cells197. In addition, 
control of MSCs towards adipogenic and osteogenic differentiation has been 
achieved by using small-molecule chemical groups tethered to polyethylene 
glycol (PEG) hydrogels198. 
 
1.9.2 Protein adsorption 
The first event that rapidly occurs upon contact of a biomaterial with biological 
fluids in vivo or in vitro is protein adsorption on the surface. Initial protein 
adsorption occurs spotnaneously199 and is driven by short- and long-range 
forces including electrostatic, hydrophobic, hydrogen bonding and van der 
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Waals interactions200. The composition of the adsorbed protein layer changes 
over time due to the competitive displacement of faster diffusing molecules by 
proteins with higher affinity proteins for the surface201. 
 
For most cell types, adhesion to the ECM is essential for survival202 and cell 
morphology203, 204. Therefore, the ability of biomaterials to adsorb proteins 
determines whether they can support cell adhesion and spread. For example, 
FN coatings of titanium disks and glass supported the growth and spread of 
osteoblasts205 while it enhanced bone-derived cell adhesion on tissue culture 
polystyrene206. In addition, the structure and distribution of the adsorbed protein 
can facilitate the availability of integrin binding sites which affects protein 
activity207 and cell attachment, differentiation and migration208-210. Cell 
processes depend on adsorbed proteins as well. The expression of osteogenic 
markers in MSCs has been found to be dependent on the density of adsorbed 
FN on PCL211. Beyond initial attachment, cell-biomaterials interactions are 
dynamic. As cells spread, forces are generated in the actin cytoskeleton and 
are transmitted to the ECM. On biomaterial surfaces, these forces might be 
sufficient to reorganise and remove adsorbed proteins that cells are anchored 
to212.  
 
The characteristics of the substrate (wettability, surface energy, charge, 
topography), the protein (affinity, size, charge, concentration) and the 
environment (solvent, pH, temperature) influence protein adsorption on the 
biomaterial interface200, 213-217. For example, FN and VN were reported to 
adsorbed at a higher rate on hydroxyapatite, compared to titanium and 
stainless steel, resulting in an increase in osteoblast attachment218. Generally, 
hydrophobic surfaces tend to adsorb more protein than hydrophilic surfaces219. 
However, protein adsorption also depends on the surface charge. Higher 
plasma protein adsorption was observed with higher surface charge density of 
nanoparticles214.  
 
1.9.3 Biomaterials and growth factors 
ECM controls cell behaviour through the ability to locally bind and release 
soluble macromolecules, such as GFs which have a strong effect in regulating 
cell responses. GFs display some limitations due to their low protein stability, 
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short circulating half-life, rapid rate of cellular internalization, and localized 
tissue activity as a mechanism for spatial and temporal control220. However, 
due to their potential as therapeutic tools, a lot of effort has been dedicated to 
design biomaterials that bind and release GFs using ECM components. The 
focus of such approaches is to locally deliver controlled and sustained low 
doses of GF220, 221. GF delivery can be designed by both encapsulation and 
surface immobilisation approaches222, 223. Another approach is to functionalise 
the material surface with specific GF binding sites. For example, biomaterials 
have been modified with heparin which contain multiple GF binding domains224.  
 
1.9.3.1 Bone tissue engineering 
During bone formation, BMPs are involved in the recruitment and differentiation 
of stem cells into bone tissue. Bone TE (BTE) combines the use of 
osteoinductive scaffolds, osteogenic cells which either initiate bone formation or 
induce resident cells to do so and osteoinductive GFs to trigger bone formation. 
In a GF-based treatment, the balance between release and retention of such 
GFs is critical as they can trigger adverse clinical effects such as 
inflammation225, 226. A common, less invasive, strategy is to use injectable GFs. 
However, several days of stimulation and high doses are required due to BMP 
short half-life and rapid clearance. This can cause side effects such as ectopic 
ossification220.  
 
Incorporation of GFs in synthetic materials include covalent227 or non-
covalent228 binding. For example, physical or chemical entrapment in 
biomaterials provides a way to present GFs in a controlled spatiotemporal 
manner229. In this approach, release of GFs can be achieved through diffusion, 
scaffold degradation or through the affinity of biomolecules to the surface230. 
Different types of ECM proteins have also the potential to be used in TBE. 
Such proteins or peptides do not only induce osteogenesis, but they are also 
involved in cell adhesion and proliferation. For example, enhanced osteogenic 
expression in MSC was observed when RGD was immobilised on titanium 
oxide nanotubes231. Although the RGD motif can promote cell adhesion through 
α5β1, the PHSRN is required for stable binding. In line with this, osteogenic 
differentiation of osteoblasts was increased in alginates which combined both 
RGD and PHSRN sequences232.   
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1.9.4 Project aims 
Stem cells reside in vivo in the niche where they receive and integrate multiple 
cues which ultimately regulate cell behaviour. However, cells lose the 
expression of their markers outside of their niche compromising their 
differentiation potential233. Engineering biomaterials with defined properties is 
essential in recapitulating to a degree the physiological properties of the cell 
microenvironment and direct stem cell fate outside of their niche. A common 
approach for surface functionalization is coating with adhesive peptides such 
as the RGD motif186, 187, 234. Despite the versatility of such surfaces, they 
display limited biological activity. For example, they have a lower adhesion 
potential than full-length ECM proteins due to lack of synergistic domains. The 
use of ECM molecules provides an alternative way to mimic the complexity of 
cell-ECM interactions. Apart from integrin binding sites, they also contain sites 
for protein-protein interactions and GF binding.  
 
Among the ECM proteins, FN is an interesting protein to study. It undergoes 
structural changes and can be stretched by several folds via cell-generated 
traction forces leading to the unfolding of cryptic binding sites235, 236. 
Ellipsometric measurements showed a more extended FN organization on 
hydrophobic than on hydrophilic titanium alloy237. Atomic force microscopy has 
also demonstrated a more rigid and elongated FN conformation on hydrophobic 
surfaces238, 239. Roughness and nanoscale surface topography have been 
shown to influence FN adsorption too240, 241. 
 
Past studies have investigated how the polymer surfaces poly(ethyl acrylate), 
PEA and poly(methyl acrylate), PMA affect FN conformation. PEA differs from 
PMA in methyl group in the side chain. Although these polymers are chemically 
similar, two distinct conformation of FN are observed upon adsorption. FN 
adopts a network-like conformation on PEA. In contrast, globular aggregates 
are formed on PMA (Figure 1.6). The differential distribution of FN leads to 
changes in its biological activity for example in the availability of the integrin 
binding domain (FNIII9–10)242, the PHSRN domain243 and the heparin II binding 
domain (FNIII12-14)244. 
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Figure 1.6. Chemical structure of PEA and PMA. AFM height images showing 
FN distribution on PEA and PMA.  
  
The main objectives of this thesis is: 
• To explore how a differential conformation of FN can be achieved by 
using a series of copolymers with specific ratios of EA/MA (100/0, 
70/30, 50/50, 30/70, 0/100).  
• To assess whether such conformation changes affect the availability of 
binding domains and BMP-2 binding.  
• To use this system in order to study hMSCs fate including adhesion, 
morphology and osteogenic differentiation.  
• To develop a method in order to isolate focal adhesions on PEA and 
PMA and to further analyse their protein composition.  
• To characterise the cell migratory behaviour on FN-coated PEA and 
PMA.  
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2. Surface characterisation 
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2.1 Introduction 
This chapter describes how the degree of FN fibrillogenesis can be modulated 
by the series of copolymers. Fluorescence microscopy and FRET spectroscopy 
showed that FN structure changes from a compact form when initially bound to 
cells to an extended conformation. Distinct degrees of FN extension were also 
observed during this process245. Time-lapse AFM with fluorescence microscopy 
demonstrated a step-like pattern of early FN extension which was divided into 
three stages depending on the fibril length246. In addition, FN conformation has 
been shown to affect growth factor binding244. 
 
We seek to understand how the EA/MA ratio impacts FN organisation and 
whether intermediate degrees of FN fibrillogenesis are obtained. We also 
explore whether such conformation changes affect the exposure of important 
binding domains of FN. To do so, surfaces were characterised in terms of 
wettability as well as FN adsorption. AFM was used to investigate FN 
conformation and domain availability was documented by carrying out 
antibody-based methods. As part of surface characterisation, the BMP-2 
adsorption on the FN-coated copolymers was investigated too.    
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2.2 Materials and methods 
2.2.1 Materials 
List of reagents 
Toluene……………………………………………………… Alfa Aesar 
Ethyl acrylate……………………………………………….. Sigma-Aldrich 
Methyl acrylate……………………………………………… Sigma-Aldrich 
Benzoin.……………………………………………………... Sigma 
Absolute ethanol……………………………………………. VWR Chemical 
Dulbecco’s phosphate buffered saline (DPBS)…………. Life Technologies 
Formaldehyde………………………………………………. Fisher Scientific 
Tween 20®…………………………………………………. Sigma 
Bovine serum albumin (BSA)……………………….......... Roche/Sigma 
Human plasma fibronectin………………………………… Sigma-Aldrich 
Mouse monoclonal HFN7.1 antibody…………………….. DSHB 
Mouse monoclonal P5F3 antibody……………………….. Santa Cruz Biotechnology 
Mouse monoclonal mAb1937 antibody………………….. Merck-Millipore 
Horseradish peroxidase (HRP) anti-mouse 
antibody……………………………………………………... 
 
Invitrogen 
Substrate solution………………………………................ R&D Systems 
Stop solution………………………………………………... R&D Systems 
Odyssey blocking solution………………………………… LI-COR® 
IRDye® 800CW anti-mouse antibody……………………. LI-COR® 
Micro BCA™ protein assay kit……………………………. ThermoFisher Scientific 
Human BMP-2 produced in CHO………………………… R&D Systems  
Human BMP-2 DuoSet ELISA……………………………. R&D Systems  
Anti-BMP-2/BMP-4 antibody……………………………… Santa Cruz Biotechnology 
Gold particle–conjugated anti-rabbit 
antibody…………………………....................................... 
 
Aurion 
 
2.2.2 Samples preparation 
PEA, PMA bulk polymers as well as bulk copolymers (70%EA/30%MA, 
50%EA/50%MA, 30%EA/70%PMA) were synthesised by radical polymerisation 
of ethyl acrylate and methyl acrylate initiated by benzoin as the photoinitiator at 
1 wt%. Polymer solutions were prepared by dissolving using toluene with 4% 
w/v PEA, 4.5% w/v EA70/MA30, 5% w/v EA50/MA50, 5.5% w/v EA30/MA70 
and 6% w/v PMA. Glass coverslips (12 mm diameter) were sonicated in 
ethanol for 30 min. Next, they were rinsed with ethanol and dried at 60 oC. 
Solutions (100 µl) were deposited onto the glass coverslips and were spin 
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coated at a velocity of 3000 rpm with an acceleration of 3000 rpm/sec for 30 
sec. Samples were dried at 60oC in vacuum for 2 h. 
 
2.2.3 Protein coating 
Human plasma FN solutions were prepared in Dulbecco’s phosphate buffered 
saline (DPBS) at 20 µg/ml. Unless otherwise stated, samples were coated with 
FN solutions for 1h. For BMP-2 coating, FN-coated surfaces as well as 
samples without adsorbed FN were incubated with 1% w/v BSA/PBS for 30 
minutes. Next, samples were incubated with BMP-2 for 1 h at 25 ng/mL or 100 
ng/mL in DPBS. Coating at 25 ng/mL was carried out in ELISA for the 
quantification of BMP-2 adsorption and for characterising ALP expression. 
Coating at 100 ng/mL was carried out to characterise RUNX2 and OCN 
expression.  
 
2.2.4 Water contact angle  
Water contact angle (WCA, θ) measurements on the surfaces were carried out 
before and after FN adsorption. Static contact angle (SCA), advancing contact 
angle (ACA) and receding contact angle (RCA) were measured (Figure 2.1).  
 
 
Figure 2.1. Representative pictures of SCA, ACA and RCA on FN-coated PEA. 
 
For the SCA, a 3 µl water drop was deposited onto the surface and images 
were recorded for 30 sec at 20 frames/sec while measuring the angle of the 
drop with the polymer surface. SCA was then defined by fitting Young-Laplace 
equation around the droplet. The ACA was determined when the SCA 
expanded in volume by adding 10 µl of water at a rate of 0.1 µl/sec resulting in 
increase of the baseline. Images were recorded for 80 sec at 5 frames/sec. 
RCA was determined by removing 13 µl of water at a rate of 0.1 µl/sec resulting 
in the contraction of the water drop until all water was removed. Images were 
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recorded for 130 sec at 5 frames/sec. RCA was defined at the point at which 
the baseline decreased. Measurements were carried out using a Theta optical 
tensiometer (Biolin Scientific). Three samples were used and three different 
measurements were recorded on each sample. High contrast images of water 
droplets were recorded and the OneAttension software was used to determine 
droplet shape. 
 
2.2.5 Atomic force microscopy 
2.2.5.1 Tapping mode 
Samples were coated with FN at 20 µg/ml for 10 minutes. They were washed 
twice with PBS and then with milliQ water and they were dried with N2 flow. To 
visualise FN distribution and conformation, several areas on the samples were 
scanned. Atomic force microscopy (AFM; Nanowizard 3 from JPK) was 
conducted in tapping mode using cantilevers with force constant of 3 N/m, a 
resonance frequency of 75 kHz and a pyramidal tip with an 8 nm radius (MPP-
21220, Bruker). To quantitatively assess FN distribution, images were exported 
to Fiji and the skeletonize plugin was applied. Next, the fractal dimension (FD) 
was measured using the FracLac plugin.  
 
2.2.5.2 Force spectroscopy 
Samples were incubated with milliQ water overnight. For force spectroscopy 
measurements, 5 µm silica beads were attached on a tipless silicon cantilever 
with a force constant of about 3 N/m. To do so, a solution containing the beads 
was mixed with ethanol (1:50). Next, the solution was sonicated for 10 min and 
it was deposited onto a glass slide. Beads were spread using N2 flow. Epoxy 
glue was deposited onto the other side of the slide. To embed the beads, the 
cantilever was moved manually until its end was dipped into the glue. The 
cantilever was then lifted and a bead was attached to its glued end. 
 
For the force spectroscopy measurements, the cantilever deflection was 
calibrated. The first step involved converting a certain measured change in 
photodetector voltage to the distance in nanometres (nm) the cantilever 
deflects. This conversion factor is usually called the sensitivity. To do so, a 
force-distance curve on a clean glass slide was performed. The repulsive 
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contact region of the curve was linear and it was used to determine the 
sensitivity. The spring constant was then measured using the thermal noise 
method and used to convert the cantilever deflection into a force using Hooke’s 
law.  Force spectroscopy measurements were then carried out using a set-
point of 100 nN, a zeta length of 10 μm, and a velocity of 2.5 µm/s at room 
temperature. Force mapping was carried out. Four areas (50 μm x 50 μm) were 
chosen on each surface. In every map, 25 force curves were generated. 
Results were analyzed using the JPK processing software and force curves 
were fitted with a Hertz model at 50 nm indentation. 
 
2.2.6 Micro-bicinchoninic acid protein quantification 
BCA assay was performed for the colorimetric detection and quantification of 
the protein. Samples were coated with FN at 20 µg/ml for 1 h. Next, 150 µl of 
supernatant was collected and it was loaded in a 96-well plate. A set of protein 
standards was prepared by using albumin (diluted in PBS) starting at 40 µg/mL 
and a 4-point serial dilution in duplicate was prepared including a blank 
standard (PBS). FN solution used for the coating was used as internal 
standard. Standards together with the FN solution used for coating were also 
loaded in the 96-well plate. In addition, the working reagent was prepared by 
mixing 25 parts of reagent A, 24 parts of reagent B and 1 part of reagent C. 
Next, BCA working reagent was added and the plate was incubated at 37°C for 
2 hours. BCA is used as the detection reagent for Cu+1 which is formed when 
Cu+2 is reduced by protein in an alkaline environment. After that, the 
absorbance was measured at 562 nm on a plate reader (Tecan NanoQuant 
Infinite M200 Pro).  
 
To analyse the results, the average of the adsorption reading (at 562 nm) of the 
blank standard was subtracted from the readings (at 562 nm) of all the other 
individual standards and unknown sample replicates. Next, a standard curve 
was prepared by plotting the average of each albumin standard (after 
correction) against its concentration in μg/ml. The best-fit curve generated by 
regression analysis was used to determine the protein concentration of each 
unknown sample and of the FN solution used for substrate coating. To quantify 
the amount of FN remained on the surface, the amount of protein of the 
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unknown samples was subtracted from the amount of FN contained in the initial 
coating solution.    
 
2.2.7 Enzyme-linked immunosorbent assay 
FN coated samples were incubated with 1% v/v BSA/PBS for 30 minutes. 
Primary antibody was prepared in 1% v/v BSA/PBS with HFN7.1. Samples 
were incubated for 1 hour followed by washes with 0.5% v/v Tween20/PBS in 
agitation. Anti-mouse HRP conjugated secondary antibody was prepared in 1% 
v/v BSA/PBS. Samples were incubated for 1 hour. After the washing steps, 
samples were transferred to a new plate and incubated with substrate in dark. 
After 20 minutes, a stop solution was added to the wells. The solution was 
transferred to a 96 well-plate and the absorbance was measured at 450 nm 
and 540 nm on a plate reader (Tecan NanoQuant Infinite M200 Pro). For 
results analysis, the 540-nm readings were subtracted from the respective 450-
nm readings to correct for optical imperfections; next, the average of each 
sample was plotted.  
 
2.2.8 Quantification of BMP-2 adsorption 
A 96-well plate was incubated with capture antibody specific for BMP-2 
overnight. Next, antibody solution was removed and the wells were washed 
with wash buffer (0.05% Tween20/PBS) three times. The plate was blocked 
with blocking buffer (1% v/v reagent diluent/milliQ water) for 30 minutes coated 
with BMP2. After 1 h, the supernatant was collected and transferred in low-
protein binding tubes. Samples were washed with PBS which was also 
collected in the tubes. BMP2 standards were prepared in PBS starting at 48 
µg/mL and followed by an 11-point serial dilution. A blank standard (PBS) was 
included too. Apart for the external standards, BMP2 solution used for coating 
and 1% v/v BMP-2 solution (in PBS) were used as internal standards.  
 
The collected supernatants (100 μl) and standards were added to a 96-well 
plate. After 2 hours, solution was removed and the wells were washed. 
Detection antibody was prepared in reagent diluent and 100 μl were added to 
the wells. After 2 hours, solution was removed followed by washing steps. 
Streptavidin-HRP was added at a working dilution (in reagent diluent) and the 
plate was incubated for 20 minutes in dark. Washing steps were repeated and 
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the plate was incubated with substrate solution for 20 minutes in dark. Stop 
solution was added in the wells and absorbance was measured at 450 nm and 
540 nm on a plate reader.  
 
For analysis, the 540-nm readings were subtracted from the 450-nm readings 
to correct for the optical imperfections. Then, the BMP-2 concentration (in 
ng/ml) of each standard and the corresponding absorbance value was logged 
and a standard-curve was generated. Next, the BMP-2 concentration (in ng/ml) 
was plotted against the absorbance. The best-fit curve generated by regression 
analysis was used to determine the concentration of each unknown sample and 
of the internal standards (BMP-2 solution used for coating). Next, the amount of 
BMP-2 in the supernatant was estimated. The amount of BMP-2 adsorbed on 
the surfaces was quantified by subtracting the amount of BMP-2 in supernatant 
from the amount of BMP-2 in the solution used for coating. 
 
2.2.9 In-cell Western™ assay 
FN-coated samples were incubated with blocking solution (Odyssey blocking 
buffer) for 2 h. Next, primary antibodies were prepared in blocking solution 
containing rabbit polyclonal anti-FN (1:400), mouse mAb1937 (1:2000) and 
mouse P5F3 (1:300) antibodies. Samples were incubated with antibody 
solutions and after 1 h they were washed (0.1% v/v Tween20/PBS) five times 
for 5 min with gentle shaking. Secondary antibodies were prepared in blocking 
solution containing infrared labelled anti-rabbit or anti-mouse IRDye® 800CW 
antibody (1:800) for 1 h in dark. Samples were washed again and transferred to 
a new plate. Next, samples were scanned with detection in 800 nm channel 
using an Odyssey® system. To analyse the results, the average readings of 
each sample was plotted. 
 
2.2.10 Immunogold staining 
Samples were coated with FN at 20 µg/ml for 10 min. After they were washed 
twice with PBS, they were coated with BMP-2 at 100 ng/ml for 1 h. Next, 
samples were fixed (4% formaldehyde/PBS) for 30 min. Another set of fixed 
FN-coated samples were included too. All samples were washed three times 
with PBS. Next, a primary antibody solution was prepared containing anti–
rabbit BMP-2/BMP-4 antibody in PBS (1:50). Samples were incubated with 
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antibody solution for 1 h. Next, samples were washed (0.5% v/v Tween 
20/PBS) three times for 1 min. Secondary antibody was prepared containing 
15-nm gold particle–conjugated anti-rabbit immunoglobulin G (1:20). Samples 
were incubated with antibody solution for 1 h. Next, samples were washed and 
fixed. Finally, samples were washed with milliQ water and were dried with N2 
flow. 
 
2.2.11 Statistical analysis 
Data are represented as mean ± standard deviation (SD) and were analysed 
using GraphPad Prism 5. Statistically significant differences were assessed by 
t-test using a Tukey’s post-test.  A two-way ANOVA using a Bonferroni post 
hoc test was applied for multiple comparisons at a 0.05 significance level, with 
*p < 0.05, **p < 0.01, ***p < 0.0001. 
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2.3 Results 
2.3.1 Water Contact Angle 
WCA measurements were carried out to characterise the wettability of the 
surfaces. SCA as well as ACA and RCA were characterised before and after 
FN adsorption (Table 2.1, Table 2.2). 
 
Substrate SCA ACA RCA Hysteresis 
PEA100 67.58 ± 5.18 105.70 ± 1.04 36.45 ± 1.32 69.25 ± 1.22 
PEA70 64.91 ± 2.11 102.45 ± 1.72 32.37 ± 5.3 70.07 ± 6.63 
PEA50 70.77 ± 4.99 96.76 ± 2.04 31.05 ± 1.17 65.64 ± 2.98 
PEA30 67.76 ± 1.49 96.76 ± 3.32 38.85 ± 11.83 57.91 ± 11.05 
PMA100 68.87 ± 5.25 92.26 ± 4.72 30.61 ± 5.71 61.66 ± 6.09 
 
Table 2.1. WCA measurements. Measurements were carried out prior FN 
coating. Error values are standard deviation (n=3 per sample, 3 samples 
tested). 
 
Substrate SCA ACA RCA Hysteresis 
PEA100 66.67 ± 1.71 96.26 ± 5.67 8.62 ± 0.67 87.64 ± 5.81 
PEA70 66.01 ± 1.87 97.00 ± 2.43 13.96 ± 2.82 83.03 ± 3.38 
PEA50 69.11 ± 7.97 79.08 ± 10.45 18.51 ± 2.35 60.57 ± 9.29 
PEA30 60.31 ± 0.74 71.40 ± 3.49 14.22 ± 1.96 57.17 ± 3.95 
PMA100 57.65 ± 1.84 70.02 ± 4.49 11.99 ± 6.38 58.03 ± 7.98 
 
Table 2.2. WCA measurements. Measurements were carried out after FN 
coating. Error values are standard deviation. (n=3 per sample, 3 samples 
tested). 
 
No differences were found in the SCA (from ~ 67o on PEA to ~ 68o on PMA) of 
the surfaces before FN coating indicating similar wettability (Figure 2.2). SCA of 
the surfaces ranged from ~65o to ~70o indicating that surfaces are hydrophobic. 
Contrary, SCA decreased linearly with decreased EA units (from ~66o on PEA 
to ~57o on PMA) after FN coating. In particular, SCA was significantly higher on 
FN-coated PEA and PEA70 than on FN-coated PEA30 and PMA. In addition, 
SCA on PEA30 and PMA decreased when samples were coated with FN.   
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Figure 2.2. Static contact angle. Graphs represent the SCA of the surfaces 
before and after FN coating. 
 
Surface wettability affects phenomena such as protein adsorption247, and is 
indicative of surface properties, such as chemistry248. However, the 
measurement of the SCS alone is not sufficient to fully assess surface 
wettability. Characterising the dynamic angles (ACA and RCA) were required 
too. ACA decreased with decreased concentration of EA (Figure 2.3).  
 
Figure 2.3. Advancing contact angle. Graphs represent the ACA of the 
surfaces before and after FN coating. 
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Substrate                                                                                      P value                           
Without FN  
PEA100 vs. PEA50………………………………………... ** 
PEA100 vs. PEA30………………………………………… *** 
PEA100 vs. PMA100………………………………………. *** 
PEA70 vs. PEA50 …………………………………………. * 
PEA70 vs. PEA30 …………………………………………. * 
PMA70 vs. PMA100……………………………………….. *** 
With FN  
PEA100 vs. PEA50………………………………………… *** 
PEA100 vs. PEA30………………………………………… *** 
PEA100 vs. PMA100 ………………………….................. *** 
PEA70 vs. PEA30 (with FN) ……………………………… *** 
PMA70 vs. PMA100 …………………………................... *** 
PEA50 vs. PEA30………………………………………….. ** 
PEA50 vs. PMA100………………………………………... ** 
Without FN vs. with FN   
PEA100…………………………………………………….. ** 
PEA50………………………………………………………. *** 
PEA30………………………………………………………. *** 
PMA100……………………………………………………... *** 
Table 2.3. List of statistically differences for ACAs. P values represent the 
degree of significance. Stars are **P<0.1 and ***P<0.01. (n=3 per sample, 3 
samples tested). 
 
In particular, ACA was higher on PEA100 and PEA70 than on PEA50, PEA30 
and PMA. ACA followed a similar trend when samples were coated FN. 
However, the decrease was more pronounced with decreased ratio of EA 
which is indicated by the lower ACA on the FN-coated PEA50, PEA30 and 
PMA (Table 2.3).  
 
RCA was lower on all samples after FN adsorption compared to samples prior 
coating suggesting that the protein coated surfaces become more hydrophilic 
(Figure 2.4, Table 2.4).  
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Figure 2.4. Receding contact angle. Graphs represent the RCA of the 
surfaces before and after FN coating. 
 
Substrate P value 
Without FN  
PEA70 vs. PEA30………………………………………….. * 
PEA50 vs. PEA30………………………………………….. * 
With FN  
PEA100 vs. PEA50………………………………………... ** 
PEA30 vs. PMA100 ……………………………………….. ** 
Without FN vs. with FN  
PEA100 ……………………………………………………... *** 
PEA70 …………………………………………………........ *** 
PEA50……………………………………………………….. *** 
PEA30 ………………………………………………………. *** 
PMA100……………………………………………………… *** 
Table 2.4. A list of significant differences for ACAs. P values represent the 
degree of significance. Stars are *P<0.5 **P<0.1 and ***P<0.01. (n=3 per 
sample, 3 samples tested). 
 
Hysteresis was estimated too and represents the difference between ACA and 
RCA. Hysteresis was similar on samples prior FN coating. After FN coating, it 
decreased significantly with decreased concentration of EA. More specifically, 
hysteresis on PEA and PEA70 was higher compared to the rest of the samples. 
In addition, hysteresis of FN-coated PEA and PEA70 was higher than the 
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hysteresis of those samples without protein adsorption. This can be explained 
by the decrease of RCA after FN adsorption (Figure 2.5).  
 
Figure 2.5. Hysteresis. Graphs represent the hysteresis of the surfaces 
without (white bars) and with (black bars). 
 
without FN with FN  
• SCA remains constant 
 
• ACA decreases with increased 
MA concentration 
 
• PEA30 with highest RCA 
 
• Hysteresis remains constant 
• SCA decreases with increased MA 
concentration 
 
• ACA decreases with increased MA 
concentration 
 
• PEA50 with highest RCA 
 
• Hysteresis decreases with 
increased MA concentration 
 
without VS with FN  
• SCA is higher on FN-coated PEA30 and PMA100 compared to PEA30 and 
PMA100 without protein coating 
 
• ACA is lower on FN coated PEA100, PEA50, PEA30 and PMA100  
compared to PEA100, PEA50, PEA30 and PMA100 without protein coating 
 
• RCA decreases significantly on FN-coated samples compared to samples 
without protein coating 
 
• Higher hysteresis on FN-coated PEA100 and PEA70 compared to PEA100 
and PEA70 without protein 
Table 2.5. Summary of WCA results.  
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2.3.2 Force spectroscopy 
The elastic modulus of the surfaces was analysed by atomic force 
spectroscopy measurements. To do so, samples were immersed in milliQ water 
overnight and a 5 μm bead was attached to a silicon cantilever in order to ident 
the surfaces. Analysis of the force curves showed that the young’s modulus of 
the surfaces was in the range of hundreds of kPa (Figure 2.6). It should be 
noted though that that large variation in stiffness was observed. This was 
because the areas on the surfaces with high Young’s modulus affecting the 
error bars. Despite the variation observed in the elastic modulus, no statistical 
differences were found.  
 
 
Figure 2.6. Stiffness characterisation. Young’s modulus of surfaces (top). 
Example of force curve obtained from measurements. The Hertz model was 
applied to calculate the Young’s modulus (bottom). (n=100 per sample, 1 
samples tested). 
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2.3.3 FN conformation  
AFM images in tapping mode were taken to assess how the EA/MA ratio 
affects FN distribution on the surfaces upon adsorption and whether different 
degrees of FN fibrillogenesis can be obtained.  
 
Figure 2.7. FN fibrillogenesis. Height and phase AFM images. Samples were 
coated with a FN solution at a concentration of 20 μg/ml for 10 min. Scale bar 
is 500 nm.  
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Figure 2.8. Fractal dimension (FD) calculated from AFM images. (4 
images/sample were analysed). 
 
AFM height and phase images (Figure 2.7) demonstrate the distribution and 
conformation of adsorbed FN on the surfaces. It is shown that the degree of FN 
fibrillogenesis depends on the EA/MA ratio. As described previously, PEA 
triggers the formation of a well-connected network of FN fibrils. With decreased 
concentration of EA, the density of the interconnected network decreases as 
well. This conformation is lost with decreased EA/MA ratio resulting in a 
globular conformation of FN on PMA. To quantitatively assess the density of 
the FN network, AFM images were analysed using ImageJ and the plugin 
FracLac. The Fractal dimension decreased with decreased concertation of EA 
units indicating that a well-connected network is adopted on PEA (Figure 2.8).  
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2.3.4 FN surface density 
The surface density of FN adsorbed on the surfaces was indirectly quantified 
by measuring the depletion of FN from solution. For a direct way to assess the 
level of adsorbed FN, an ICW™ assay was performed. The surface density of 
FN was similar on all the surfaces (Figure 2.9, a). Similarly, ICW™ assay using 
a polyclonal anti-FN antibody did not reveal any statistical differences in the 
relative availability of adsorbed FN (Figure 2.9, b).   
 
Figure 2.9. Surface density of FN adsorbed on the copolymers for 1 h.  (a) 
BCA assay to indirectly quantify the amount of adsorbed FN (n=3 per sample, 3 
biological replicates). (b) ICW™ assay using a polyclonal anti-FN antibody to 
assess FN availability. (n=3 per sample, 1 biological replicates). 
 
2.3.5 Availability of FN domains 
To evaluate how the EA/MA ratio of the materials affects the availability of 
important binding domains of FN after adsorption, ELISA and ICW™ assay 
were performed. Monoclonal antibodies used were the HFN7.1, mAb1937 and 
P5F3. HFN7.1 is directed against the FNIII9-10 repeat of FN which is involved in 
integrin binding and cell adhesion. The mAb1937 is directed against the FNIII8 
repeat which is near the synergy domain. The P5F3 is directed against the 
FNIII12-14 repeat which contributes to growth factor binding. 
 
The availability of the FNIII9-10 repeat (integrin binding domain) increases 
linearly with increased ratio of EA/MA. PEA and PEA70 displayed the higher 
availability of FNIII9-10 repeat compared to the rest of the samples. Also, higher 
availability is found on PEA50 and PEA30 compared to PMA (Figure 2.10).  
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Figure 2.10. ELISA to probe for structural differences of FN conformation 
dependent on EA/MA ratio. Availability of the FNIII9-10 (HFN7.1 antibody) on 
FN-coated surfaces and non-protein coated surfaces. (n=3 per sample, 3 
biological replicates) 
 
An ICW™ assay was carried out as well. In this case, the antibodies P5F3 
(against FNIII12-14 repeat) and mab1937 (against the FNIII8 repeat) were used.  
 
Figure 2.11. ICW™ assay to probe for structural differences of FN 
conformation dependent on EA/MA ratio. Availability of the FNIII12-14 (P5F3 
antibody) on FN-coated surfaces and non-protein coated surfaces. (n=3 per 
sample, 3 biological replicates) 
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Figure 2.12. ICW™ assay to probe for structural differences of FN 
conformation dependent on EA/MA ratio. Availability of the FNIII8 repeat 
(mab1937 antibody) on FN-coated surfaces and non-protein coated surfaces. 
(n=3 per sample, 3 biological replicates) 
 
The FNIII12-14 repeat is less available with decreased ratio of EA/MA. 
Particularly, the FNIII12-14 repeat is less available on PEA30 and PMA 
compared to the rest of the samples (Figure 2.11). In addition, the availability of 
FNIII8 repeat is higher with increased EA units. PEA, PEA50 and PEA30 
demonstrated higher availability of this repeat compared to PEA70 and PMA 
(Figure 2.12).  
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2.3.6 BMP2 adsorption 
A sandwich ELISA was performed to assess whether the differential 
conformation of FN affects the surface density of BMP-2 bound on FN-coated 
surfaces. To do so, FN and next BMP-2 (at 25 ng/ml) were adsorbed on the 
materials.  
 
Figure 2.13. Quantification of BMP-2 adsorption. Standard curve used to 
quantify the amount of BMP-2 (top). Surface density of BMP-2 adsorbed on 
FN-coated surfaces (left, blue bars) and on surfaces without protein (right, 
white bars).  
 
No statistically significant differences were found in the surfaces density of 
BMP-2 among the FN-coated surfaces indicating that FN conformation does 
not alter BMP-2 adsorption (Figure 2.13).  
 
Substrate P value 
BMP-2   
PEA100 vs. PEA50……………………………………………… * 
PEA100 vs. PEA30……………………………………………... ** 
PEA100 vs. PMA100………………………………………........ * 
PEA100 vs. glass ……………………………………………….. *** 
PEA70 vs. PEA30……………………………………………….. ** 
PEA70 vs glass…………………………………………………… *** 
PEA50 vs. glass…………………………………………………… ** 
PMA100 vs. glass………………………………………………… * 
Table 2.6. Statistically significant differences for the BMP-2 coated 
surfaces. P values represent the degree of significance. Stars are *P<0.5 
**P<0.1 and ***P<0.01. (n=3 per sample, 3 biological replicates), 
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2.3.7 BMP-2 binding  
To examine how BMP-2 binds to FN-coated surfaces, an anti-BMP-2 antibody 
and then a secondary antibody labelled with a gold particle were used. Next, 
AFM was performed to localise BMP-2 molecules.  
 
Figure 2.14. BMP-2 adsorption on FN-coated surfaces. Phase AFM images 
after adsorption of FN (20 µg/ml) and BMP-2 (100 ng/ml) and after adsorption 
of FN. Scale bar is 500 nm.  
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Phase AFM pictures showed that BMP-2 is adsorbed on the on top of open 
network of FN molecules (Figure 2.14). Particles were mostly seen on FN 
network formed on PEA and PEA70 (indicated by the white arrows). However, 
just few particles were seen on surfaces with decreased concentration of EA. In 
addition, on surfaces where BMP-2 was not adsorbed no gold nanoparticles 
were observed.  Phase AFM images of FN/BMP-2 coated PEA at different 
magnifications (5 μm, 1 μm and 500 nm) demonstrate that BMP-2 is bound 
only on the extended FN molecules. A section of one gold nanoparticle bound 
on adsorbed FN show a height profile of ~ 7 nm (Figure 2.15).  
 
 
Figure 2.15. Phase AFM images at different magnifications showing BMP-
2 interaction with FN network formed on PEA. PEA was coated with FN (20 
µg/ml) and BMP-2 (100 ng/ml) and an immunogold staining was carried out.  
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2.4 Discussion  
This chapter describes the characterisation of material properties and, 
particularly, how the EA/MA ratio alters the interactions of FN with the surface 
and the biological activity of the protein. Surfaces were assessed in terms of 
wettability, stiffness, FN conformation as well as surface density upon 
adsorption. In addition, the availability of important binding sites of FN was 
investigated. BMP-2 adsorption on FN-coated surfaces was studied too. 
 
Characterising material wettability is a common approach to measure the 
hydrophobicity of a solid surface. Differences found in wettability depend on the 
surface properties such as surface roughness, topography, homogeneity or 
molecular mobility249. In this work, the wettability of the surface was 
characterised by measuring the SCA, ACA, RCA and the hysteresis. SCA was 
similar through the series of copolymers before FN coating. After FN 
adsorption, SCA decreased with decreased ratio of EA/MA indicating that the 
surfaces become more hydrophilic with decreased EA concentration (Figure 
2.2). ACA decreased with decreased ratio of EA/MA prior or after FN coating. 
Generally, ACA was higher on PEA and PEA70 than on PEA50, PEA30 and 
PMA. Interestingly, this difference was more pronounced on FN-coated 
samples because of the lower ACA in PEA50, PEA30 and PMA (Figure 2.3). It 
can be postulated that FN-coated surfaces become more homogeneous with 
decreased EA units therefore they facilitate the spreading of the contact line. 
RCA was similar among the samples before and after protein coating. 
However, it was lower on the FN-coated surfaces compared to the non-protein 
coated samples (Figure 2.4). This suggests that the liquid molecules resist the 
flow on the surfaces coated with FN. Additionally, hysteresis significantly 
decreases with decreased concentration of EA units after FN adsorption which 
can be explained by the drastic decrease of RCA (Figure 2.5). These results 
support that FN-coated samples are smoother after FN coating with decreased 
concentration of EA indicating that FN is more homogenously distributed with 
increased EA/MA ratio.  
 
AFM was carried out to explore how the different ratio of EA/MA units affects 
the conformation of adsorbed FN. Height and phase images showed that FN 
organises into a network-like conformation on PEA. This network becomes less 
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connected with decreased EA/MA ratio. Eventually, the connection is lost and 
globular aggregates are formed on PMA (Figure 2.7). Analysis of the images 
confirms the results demonstrating that different degrees of FN fibrillogenesis 
are obtained by changing the EA/MA ratio (Figure 2.8). It can be therefore 
suggested that the specific material-protein interactions result in a different 
degree of FN fibrillogenesis dependent on the EA/MA ratio. Force spectroscopy 
measurements in liquid were carried out to characterise the stiffness of the 
surfaces. The Young’s modulus of the surfaces exhibits a wide variation on all 
the surfaces and ranges from about 0.2 MPa to 0.9 MPa. Tissue elasticity 
ranges in stiffness from soft (0.1 kPa in brain) to rigid (100 kPa in collagenous 
bone)193. Difference in substrate stiffness affect MSC response in vitro too. 
Engler et al. showed that MSCs respond to material stiffness ranging from 0.1-
40 kPa with osteogenic phenotype at high elastic modulus193. Given that the 
stiffness of the copolymers is higher than what cells can sense, the surfaces 
are considered stiff. Therefore, any differences observed in cell behaviour can 
be attributed to FN conformation and not to the mechanical properties of the 
surfaces.  
 
The surface density of FN and the available adsorbed FN were quantified by 
BCA and ICW™ assay respectively. Even though no changes in the amount of 
adsorbed FN were found (Figure 2.9), FN conformation is different as observed 
via AFM. FRET analysis has indicated that FN fibrils are highly elastic and cell-
generated contractile forces are sufficient to stretch them by several folds250. 
Consequently, some cryptic binding domains, and particularly the FN type III 
domains, might be exposed 236. Such conformational changes influence FN-FN 
interactions235, integrin binding and cell behaviour66. Taking this into 
consideration, we investigated how the different degrees of FN fibrillogenesis 
alter the differential availability of cell and growth factor binding domains. To 
investigate domain exposure, ELISA and ICW™ assays were performed.  
ELISAs and ICW™ assay using monoclonal antibody against the flexible linker 
in FNIII9-10 (integrin binding domain), FNIII8 and FNIII12-14 repeat (GF binding 
domain), showed decreased availability with decreased concentration of EA 
units (Figure 2.10, Figure 2.11, Figure 2.12). These results indicate that the 
network conformation of FN formed with increased EA concentration facilitates 
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the exposure of these domains. In addition, surfaces with higher EA/MA ratio 
promote the simultaneous availability of the integrin and GF binding domain.   
 
ELISA showed that similar amounts of BMP-2 were adsorbed on FN-coated 
surfaces (Figure 2.13). However, immunogold staining and AFM imaging 
showed that adsorbed BMP-2 is found to preferentially bind to the open and 
more extended FN molecules formed on PEA and PEA70. On the contrary, a 
decrease in the number of bound BMP-2 was observed with decreased 
concentration of EA (Figure 2.14). It should be mentioned that AFM images 
demonstrate specific BMP-2 binding on FN after fixing. BMP-2 that was not 
bound to FN (for example on PMA) might have been washed away due to the 
several washes and thus no particles were observed. In contrast, ELISA 
protocol required less washes and, subsequently, adsorbed BMP-2 on the 
surfaces might have been quantified. Therefore, no differences were found.  
 
These results indicate that the degree of FN fibrillogenesis and, particularly, the 
extended network conformation of FN on PEA and PEA70, can control specific 
BMP-2 binding onto the FN fibrils. Taking into consideration that the availability 
of FN repeats involved in cell binding changes depending on the EA/MA ratio, it 
can be suggested that the synergistic presentation of BMP-2 and cell binding 
domains can be obtained in a controlled manner.  
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3. MSC response 
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3.1 Introduction 
The role of FN and its organisation in guiding stem cell differentiation has been 
previously demonstrated too. In vitro studies have shown that FN conformation 
can regulate the osteogenic differentiation of osteoblast-like cells251 and 
MSCs244. Furthermore, changes in FN structure mediated by the surface 
chemistry of SAMs altered integrin binding and enhanced the expression of 
osteogenic markers197. Similarly, conformation changes of FN induced by 
sulfated hyaluronan resulted in an increase of ALP activity underlying the role 
of protein conformation on cell differentiation252. 
 
The previous chapter described the surface properties and how surface the 
EA/MA ratio affects FN conformation and the availability of binding domains. 
This chapter focuses on examining how the changes in FN activity on the 
material interface can tune the response of MSCs in terms of adhesion and 
osteogenic differentiation via the different degrees of FN fibrillogenesis. Taking 
into consideration that cell adhesion plays an important role in cell functions, 
FAs and cell morphology were characterised. The potential of the material 
interface to drive MSCs into osteogenic commitment was also investigated. To 
do so, osteogenic differentiation was assessed by characterising the 
expression of the markers RUNX2, ALP and OCN.  
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3.2 Materials and Methods 
3.2.1 Materials 
List of reagents 
Dulbecco’s Modified Eagle’s Medium………………... Sigma 
Sodium pyruvate……………………………………….. Sigma 
L-glutamine……………………………………………... Sigma 
Penicillin streptomycin…………………………………. Sigma 
Fungizone……………………………………………….. Life Technologies 
Foetal bovine serum……………………………………. Life Technologies 
Trypsin/EDTA……………………………………………. Sigma 
L-ascorbic acid………………………………………….. Sigma-Aldrich 
Dexamethasone…………………………………………. Sigma 
Sodium phosphate monobasic (NaH2PO4)…………... Sigma 
Formaldehyde…………………………………………… Fisher Scientific 
Triton X-100……………………………………………… Sigma 
Tween®20……………………………………………….. Sigma 
Bovine serum albumin………………………………….. Roche/Sigma 
Saccharose………………………………………………. Fisher Chemicals 
Sodium chloride…………………………………………. Fisher Chemicals 
Magnesium chloride……………………………………. VWR Chemicals 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES)…………………………………………………. Sigma 
ALP kit, Leukocyte kit ………………………………….. Sigma-Aldrich 
Acetone………………………………………………….. Fisher Chemicals 
Mouse monoclonal vinculin antibody………………… Sigma 
Mouse monoclonal osteocalcin antibody……………... Santa Cruz Biotechnology 
Rabbit polyclonal RUNX2 antibody……………………. Santa Cruz Biotechnology 
Cy-3 anti-mouse antibody ……………………………... Jackson ImmunoResearch 
Vectashied with DAPI…………………………………… Vector Laboratories 
Phallacidin……………………………………………….. Life Technologies 
CellTag ICW700…………………………………………. LI-COR® 
Anti-mouse ICW800…………………………………….. LI-COR® 
Anti-rabbit ICW800……………………………………… LI-COR® 
 
3.2.2 Human Mesenchymal Stem Cells 
Human mesenchymal stem cells were purchased from PromoCell®. Cells 
express the markers CD73/CD90/CD105 whereas they lack expression of 
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CD14/CD19/CD45/HLA-DR. For expansion, cells were thawed from stock and 
were maintained in high glucose DMEM supplemented with 10% v/v FBS, 1% 
v/v antibiotic mix (2.9% v/v L-Glutamine, 1.9% v/v penicillin/streptomysin, 0.2 % 
v/v fungizone) and 0.1% v/v sodium pyruvate at 37°C, 5% CO2. Media change 
was carried out every 3 to 4 days. For splitting or cell seeding, cells were rinsed 
with warm PBS followed by 2 ml of trypsin/EDTA. After removing the solution, 
cells were incubated at 37 °C for 60 to 120 sec until the cells were detached 
from the tissue culture flask. Next, complete medium (supplemented with 10% 
v/v FBS) was added to the flask, cell suspension was transferred to a falcon 
tube and centrifuged at 1300 rpm for 5 min. Afterwards, the supernatant was 
removed and the cell pellet was suspended in 1 ml of FBS-free medium. Cell 
density was measured using a Neubauer haemocytometer. Cells were used at 
passages P0 to P5 for cell attachment (3.2.3.1) and cell adhesion (3.2.3.2, 
3.2.3.3) experiments. Cells were used at passages P0 to P3 for experiments 
characterising osteogenic differentiation (3.2.4.1, 3.2.4.2, 3.2.4.3, 3.2.5). 
 
3.2.3 Adhesion of hMSCs 
3.2.3.1 Cell attachment 
UV-sterilised samples were coated with FN at 20 µg/ml for 1 h. According to a 
previously described protocol253, cells were washed twice with PBS and 
blocked with heat-denatured 1% w/v BSA /PBS for 30 min. Cells were 
trypsinised, harvested and resuspended in complete medium and cell 
suspension was incubated at 37 °C, 5% CO2 for 10 min. Next, cells were 
seeded onto the surfaces at a seeding density of 90000 cells/cm2 for 20 
minutes at 37 °C. Then, samples were washed twice with PBS, they were fixed 
(3.7% v/v formaldehyde/PBS) for 30 min at 4°C and washed again with PBS. 
Next, samples were incubated with permeabilisation buffer (0.5% v/v Triton X-
100, 10.3% w/v saccharose, 0.292% w/v NaCl, 0.06% w/v MgCl2, and 0.476% 
w/v HEPES adjusted to pH 7.2) for 5 min and mounted with vectashield with 
DAPI. Images were taken and the number of cells was quantified using the 
CellC total cell count analysis.  
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3.2.3.2 Cell adhesion 
UV-sterilised samples were coated with FN at 20 µg/ml for 1 h. hMSCs were 
harvested by trypsinization and cell suspension was diluted in FBS-free 
medium to a final density of 1000 cells/cm2. Then cells were seeded onto the 
surfaces and were incubated at 37°C, 5% CO2 for 3 h and 24 h. For the early 
time point, cell culture was maintained in FBS-free conditions. For the later time 
point medium was replaced with complete medium 3 hours after seeding. After 
the given time, cells were washed with warm PBS and were fixed as described 
previously. Samples were kept in PBS at 4°C.   
 
3.2.3.3 Cell adhesion on FN/BMP-2 coated surfaces 
One day before cell harvesting, medium was changed with medium containing 
1% v/v FBS. The next day, UV-sterilised samples were coated with FN at 20 
µg/ml for 1 h. After they were washed twice with PBS, they were blocked with 
heat-denatured 1% w/v BSA/PBS for 30 minutes. Next, they were coated with 
BMP-2 at 100 ng/ml for 1 hour. Then, cells were harvested and cell suspension 
was diluted in 1 ml of FBS-free medium at a final density of 3000 cells/cm2. 
Culture was maintained in FBS-free medium at 37°C, 5% CO2 and after 2h 
medium was replaced with medium containing 1% v/v FBS. Three days after 
seeding, cells were fixed as described previously.    
 
3.2.4 Osteogenesis of hMSCs  
3.2.4.1 ALP expression at different time points 
Glass samples were coated with FN. Next, they were blocked with heat-
denatured 1% w/v BSA/PBS for 30 minutes and then they were coated with 
BMP-2 at 100 ng/ml for 1 h. Glass samples coated only with FN (20 µg/ml) 
were included too. hMSCs were harvested and cell suspension was diluted in 1 
ml of FBS-free medium at a seeding density of 10000 cells/cm2 and cell culture 
was maintained at 37°C in FBS-free conditions for 2 h. Medium was replaced 
with medium containing 1% v/v FBS which was also used for medium change 
every 3 d. For the osteogenic differentiation control, cell suspension was also 
diluted in complete medium at a seeding density of 10000 cells/cm2 and cells 
were seeded on FN-coated glass. In this case, medium was replaced with 
osteogenic medium (10% v/v FBS, 0.1 µM dexamethasone, 25 µg/mL L-
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ascorbic acid, 3 mM NaH2PO4) when cells reached confluency. Cell culture 
was maintained at 37°C for 1 d, 14 d and 21 d.    
  
3.2.4.2 ALP expression on the copolymers 
The same procedure was followed as described above. Samples were 
PEA100, PEA70, PEA50, PEA30, PMA100 and glass. FN-coated copolymers 
and glass samples were included too. Culture was maintained at 37°C, 5% CO2 
for 21 d. 
 
3.2.4.3 RUNX2 and OCN expression 
UV-sterilised samples were coated with FN (20 µg/mL). Next they were blocked 
with heat-denatured 1% w/v BSA/PBS for 30 minutes and coated with BMP-2 
at 100 ng/ml for 1 h. Copolymers coated only with FN as well as FN-coated 
glass samples were included too. Cells were harvested and cell suspension 
was diluted in medium with 2.5% v/v FBS at a seeding density of 2500 
cells/cm2. Next, cells were seeded onto the surfaces. Furthermore, cell 
suspension was diluted in complete medium at a seeding density of 2500 
cells/cm2 and cells were seeded on FN-coated glass. Cell culture was 
maintained at 37°C, 5% CO2 and medium was changed every 2 to 3 d. For the 
copolymers coated with FN and FN/BMP-2, medium was replaced with medium 
containing 2.5% v/v FBS and BMP-2 at 25 ng/ml whereas, for the FN-coated 
glass samples, medium was replaced with osteogenic medium when cells 
reached confluency. Cell culture was maintained for 5 d to characterise RUNX2 
expressions and 21 d to characterise OCN expression.   
 
3.2.5 ALP staining  
Prior to the assay, a fixative and an alkaline-dye mixture were prepared. The 
fixative solution was prepared by mixing 25.5% v/v citrate solution, 66.3% v/v 
acetone and 8.2% v/v 37% formaldehyde. To prepare the alkaline-dye mixture, 
equal volumes of nitrite solution and FBB-alkaline solution were mixed gently 
(2.1% v/v nitrite solution, 2.1% v/v FBB-alkaline solution). The solution was 
allowed to stand for 2 min and then it was added to milliQ water. Next, 2.1% v/v 
naphthol AS-BI alkaline solution was added to the solution. Samples were 
washed with warm PBS and incubated with fixative solution for 30 sec. Next, 
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they were washed with milliQ water for 45 sec and they were incubated with 
alkaline-dye mixture for 15 min in dark. After removing the solution, samples 
were rinsed with milliQ water for 2 min. Next, samples were incubated with 
neutral red solution for 2 min for counterstain. Next, samples were rinsed 
thoroughly in tap water and then they were air-dried. For analysis, images were 
exported to Fiji. The trainable Weka segmentation was used to train a classifier 
to distinguish ALP aggregates from the background. After applying the 
classifier in all the pictures, a binary pixel segmentation was produced which 
was used for quantification of ALP area. 
 
 
Figure 3.1. Quantification of ALP expression. A trainable Weka 
segmentation was applied to the original images which were next converted to 
binary images. Scale bar is 100 µm. 
 
3.2.6 Immunohistochemistry  
Fixed cells were washed three times with PBS and were incubated with 
permeablisation buffer (0.5% v/v Triton X-100, 10.3% w/v saccharose, 0.292% 
w/v NaCl, 0.06% w/v MgCl2, and 0.476% w/v HEPES adjusted to pH 7.2) for 5 
min followed by blocking with 1% v/v BSA/PBS for 30 min. Next, samples were 
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incubated with primary antibody containing mouse anti-vinculin antibody 
(1:400) or mouse anti-osteocalcin antibody (1:100) in 1% v/v BSA/PBS for 1 
hour. Next, they were washed twice with 0.5% v/v Tween20/PBS. Samples 
were incubated with secondary Cy3 anti-mouse IgG (1:100) and BODIPY FL 
phallacidin (1:100) in 1% v/v BSA/PBS for 1 hour. After washing, samples were 
placed on glass slides and mounted with Vectashield containing DAPI.  
 
3.2.7 In-Cell Western™ assay 
An ICW™ assay was carried out to characterise RUNX2 and OCN expression. 
Fixed cells were washed with PBS, they were incubated with permeabilisation 
buffer for 5 min and were blocked with 1% w/v BSA/PBS for 30 min with gentle 
shaking. Primary antibodies were prepared in 1% w/v BSA/PBS containing anti-
rabbit RUNX2 (1:100) or anti-mouse osteocalcin (1:100) antibodies. Samples 
were incubated with the primary antibody and after 1 hour they were washed 
three times for 5 minutes with 0.5% v/v Tween20/PBS in shaking. Secondary 
antibody was prepared in 1% w/v BSA/PBS containing anti-mouse or anti-rabbit 
IRDye 800 CW (1:800) and CellTag 700 Stain (1:500). CellTag is a near-
infrared fluorescent cell stain which accumulates in both the nucleus and 
cytoplasm. Samples were incubated for 1 hour in dark and next the washing 
steps were repeated. Finally, samples were transferred to a new plate and 
readings were measured on Odyssey® plate reader with detection in 800 and 
700 nm channels. The intensity settings were kept constant for each scan.  
 
3.2.8 Cell imaging 
Fluorescent pictures were taken using an epifluorescence microscope (Zeiss 
AXIO Observer Z1, Jena, Germany). 
 
3.2.9 Image analysis of FAs and cell size and OCN quantification 
To characterise FA morphology, vinculin fluorescent images were quantified 
using the online adhesion server254 (Figure 3.2). For cell size quantification, 
actin fluorescence images were imported to ImageJ and the Otsu’s method 
was applied to automatically threshold the images. Next, binary images were 
created which were used and to quantify cell area and circularity (Figure 3.3).  
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Figure 3.2. FA analysis. Vinculin immunofluorescence images were 
processed though the online adhesion server and binary images highlighting 
FAs were obtained. Scale bar is 50 µm.   
 
 
Figure 3.3. Cell area analysis. Actin immunofluorescence images were 
exported to ImageJ a threshold was applied to quantify total cell area. Scale 
bar is 50 µm.   
 
3.2.10 Statistical analysis 
Data are represented as mean ± SD and were analysed using GraphPad Prism 
5. Statistically significant differences were assessed by t-test using a Tukey’s 
post-test.  A two-way ANOVA using a Bonferroni post hoc test was applied for 
multiple comparisons at a 0.05 significance level, with *p < 0.05, **p < 0.01, 
***p < 0.0001. 
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3.3 Results 
3.3.1 Attachment assay 
A short cell attachment and DAPI staining were performed to assess the initial 
attachment of hMSCs on the protein coated copolymers. Initial adhesion was 
allowed for 20 min and characterisation was carried out according to a standard 
protocol253. Non-protein coated surfaces did not favour cell attachment. To 
measure the percentage of cells attached on the FN-coated copolymers, the 
nuclei number was quantified.  Analysis showed that a similar percentage of 
cell attachment was found on the surfaces (Figure 3.4). 
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3.3.2 Figure 3.4. Cell attachment of hMSCs. DAPI staining of hMSCs 
cultured on surfaces without and with FN coating (a and b respectively). 
Scale bar is 500 µm. Quantification of cell attachment. Percentage of 
cells attached on the surfaces with respect to cell density (c). (n=3 per 
sample)Adhesion assay  
MSC adhesion on the FN-coated copolymers was explored by performing a 3 h 
and 24 h adhesion experiment. For the earlier time point, the culture was 
maintained in serum free conditions so that the initial cell-material interactions 
occurred through the layer of adsorbed FN. For the latter time point, medium 
was replaced with medium supplemented with 10% v/v FBS 3 h after seeding. 
Cells were seeded at a low density to avoid cell-cell contact. 
Immunofluorescence staining of vinculin and actin was performed to 
characterise the FAs and cell morphology (Figure 3.5, Figure 3.6). 
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Figure 3.5. Adhesion of hMSCs. Immunofluorescent pictures of hMSCs on 
FN-coated surfaces 3 h after seeding in serum-free conditions. Fluorescent 
staining of vinculin (in red), F-actin (in green) and nucleus (in blue). Scale bar is 
50 µm. (n=3 per sample, 2 biological replicates). 
 
 
Figure 3.6. Adhesion of hMSCs. Immunofluorescent pictures of hMSCs on 
FN-coated surfaces 24 h after seeding. Fluorescent staining of vinculin (in red), 
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F-actin (in green) and nucleus (in blue). Scale bar is 50 µm. (n=3 per sample, 2 
biological replicates). 
 
FAs were developed on all the surfaces and cells appeared well spread.  Image 
analysis of vinculin staining was carried out to quantify the area and length 
distribution of FAs. Focal complexes shorter than 1 μm were removed from the 
analysis. For quantitative analysis, FAs were classified based on the area as 
immature (0-1 µm2), intermediate (1-2 µm2) and mature (>2 µm2) and further 
sub-classified by length as short (1-2 µm), intermediate (2-3 µm) and long (>3 
µm)255, 256.  Both the area and length distribution histograms of FAs showed a 
skewed distribution towards smaller adhesions at both time points (Figure 3.7, 
Figure 3.8). 
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Figure 3.7. Area distribution histograms of FAs on FN-coated copolymers 3 h 
(top) and 24 h (bottom) after seeding. (25-30 images per condition, were 
analysed. n=3 per sample, 2 biological replicates) 
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Figure 3.8. Length distribution histograms of FAs on FN-coated copolymers 3 h 
(top) and 24 h (bottom) after seeding. (25-30 images per condition were 
analysed. n=3 per sample, 2 biological replicates). 
 
To further analyse FA morphology, the average area and length of FAs was 
plotted. No statistically significant differences were found in FA area among the 
seried of the copolymers over time (Figure 3.9). The length of FAs formed on 
PEA30 was found higher than on PMA100 at the early time point (Figure 3.10).  
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Figure 3.9. FA average area (μm2) of hMSCs on FN-coated copolymers. FA 
average area (μm2) of hMSCs on FN-coated copolymers. Culture was 
maintained for 3 h (white bars) and 24 h (black bars). (25-30 images per 
condition were analysed. n=3 per sample, 2 biological replicates). 
 
Figure 3.10. FA average length (μm) of hMSCs on FN-coated copolymers. 
Culture was maintained for 3 h (white bars) and 24 h (black bars). (25-30 
images per condition were analysed. n=3 per sample, 2 biological replicates) 
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To assess whether larger FAs are formed on the FN-coated surfaces, the 
values of FA area and length of each cell were filtered based on their size. FAs 
with size greater than 2 μm2 (for the area) and 3 μm (for the length) were 
averaged for each cell and plotted. No differences were revealed in the 
formation of larger FAs (≥ 2 μm2 and ≥ 3 μm) through the series of FN-coated 
copolymers over time. The number of larger FAs ≥ 2 μm2 was not statistically 
different in the series of the copolymers (Figure 3.11). However, longer and 
more FAs ≥ 3 μm were formed on PEA100 compared to PMA100 (Figure 3.12).  
 
Figure 3.11. FA average area and number on FN-coated copolymers. FA 
average area ≥ 2 μm2 in hMSCs (a). Percentage of FAs ≥ 2 μm2 in hMSCs. 
Culture was maintained for 3 h (white bars) and 24 h (black bars). (25-30 
images per condition were analysed. n=3 per sample, 2 biological replicates). 
 
Figure 3.12. FA average length and number on FN-coated copolymers. FA 
average length ≥ 3 μm in hMSCs (a). Percentage of FAs ≥ 3 μm in hMSCs. 
Culture was maintained for 3 h (white bars) and 24 h (black bars). (25-30 
images per condition were analysed. n=3 per sample, 2 biological replicates). 
 
Cell morphology was assessed to further explore the effect of FN organisation 
on the copolymers. Analysis was carried out by applying a threshold on actin 
fluorescence images to quantify cell area and circularity. Cell area decreased 
with decreased concentration of EA units 3 h after seeding. Cells displayed the 
smaller spread area on PMA at the early time point whereas cell area was 
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similar on the rest of the samples. Spread area decreased over time on all 
surfaces apart from PMA and no differences were found (Figure 3.13).  
 
Figure 3.13. Area of hMSCs on FN-coated copolymers over time. The graph represents the cell 
area 3 h (white bars) and 24 h (blue bars) after seeding. (25-30 per condition images were 
analysed. n=3 per sample, 2 biological replicates). 
Cell circularity decreased with decreased EA/MA ratio at the early time point. 
More specifically, it was higher on PMA than on PEA and PEA70 3 h after 
seeding. However, cell circularity decreased only on PMA over time whereas it 
was similar on the rest of the samples at both time points (Figure 3.14).  
 
Figure 3.14. Circularity of hMSCs on FN-coated copolymers over time. The 
graph represents the cell area 3 h (white bars) and 24 h (blue bars) after 
seeding. (25-30 images per condition were analysed. n=3 per sample, 2 
biological replicates) 
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3.3.3 Cell morphology on FN/BMP-2 coated surfaces 
Cell adhesion depends on several factors including the ECM composition as 
well as on the availability of cell surface and GF receptors. To determine 
whether binding of BMP-2 on FN-coated surfaces influences cell morphology, 
MSCs were seeded at low seeding density on FN/BMP-2 coated surfaces and 
maintained in low-serum condition for 1 d. Next, a vinculin, actin and nuclei 
staining was carried out (Figure 3.15, Figure 3.16). 
 
 
Figure 3.15. Immunofluorescent images of hMSCs seeded on FN/BMP-2 
coated surfaces. Culture was maintained for 24 h. Staining of vinculin (red), F-
actin (green) and nucleus (blue). Scale bar is 100 µm. (n=3 per sample, 2 
biological replicates). 
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Figure 3.16. Immunofluorescent images of hMSCs seeded on FN coated 
surfaces. Culture was maintained for 24 h. Staining of vinculin (red), F-actin 
(green) and nucleus (blue). Scale bar is 100 µm. (n=3 per sample, 2 biological 
replicates). 
 
Cell area and circularity were quantified by processing the actin fluorescence 
pictures. No statistically significant differences were found indicating that BMP-
2 bound on FN-coated copolymers did not affect cell morphology (Figure 3.17, 
Figure 3.18).  
 
Figure 3.17. Area of hMSCs on FN/BMP-2 coated surfaces (red bars) and FN-
coated bars (white bars) 24 h after culture. (25-30 images per condition were 
analysed. n=3 per sample, 2 biological replicates). 
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Figure 3.18. Circularity of hMSCs on FN/BMP-2 coated surfaces (red bars) 
and on FN-coated bars (white bars) 24 h after culture. (25-30 images per 
condition were analysed. n=3 per sample, 2 biological replicates). 
 
3.3.4 Osteogenesis of hMSCs 
3.3.4.1 RUNX2 
The potential of the surfaces to guide hMSCs towards osteogenic lineage 
depending on the degree of FN fibrillogenesis was explored. Cells were 
cultured on surfaces after coating with FN and BMP-2 at low seeding density 
and low serum concentration. Surfaces coated only with FN were included as 
well. As a positive control, cells were seeded on FN-coated glass and culture 
was maintained in osteogenic medium. An ICW™ assay was performed 5 d 
after seeding to characterise RUNX2 expression normalised to the cell number.  
 
RUNX2 expression was higher with increased EA/MA ratio on FN/BMP-2 
copolymers 5 d after seeding. Higher RUNX2 expression was found on PEA 
where FN organises into a network-like conformation compared to PEA30 and 
PMA. In contrast, no difference in RUNX2 expression was found on FN-coated 
surfaces. Furthermore, RUNX2 expression was significantly higher on 
FN/BMP-2 coated PEA compared to PEA coated only with FN (Figure 3.19). 
Regarding the positive control, RUNX2 expression was similar compared to 
FN/BMP-2 coated PEA (Figure 3.19). These results demonstrate that the more 
extended conformation of FN has an effect on BMP-2 activity which 
subsequently alters RUNX2 expression.  
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Figure 3.19. ICW™ analysis of RUNX2 expression on the copolymers at 5 
d. (a) Graph shows RUNX2  expression in hMSCs seeded on FN/BMP2 coated 
(black bars) and FN coated (white bars) surfaces normalised to the cell 
number. (b) Graph shows RUNX2 expression by hMSCs seeded on FN coated 
glass in osteogenic medium. (n= 3 per sample, 1 biological replicate).  
 
 
Figure 3.20. ICW™ plate image for RUNX2 expression at 5 d. hMSCs were 
seeded on FN/BMP2 coated (left), FN coated (middle) surfaces and on FN 
coated glass (right). Surfaces were incubated with an anti-RUNX2 antibody and 
with an infrared fluorescent dye detected at 800 nm channel (green). To 
normalise to the cell number, surfaces were incubated CellTag which is a near-
infrared dye and is detected at 700 nm (red). 
 
3.3.4.2 ALP expression over time 
ALP expression was evaluated to further investigate hMSC osteogenic 
differentiation in the material interface. Initially, ALP expression was 
 76 
 
characterised over time. Cells were cultured on glass coated with FN and BMP-
2 at high seeding density. Culture was maintained in low serum concentration 
and ALP expression was determined by carrying out a colorimetric assay at 
three time points (1 d, 14 d and 21 d after seeding).  
 
 
Figure 3.21. ALP expression in hMSCs. Cells were seeded on FN/BMP-2 
coated glass (left column) and on FN-coated glass where osteogenic medium 
was used (right). Scale bae is 100 µm. (n=3 per sample). 
 
The black aggregates on images demonstrate ALP expression (Figure 3.21). 
Image analysis and quantification showed that higher expression occurs 21 
days after seeding. When hMSCs were cultured in osteogenic medium, 
increased cell proliferation and ALP expression were observed (Figure 3.22).  
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Figure 3.22. Quantification of ALP area.  Cells were seeded on FN/BMP-2 
coated glass (white bars) and on FN-coated glass where osteogenic medium 
was used (black bars). ALP staining was carried out 1 d, 14 d and 21 d after 
seeding. (20 pictures per condition were analysed, n=3 per sample, 1 biological 
replicate). 
 
After assessing ALP expression over time, the assay was repeated including 
the copolymers. MSCs were seeded onto the copolymers coated with either 
FN/BMP-2 or FN and the culture was maintained for 21 d in low serum 
conditions. ALP aggregates were observed on all the FN-coated surfaces in 
both conditions (Figure 3.23, Figure 3.24).  
 
Figure 3.23. ALP expression. hMSCs were seeded on the copolymers coated 
with FN/BMP-2 and ALP expression was characterised 21 days after seeding. 
Scale bar is 100 µm. (n=3 per sample). 
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Figure 3.24. ALP expression. hMSCs were seeded on the FN-coated 
copolymers coated on FN-coated glass. Cells on FN-coated where incubated in 
osteogenic medium when they reached confluency. ALP expression was 
characterised 21 days after seeding. Scale bar is 100 µm.(n=3 per sample). 
 
Segmentation of the images and quantification of ALP area showed higher ALP 
expression on FN/BMP-2 coated PMA where FN forms globular aggregates. 
ALP expression was significantly lower on the rest of the sample at both 
conditions (with or without BMP-2 coating) (Figure 3.25). 
 
 
Figure 3.25. Quantification of ALP at 21 d (Figure 3.23, Figure 3.24). (a) 
Graph shows total ALP area on FN/BMP2 coated (black bars) and FN coated 
(white bars). (b) Graph shows total ALP area by FN coated glass where 
osteogenic medium was used. (20 images per condition were analysed, n=3 
per sample, 1 biological replicate). 
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3.3.4.3 Osteocalcin 
To further analyse osteogenic differentiation on the material interface, the 
expression of the late marker OCN was characterised. MSCs were cultured on 
FN/BMP-2 coated and on FN-coated surfaces. Cell culture was maintained for 
21 d in low serum conditions. An immunofluorescence staining for OCN, actin 
and nuclei was carried out (Figure 3.26, Figure 3.27).   
 
 
Figure 3.26. OCN expression in hMSCs at 21 d. Immunofluorescence 
images of hMSCs on FN/BMP-2 coated surfaces. Fluorescence staining of 
OCN (in red), F-actin (in green) and nucleus (in blue). Scale bar is 100 µm. 
(n=3 per sample). 
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Figure 3.27. OCN expression in hMSCs at 21 d. (a) Immunofluorescence 
images of hMSCs on FN coated surfaces. (b) Osteogenic differentiation of 
hMSCs at 21 d with osteogenic medium.  Fluorescence staining of OCN (in 
red), F-actin (in green) and nucleus (in blue). Scale bar is 100 µm. (n=3 per 
sample). 
 
Figure 3.28. Quantification of OCN expression at 21 d (Figure 3.26, Figure 
3.27). (a) Graph shows OCN expression in hMSCs seeded on FN/BMP2 
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coated (black bars) and FN coated (white bars) surfaces normalised to the cell 
number. (b) Graph shows OCN expression in hMSCs seeded on FN coated 
glass in osteogenic medium. (20 images per condition were analysed, n=3 per 
sample, 1 biological replicate). 
 
Generally, more OCN aggregates were observed on copolymers coated with 
FN/BMP-2 in contrast to the FN-coated surface (Figure 3.28). Quantification of 
the fluorescence pictures demonstrated that OCN expression decreased with 
decreased EA/MA ratio when copolymers were coated with FN/BMP-2. PEA 
and PEA70, where FN adopts a more extended conformation, showed higher 
levels of OCN expression compared to PMA (Figure 3.28). In addition, PEA 
coated with FN/BMP2 elicited a higher OCN expression compared to control 
PEA. It should be noted though that the presence of BMP-2 did not have any 
effect on OCN expression on the copolymers. Additionally, OCN expression 
was higher when cells were incubated with osteogenic medium (Figure 3.28, 
b).  
 
An ICW™ assay was carried out too. Cell culture was maintained for 21 d in 
low serum concentration and OCN expression was normalised to the cell 
number.  
 
Figure 3.29. ICW™ analysis of OCN expression on the copolymers at 21 d. 
(a). Graph shows OCN expression in hMSCs seeded on FN/BMP2 coated 
(black bars) and FN coated (white bars) surfaces normalised to the cell 
number. (b) Graph shows OCN expression by hMSCs seeded on FN coated 
glass in osteogenic medium. (n=4 per sample, 1 biological replicate). 
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OCN expression decreased with decreased EA/MA ratio; higher on FN/BMP-2 
coated PEA compared to PEA70, PEA50 and PEA30. In addition, BMP-2 
coating caused an increased in OCN expression on PEA, PEA50 and PMA 
compared to control PEA, PEA50 and PMA (coated only with FN) (Figure 3.29, 
a). Furthermore, OCN expression on osteogenic control was higher than the 
rest of the conditions (Figure 3.29, b). 
 
 
Figure 3.30. ICW™ plate image for OCN expression at 21 d. hMSCs were 
seeded on FN/BMP2 coated (left), FN coated (middle) surfaces and on FN 
coated glass (right). Surfaces were incubated with an anti-OCN antibody and 
with an infrared fluorescent dye detected at 800 nm channel (green). To 
normalise to the cell number, surfaces were incubated CellTag, which is a 
near-infrared dye and is detected at 700 nm (red). 
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3.4 Discussion 
ECM is a complex three-dimensional network of non-cellular components. It 
provides not only a physical scaffold to cells but it also regulates a wide range 
of cellular processes including growth and differentiation. Understanding the 
cell-ECM interactions is critical in the development of material-based 
approaches which aim at tuning cell response. In the previous chapter, it was 
demonstrated that changes in the EA/MA ratio can determine the degree of FN 
fibrillogenesis which subsequently results in a differential availability of FN 
domains essential for cell attachment and growth factor binding. This chapter 
describes how these changes in FN activity can tune the response of hMSCs. 
Cell adhesion as well as osteogenic differentiation of hMSCs on the material 
interface were explored.  
   
A short adhesion experiment showed that FN is required to promote cell 
adhesion. However, no significant differences were found in the number of 
hMSCs attached on the FN-coated surfaces (Figure 3.4). Another adhesion 
experiment was carried out at two time points (3 h and 24 h) in order to explore 
FA morphology as well as cell size and circularity. MSCs appeared well spread 
and formed FAs on all the surfaces over time (Figure 3.5, Figure 3.6). Analysis 
of FA area and length showed skewed distribution towards smaller FAs on all 
the surfaces (Figure 3.7, Figure 3.8). Analysis of the longer FAs (≥ 2 μm2 and ≥ 
3 μm) showed that longer FAs ≥ 3 μm were formed on PEA than on PMA at the 
early time point. The number of FAs was also higher (Figure 3.12). 
Quantification of cell area demonstrated higher cell spreading with increased 
EA/MA ratio at the early time point. Interestingly, the cell size decreased over 
time on all the surfaces apart from PMA where it remained constant over time 
(Figure 3.13). Contrary, cell circularity decreased with increased EA/MA ratio 
and it was higher on PMA at the early time point compared to the late time 
point. For the rest of the samples, cell circularity was similar at both time points 
(Figure 3.14). These results demonstrate that the more extended FN 
conformation, which corresponds to increased EA/MA ratio, promotes the 
spreading of MSCs at an early time point. Interestingly, cell size decreased 
significantly over time. In in vitro cell adhesion, cells initially sense their 
substrate via attachment followed by spreading of the cell body, and the 
organisation of actin cytoskeleton257. The decrease in cell size at the late time 
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point suggests that cells have adapted to their environment and as a result their 
response is different.  
 
During cell spreading, cells interact with ECM via integrin receptors which 
contribute to signal transmission. FN, in particular, supports cell adhesion via 
binding of the integrins including α5β1, αvβ1 and αvβ3 to the RGD and PHSRN 
motif45, 59, 258. In addition, interruption of the synergistic RGD-PHSRN 
interaction reduces cell attachment and influences downstream FAK 
signalling259. It was previously described that the availability of the FNIII8 and 
FNIII9-10 domains (Figure 2.10, Figure 2.12) in the surfaces increases with 
higher EA/MA ratio which indicates a more connected and extended FN 
network. Therefore, cells might attach and spread better on surfaces with 
increased EA/MA ratio because more sites for integrin binding are available 
therefore integrin binding with higher affinity can be achieved. Decreased cell 
circularity with increased EA/MA ratio also shows that cell morphology depends 
on the conformation of the underlying layer of adsorbed FN. Cells become 
rounder on surfaces where FN appears in a globular morphology further 
suggesting that this specific FN organisation is less favourable for integrin 
engagement and cell spreading.  
 
The FNIII12-14 domain acts as a highly promiscuous growth factor binding 
site70, 260. BMP-2 has been studied extensively in order to study signalling 
pathways which control several aspects of cell behaviour. For example, 
immobilised BMP-2 has been shown to regulate cell adhesion and osteogenic 
differentiation as well as to control downstream signalling pathways223, 261, 262. 
This work explores the potential of the copolymers to drive hMSC osteogenesis 
using BMP-2 bound on FN-coated materials. To do so, the expression of 
known osteogenic markers was characterised at different time points. As 
previously described, RUNX2 is a major regulator of osteogenic 
differentiation126. In this work, hMSCs were seeded on FN/BMP-2 coated 
copolymers and RUNX2 expression was characterised by performing an ICW™ 
assay 5 d after seeding (Figure 3.19). RUNX2 expression was enhanced with 
increased EA/MA concentrations and, particularly, it was higher on FN/BMP-2 
coated PEA compared to PEA30 and PMA. In addition, FN-bound BMP-2 on 
PEA induced higher RUNX2 expression compared to the control PEA (without 
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BMP-2). However, BMP-2 binding did not affect its expression in the rest of the 
samples. In a previous study, the RGD and PHSRN motifs were chemically 
inserted onto Ti surfaces in order to characterise how their spatial distribution 
affects hMSCs response. Higher RUNX2 expression was reported on surfaces 
presenting both domains compared to surfaces presenting the PHSRN motif 
alone and higher mineralization occurred when these domains were properly 
spaced263. Another study also examined the synergistic effect of RGD and 
BMP-2 peptides on promoting osteogenic commitment. Cells seeded on these 
surfaces appeared more differentiated as indicated by a decrease of the 
stemness marker STRO-1 and an increase in RUNX2 expression264. It can be 
postulated that the extended network of FN provides a better substrate for cell 
adhesion and BMP-2 presentation. Therefore, cells receive signals more 
efficiently in order to commit towards the osteogenic lineage.  
 
ALP is commonly considered an early marker of osteogenesis, therefore its 
expression was also characterised. First, ALP expression was characterised 
over time. To do so, MSCs were seeded on FN/BMP-2 coated glass samples 
and ALP expression was measured at three time points (1 d, 14 d and 21 d 
after seeding). Higher ALP expression was found 21 d after seeding (Figure 
3.22). Following this result, ALP expression on the copolymers was measured 
after 21 d (Figure 3.25). Higher ALP expression was found on FN/BMP-2 
coated PMA compared to the rest of the samples. In addition, ALP expression 
was similar on the rest of the samples. Even though ALP is known to be 
involved in bone matrix mineralisation and osteogenesis, it might also indicate 
a less differentiated stem cell state. For example, it has been associated with 
the undifferentiated ESCs148 and iPSCs265. In addition, ALP+ stem cells were 
found to express higher levels of STRO-1. They also expressed higher levels of 
the stemness genes OCT4, Nanog and Sox2 compared to ALP- stem cells266.  
Differential ALP expression of MSCs have been also reported depending on 
the tissue of origin267. It can be hypothesized that MSCs maintain their 
stemness when cultured on FN/BMP-2 coated PMA where FN is presented in 
globules. This is in line with the higher RUNX2 expression observed on 
FN/BMP-2 coated PEA but not PMA.  These results suggest that hMSCs are 
already committed to osteogenic differentiation on PEA. 
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The matrix protein OCN is regularly a positive marker of osteogenesis and its 
expression was characterised 21 d after seeding. Immunofluorescent staining 
and image quantification showed increased OCN expression with increased 
EA/MA ratio (higher expression on FN/BMP-2 coated PEA and PEA70 
compared to PMA) which corresponds to a more connected FN network (Figure 
3.26, Figure 3.27). ICW™ assay showed similar results; higher OCN 
expression on FN/BMP-2 coated PEA compared to PEA70, PEA50 and PEA30 
(Figure 3.29). In both cases, OCN expression remained constant on the control 
samples. This result show that bound BMP-2 enhanced osteogenesis on the 
surfaces displaying a higher degree of FN fibrillogenesis. This is in accordance 
with the high RUNX2 expression of hMSCs found on FN/BMP-2 coated PEA 
compared to PEA30 and PMA.  
 
Based on the results, the degree of FN fibrillogenesis determined by the EA/MA 
ratio has an impact on FN ability to drive MSCs towards the osteogenic 
commitment. Higher RUNX2 and OCN expression was found on FN-coated 
PEA presenting BMP-2 whereas a decrease was found when FN network was 
less connected. A previous study showed that RUNX2 alone is not sufficient for 
inducing osteoblastic-specific gene expression, such as OCN, and BMP-2 is 
required for signal transduction268. In addition, several studies have associated 
the RGD domain with osteogenic differentiation. Garcia et al. reported that 
myogenic differentiation of C2C12 cells required binding to the RGD domain of 
FN66. Similarly, surface chemistry affected the osteogenic differentiation of 
osteoblast precursor cells through the binding of specific integrin receptors on 
RGD domain of adsorbed FN197.  The FNIII12-14 domain is also important in 
differentiation. Martino et al. reported enhanced morphogenesis when the 
integrin binding domain (FNIII9-10) and the growth factor binding domain 
(FNIII12-14) of FN are in close proximity suggesting synergistic signalling 
between the α5β1 integrin and the growth factor receptors269.  
 
In chapter 2, it was also demonstrated that the FNIII12-14 domain becomes 
less available with increased concentration of MA units, and in particular, 
PEA30 and PMA displayed lower availability (Figure 2.11). It can therefore be 
suggested that a higher degree of FN fibrillogenesis is necessary for the MSCs 
to receive outside signals and display a more osteogenic phenotype. In 
 87 
 
addition, immunogold staining showed higher BMP-2 binding on PEA and 
PEA70 but not on PEA50, PEA30 and PMA, demonstrating that BMP-2 is 
better presented on the open conformation of FN (Figure 2.14). It can be 
hypothesised that the well-connected network of FN on PEA allows the integrin 
binding domain of FN and BMP-2 to be in a closer proximity. This might lead to 
a more effective crosstalk resulting in enhanced osteogenic differentiation on 
PEA. With the introduction of MA units however, FN network appears less 
connected and globules are present on PEA30 and PMA. Adopting this 
conformation, the FNIII8, FNIII9-10 and FNIII12-14 domains become less available 
which might hinder the integrin/BMP-2 interaction. Subsequently, MSCs cannot 
efficiently interact with their environment and their potential to differentiation is 
poor. It is also important to note that the whole FN protein was used for the 
coatings in order to recapitulate to a degree the multifunctional nature of the 
complex ECM protein network. This system provides increased affinity as well 
as domains for cell adhesion and growth factor binding. However, it also 
increases the complexity of FN conformation upon adsorption. It can be thus 
suggested that structural changes which have not been investigated might 
contribute to the differential cell response.   
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4. Integrin adhesome 
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4.1 Introduction 
As already described, FAs are dynamic multiprotein structures which physically 
connect the actin cytoskeleton to the ECM. FAs serve as anchors and allow cell 
attachment to the surrounding environment. They also contribute to signal 
transduction through integrins and trigger signalling pathways which regulate a 
wide range of cell functions, such as migration. The diverse functions of FAs 
are reflected in their protein composition which changes in response to external 
physical and mechanical signals. For example, FAs undergo spatiotemporally 
cycles of assembly and disassembly during cell migration270. In addition, FAs 
composition changes in response to changes in force in order for cells to probe 
and respond to their mechanical environment 271, 272. 
 
Due to the molecular heterogeneity of adhesion structures and their dynamic 
nature, analysis of the FA protein composition and their interactions under 
different biological conditions is rather challenging. Techniques aiming at 
isolating FAs in combination with proteomic approach have contributed to the 
identification of proteins involved in the formation of FAs as well as the 
molecular mechanism directing their interactions. Proteomics is essentially a 
large-scale study of a set of proteins with regard to expression, structure, 
function, modifications, interactions, and changes in different environments and 
conditions273. The development of new strategies for peptide sequencing using 
mass spectrometry (MS) has been critical to the rapid advance of 
proteomics274. In general, a mass spectrometer consists of an ion source and a 
mass analyser. This instrument ionises sample molecules in a gas phase and 
then the ions are separated based on their mass-to-charge (m/z) ratio. There 
are two relevant techniques for ionization: matrix assisted laser 
desorption/ionization (MALDI) and electrospray ionization (ESI). Both 
approaches are able to ionise large and polar molecules without physically 
destroying them. Their difference is that a peptide mixture is co-crystallised with 
a UV laser in MALDI whereas the peptide mixture is ionised in a liquid solvent 
system which can be coupled to liquid-based separation method273.   
 
The complex protein network which FAs form has been collectively described 
as the ‘integrin adhesome’275. Progress in proteomics has considerably 
increased the number of FA components. Recent attempts to explore the 
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adhesome composition based on immunohistochemistry and proteomic 
analysis have identified more than 200 proteins as components of the 
adhesome276-278. Zaidel-bar et al. combined data from published experimental 
studies and reported that FA components can be intrinsic and physically reside 
in adhesion sites or they can be adhesion-associated, interacting with the 
intrinsic proteins and regulating their function279.  
 
 
Figure 4.1. The adhesome network279. The network consists of 156 intrinsic 
and associated components and include serine/threonine protein 
kinases/phosphatases, tyrosine kinases/phosphatases, integrins, cytoskeletal 
and adaptor proteins, actin-binding proteins and adhesion proteins279. 
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Proteomic studies have given important insights into the architecture of the 
adhesome as well as into the signals transduced across the network. The 
adhesome is a highly connective network and it is regulated by transient 
interactions between adhesome proteins and by signalling events. Methods for 
studying the adhesome are based on isolating these components by removing 
the cell body and nucleus.  For example. ice-cold water to weaken the cells 
followed by hydrodynamic force has been used280. In another study, cells were 
treated with a hypotonic solution which contained triethanolamine (TEA) to 
isolate and maintain the native FA composition. This is a low ionic strength 
buffer which causes cell swelling and weakens the integrity of the cell 
membrane by inducing osmotic pressure inside the cell. After that step, 
membrane bound organelles, actin cytoskeleton and nuclei were washed off by 
hydrodynamic force using a Waterpik dental jet281.  
 
The aim of this work is to develop a protocol to isolate FA of MSCs cultured on 
PEA and PMA in order to determine substrate-dependent differences in protein 
composition. We hypothesise that the differential conformation of adsorbed FN 
might result in changes in the protein composition of FAs and we seek to 
identify such differences. As shown by previous studies that have isolated FA 
components for MS, a different set of proteins were enriched on cells cultured 
on FN- compared to poly-D-Lysine- coated dishes282. To do so, a previously 
outlined method was used where cells are incubated in TEA and PBS flow is 
used to remove the cell body and isolate FAs on the surfaces. 
Immunofluorescent staining of vinculin was used to validate the efficiency of the 
method. Finally, extracted proteins extracted from PEA, PMA and glass were 
analysed by MS.    
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4.2 Materials and methods 
4.2.1 Materials 
List or reagents 
Dulbecco’s modified Eagle’s medium (high glucose)…. PromoCell® 
Dulbecco’s modified Eagle’s medium (low glucose)…... Sigma 
Dulbecco’s phosphate buffered saline………………….. Life Technologies 
Glutamax…………………………………………………… Sigma-Aldrich 
Penicillin/streptomycin……………………………………. Sigma 
Foetal bovine serum………………………………………. Life Technologies 
Trypsin/EDTA………………………………………………. Sigma 
Formaldehyde……………………………………………… Fischer Scientific 
Human plasma fibronectin………………………………... R&D 
Sodium dodecyl sulfate…………………………………… VWR 
Mouse monoclonal anti-vinculin antibody………………. Sigma 
Tween20®…………………………………………………... Sigma 
Triton® X 100……………………………………………….. Sigma 
Bovine serum albumin…………………………………….. Roche/Sigma 
Biotinylated anti-mouse antibody………………………… Vector Laboratories 
Fluorescein streptavidin…………………………………... Vector Laboratories 
Rhodamine-phalloidin…………………………………….. Invitrogen 
Vectashield with DAPI…………………………………….. Vector Laboratories 
Cy-3 anti-mouse antibody…………………………………  Jackson ImmunoResearch 
FASP kit…………………………………………………….. Expedeon 
 
4.2.2 C2C12 
C2C12 cells were purchased from Sigma-Aldrich. For expansion, cells were 
thawed and maintained in DMEM supplemented with 20% v/v FBS 1% v/v 
penicillin/streptomycin at 37 °C and 5% CO2. Cells were harvested when they 
reached 70%-80% confluency. They were washed with PBS followed by 2 ml of 
trypsin/EDTA. After removing trypsin/EDTA, cells were incubated at 37 °C until 
detached from the flask. Next, 4 ml of complete medium was added to the flask 
and cell suspension was transferred to a falcon tube. Cell density was 
measured using a Neubauer haemocytometer. Cells were used at passages P0 
to P5.  
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4.2.3 Human Mesenchymal Stem Cells 
MSCs were maintained in DMEM containing 10% v/v FBS and 1% v/v at 37°C 
and 5% CO2. Harvesting and splitting was carried out as described in section 
3.2.2. Cells were used at passages P0 to P5. 
 
4.2.4 Cell culture 
UV-sterilised PEA, PMA and glass samples were coated with FN at 20 µg/ml 
for 1 h. Cells were harvested by trypsinisation and cell suspension was diluted 
in FBS-free medium to a final density of 2500 cells/cm2. Cells were seeded 
onto the surfaces and maintained in serum free conditions for 3 h. After that, 
medium was replaced with medium containing 20% v/v (for C2C12 cells) and 
10% v/v FBS (for MSCs). Culture of C2C12 and MSCs was maintained for 1 d 
and 3 d respectively at 37 °C, 5% CO2. 
 
4.2.5 Optimisation of FA isolation using C2C12 cells 
For the isolation of FAs, a TEA-containing solution was prepared (2.5 mM in 
PBS, pH 7.2). One day after seeding, cells were washed with warm PBS and 
were incubated with the TEA solution for 3 minutes. Next, cells were washed 
with PBS for 10 sec using a dental waterpik at its highest, medium or lowest 
pressure. The extension tip of the waterpik was kept perpendicular to the 
surface and it was manually moved from the one end of the coverslip to the 
other.  
 
4.2.6 Optimisation of FAs isolation using MSCs 
MSCs were seeded on PEA, PMA and glass and culture was maintained for 3 
d. To isolate FAs, two approaches were carried out. In a first attempt, cells 
were washed with warm PBS and incubated with a 2.5 mM TEA-containing 
solution for 3 min. Next, a round mask fitted on top of the sample at a distance 
of 1 mm was used. The mask had on hole in the middle with the same diameter 
size as the waterpik tip. Next cells were washed with PBS for 10 sec. In a 
second attempt, cells were incubated with TEA for 2 min and a mask with three 
holes was fitted on top of the samples. Cells were washed with PBS for 5 sec 
by adjusting the tip in two of the holes (Figure 4.2). 
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Figure 4.2. Mask used for flashing the cells with PBS. The tip of the 
waterpik jet was fitted in two off the holes.  
 
4.2.7 Immunohistochemistry 
After treatment of cells with TEA solution and washing with PBS, cells were 
fixed (3.7% v/v formaldehyde/PBS) for 30 min at 4°C. C2C12 cells were 
washed with PBS and were permeabilised for 5 min. Next, samples were 
incubated with blocking solution (1% w/v BSA/PBS) for 30 min. Primary 
antibody containing mouse monoclonal anti-vinculin antibody was prepared in 
blocking solution. Cells were incubated with the solution at 4 °C overnight. The 
next day, samples were washed three times (0.5% v/v Tween-20/PBS) for 5 
min. Then, secondary antibody was prepared in blocking solution containing 
biotinylated anti-mouse antibody for 1 h at 37 °C. Samples were washed again 
and incubated with fluorescein streptavidin and rhodamine-phalloidin for 30 min 
at 37 °C in dark. Next, cells were washed and mounted with vectashield 
containing DAPI. The protocol for staining of MSCs is described in section 
3.2.6.  
 
4.2.8 Cell imaging 
Fluorescent pictures were taken using an epifluorescence microscope (Zeiss 
AXIO Observer Z1, Jena, Germany). 
 
4.2.9 Solubilising of FAs 
Samples were incubated with 100 µl of 1% w/v sodium dodecyl sulfate solution 
for 30 sec. A cell scrapper was used to remove the remaining proteins from the 
surfaces. Protein solution was extracted from 5 samples per condition, 
transferred to a low binding protein tubes and stored at -80°C.  
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4.2.10 Filtered-aided sample preparation 
First, a urea sample solution was prepared by adding 1 ml of Tris hydrochloride 
solution to one tube of urea. In addition, a 10x iodoacetamide solution was 
prepared by adding 100 µl urea sample solution to one tube of iodoacetamide 
provided with the kit. Next, 200 µl of urea solution was mixed with the protein 
extract. The solution was transferred in a spin filter and centrifuged at 14000 x 
g for 15 min. Next, 10 µl of 10x iodoacetamide solution and 90 µl of urea 
solution were added to the spin filter and were vortexed for 1 min and 
afterwards they were incubated without mixing in dark. After 20 min, the spin 
filter was centrifuged at 14000 x g for 10 min. Next, 100 μl of urea solution was 
added to the spin filter which was centrifuged at 14000 x g for 15 min. After 
repeating this step twice, the flow-though was discarded from the collection 
tube. Next, 100 μl of 50 mM ammonium bicarbonate solution were added to the 
filter and centrifuged at 14000 x g for 10 min. This step was repeated twice. 
Next, 75 μl of digestion solution was added and vortexed for 1 min. The filter 
was incubated at 37 °C for 4 h was transferred to a new collection tube. 40 μl of 
50 mM ammonium bicarbonate solution were added and the filter was 
centrifuged for 10 min and this step was repeated once. Next, 50 μl of sodium 
solution were added and the filter was centrifuged for 10 min. Finally, the filtrate 
contained digested proteins and was acidified with trifluoroacetic acid.   
 
4.2.11 Mass spectrometry 
The digested peptides were analysed by ESI Fourier transform ion cycolotron 
resonance mass spectrometry. Data was processed using the automated 
Matrix Science Mascot Daemon server (v 2.6.0) allowing a mass tolerance of 
0.5 Da. 
 
4.2.12 Identification of FA proteins  
In order to identify the set of proteins previously identified as adhesion 
components, the adhesome website (http://www.adhesome.org/) was used. 
The adhesome network was developed from the biomedical literature and 
consists of 150 components of FAs which are both intrinsic and associated 
proteins.  
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4.2.13 Protein abundance  
Mascot uses the mass values and calculates the probability, P, that the 
observed match between the experimental data and the database sequence is 
a random event. The match with the lowest probability is reported as the best 
match. Protein score is the sum of identification scores of its peptides. There 
are different approaches to obtain quantitative proteomic information about 
protein abundance. For example, a high protein score has been used to 
characterise protein abundance283. However, scores have been considered a 
poor estimate of protein abundance284. Instead, more accurate ‘protein 
abundance indices’ have been developed and essentially represent the number 
of observed peptides divided by the number of observed peptides per 
protein285. Ishima et al. reported that the relationship between the number of 
peptides identified and the protein amount in a sample is logarithmic, described 
by the term exponentially modified protein abundance index (emPAI). emPAI 
offers a label-free quantitation of the proteins in a mixture based on protein 
coverage by the peptide matched286. The FA proteins were analysed based on 
both the emPAI and P. 
 
4.2.14 Principal component analysis  
In order to determine whether the results are variable, the protein hits were 
associated with the corresponding gene using the Entrez Gene database in 
NCBI. Next, a principal component analysis (PCA) based on the emPAI and P 
was carried out in R.   
 
4.2.15 Gene ontology and enrichment analysis 
The PANTHER (Protein Analysis THrough Evolutionary Relationships, v11.1) 
classification system287 was used to carry out a Gene Ontology (GO) 
classification. Two protein lists were generated for classification. The first list 
contained the FA proteins and the second one contained the rest of the 
identified proteins. Classification was performed according to the protein class, 
molecular function and biological process. The DAVID (Database for 
Annotation, Visualization and Integrated Discovery, v6.1) bioinformatics 
resource288 was used to characterise gene abundance. 
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4.3 Results  
4.3.1 Optimisation using C2C12 
Initially, C2C12 cells were used to optimise the protocol. Cells were cultured on 
FN-coated PEA, PMA and glass in serum free conditions for the first 3 h and, 
next, in complete medium. After 24 h, cells were treated with TEA solution for 3 
min. In order to assess the effect of PBS pressure, waterpik was set at the 
highest, intermediate and lowest setting and the tip was moved manually over 
the surfaces. To evaluate the results, a vinculin, actin and nucleus staining was 
carried out.  
 
Figure 4.3. Immunofluorescence images of C2C12 cells on FN-coated PEA 
1 d after seeding. Cells were treated with TEA for 3 min and washed with PBS 
at the highest (top row), intermediate (middle row) or low pressure (bottom 
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row). Staining of vinculin (green) actin (red) and nuclei (blue). Scale bar is 50 
µm (top row) and 100 µm (middle and bottom row). (n=1 per sample). 
 
Figure 4.4. Immunofluorescence images of C2C12 cells on FN-coated 
PMA 1 d after seeding. Cells were treated with TEA for 3 min and washed 
with PBS at the highest (top row), intermediate (middle row) or low pressure 
(bottom row). Staining of vinculin (green), F-actin (red) and nuclei (blue). Scale 
bar is 50 µm (top and middle row) and 100 µm (bottom row). (n=1 per sample). 
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Figure 4.5. Immunofluorescence images of C2C12 cells on FN-coated 
glass 1 d after seeding. Cells were treated with TEA for 3 min and washed 
with PBS at the highest (top row), intermediate (middle row) or low pressure 
(bottom row). Staining of vinculin (green), F-actin (red) and nuclei (blue). Scale 
bar is 50 µm (top row) and 100 µm (middle and bottom row). (n=1 per sample). 
 
Washing off the cells at the highest waterpik pressure resulted in the removal of 
cell body and nuclei in all the surfaces while vinculin and actin remained on the 
samples. High pressure had a stronger effect on cells seeded on PMA and 
glass where vinculin and actin were sparse (Figure 4.4, Figure 4.5, top row). In 
contrast, more vinculin was observed on PEA (Figure 4.3, top row). The same 
procedure was followed using intermediate waterpik pressure. Similarly, cell 
body and nucleus were removed from some cells on PEA. However, isolation 
was not efficient since intact cells were observed as well (Figure 4.3, middle 
 100 
 
row). For PMA and glass, intermediate pressure was sufficient to remove the 
cell body and nuclei while vinculin and actin remained attached to the surfaces 
(Figure 4.4, Figure 4.5, middle row). As expected, washing the cells at the 
lowest waterpik setting did not remove the cell body efficiently from the 
surfaces (Figure 4.3, Figure 4.4, Figure 4.5, bottom row). Based on these 
results, isolation of FAs is surface-dependent since PBS flow at the same 
setting did not give similar results. Highest flow was more efficient for isolating 
FAs on PEA whereas intermediate pressure was better for washing off cells on 
PMA and glass.   
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4.3.2 Isolation of FAs using hMSCs  
MSCs were seeded on FN coated PEA, PMA and glass and culture was 
maintained for 3 d. Next, cells were incubated with TEA solution for 3 min and 
they were washed with PBS for 10 sec using a waterpik jet. A mask with a hole 
in the middle was placed on top of the samples at a distance of 1 mm. To 
determine the effect of fluid flow on the removal of cell body, the waterpik jet 
was set at its lowest, intermediate and highest pressure setting.  
 
Figure 4.6. Isolation of FAs on FN-coated PEA at high, intermediate and 
low flow fluid. Immunofluorescent pictures of hMSCs 3 d after seeding. Cells 
were incubated with TEA for 3 min and were washed with PBS at the highest 
(top row), intermediate (middle row) or low pressure (bottom row). Fluorescent 
staining of vinculin (red), F-actin (green) and nuclei (blue). Scale bar is 50 µm 
(top row) and 100 µm (middle and bottom row). (n=1 per sample). 
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Figure 4.7. Isolation of FAs on FN-coated PMA at high, intermediate and 
low flow fluid. Immunofluorescent pictures of hMSCs 3 d after seeding. Cells 
were incubated with TEA for 3 min and were washed with PBS at the highest 
(top row), intermediate (middle row) or low pressure (bottom row). Fluorescent 
staining of vinculin (red), F-actin (green) and nuclei (blue). Scale bar is 100 µm. 
(n=1 per sample).  
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Figure 4.8. Isolation of FAs on FN-coated glass at intermediate and low 
flow fluid. Immunofluorescent pictures of hMSCs 3 d after seeding. Cells were 
incubated with TEA for 3 min and were washed with PBS at the highest (top 
row), intermediate (middle row) or low pressure (bottom row). Fluorescent 
staining of vinculin (red), F-actin (green) and nuclei (blue). Scale bar is 100 µm. 
(n=1 per sample). 
 
At high and intermediate waterpik pressure, fluid flow removed the cell body 
and nuclei from PEA leaving vinculin and actin. However, high flow resulted in 
sparse amount of vinculin left on PMA (Figure 4.7, top row). Contrary, cell body 
and DNA were more efficiently removed with intermediate flow pressure. Fluid 
flow at the lowest setting gave poor results on all surfaces. Even though the 
nucleus was removed from some cells, intact cells were found on the surfaces 
(Figure 4.6, Figure 4.7, Figure 4.8, bottom row).  
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Based on these observations, isolation of FAs was improved with increased 
PBS flow, the results were not homogenous over the surface. Intact cells that 
have maintained their cell body and nucleus were observed, particularly 
towards the edge of the samples, irrespective of the flow pressure (Figure 4.9, 
Figure 4.10, Figure 4.11). 
 
 
Figure 4.9. Isolation of FAs on FN-coated PEA at high, intermediate and 
low flow pressure. Immunofluorescent pictures of hMSCs 3 d after seeding at 
the edge of the sample. Cells were incubated with TEA for 3 min and were 
washed with PBS. Fluorescent staining of vinculin (red), actin (green) and 
nuclei (blue). Scale bar is 200 µm. 
 
 
Figure 4.10. Isolation of FAs on FN-coated PMA at high, intermediate and 
low flow pressure. Immunofluorescent pictures of hMSCs 3 d after seeding at 
the edge of the sample. Cells were incubated with TEA for 3 min and were 
washed with PBS. Fluorescent staining of vinculin (red), actin (green) and 
nuclei (blue). Scale bar is 200 µm. 
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Figure 4.11. Isolation of FAs on FN-coated glass at medium and low flow 
pressure. Fluorescent pictures of hMSCs 3 d after seeding at the edge of the 
sample. Cells were incubated with TEA for 3 min and were washed with PBS. 
Fluorescent staining of vinculin (red), actin (green) and nuclei (blue). Scale bar 
is 200 µm. 
 
Based on these results, a mask with one hole in the middle was not sufficient to 
remove the cell body and nucleus in the majority of cells. As expected, the 
efficiency of the method was surface-dependent. More specifically, fluid flow at 
the highest setting was required for PEA whereas fluid flow at intermediate 
setting was required for PMA and glass. 
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4.3.3 Isolation of hMSCs using a mask 
To remove the cell body and nuclei from the majority of cells, a mask with two 
holes was used. Similarly to the previous method, culture was maintained for 3 
d. However, cells were incubated with TEA for 2 min and they were washed 
using a waterpik jet for 5 sec from each hole. Based on the previous 
optimisation, the fluid flow was the highest setting for PEA and intermediate 
setting for PMA. Treating the cells with TEA for 2 min followed by two washes 
for 5 sec removed cell bodies and nuclei from most of the cells while FAs 
remained intact (Figure 4.12).  
 
 
Figure 4.12. Isolation of FAs in hMSCs. Immunofluorescent pictures of 
hMSCs on FN-coated PEA, PMA and glass 3 d after seeding. Cells were 
incubated with TEA for 2 min and were washed with PBS using a mask and 
high (PEA) or intermediate flow (PMA, glass). Fluorescent staining of vinculin 
(red) and F-actin (green). Scale bar is 50 µm. (n=1 per sample). 
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4.3.4 Proteomics 
4.3.4.1 PCA 
To identify the protein composition of FAs, the SDS solution was digested using 
FASP and protein identification was carried out using the Mascot search 
engine. Regarding the proteins identified in the mixture, 377 proteins were 
found on PEA, 548 on PMA and 469 on glass. As expected, the identified 
proteins covered a wide variety including cytoskeletal, cytosolic and nuclear 
proteins. There were also proteins because of contamination such as keratin. It 
should be noted that some of the common FA proteins such as paxilin were not 
identified. This might be because the peptides were below the threshold of 
detection. To analyse the results, the proteins were connected to the 
corresponding gene. In order to assess whether the results were variable, a 
PCA based on the emPAI was performed to determine the variability of the 
results. According to the analysis, results are variable (Figure 4.13). The 
proportion of variance expressed in each PC is: PC1 = 71% and PC2 = 28.9%.   
 
Figure 4.13. PCA based on the emPAI. All the proteins hits in the solubilised 
solution of PEA, PMA and glass were processed in R. (n=5 per sample, 1 
biological replicate). 
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To identify the proteins previously associated with the formation of FAs, a list in 
the adhesome network was used. It was found that 26 proteins were common 
between the list and the search results (Table 4.1). To determine whether the 
identified FA-proteins are variable on PEA, PMA and glass, a second PCA was 
carried out using this protein set. Simialy, the results were variable (Figure 
4.14). The proportion of variance epxressed in each PC is: PC1 = 92.1% and 
PC2 = 7.8%.   
 
 
Figure 4.14. PCA based on the emPAI. The protein hits in the solubilised 
solution of PEA, PMA and glass previously identified as components of FAs 
were processed in R. (n=5 per sample, 1 biological replicate). 
 
4.3.4.2 Analysis based on the emPAI and probability score 
Further analysis revealed that 15 proteins were common in PEA, PMA and 
glass (Figure 4.15), 6 we shared between PMA and glass and 1 was shared 
between PEA and PMA (Figure 4.16). In addition, 1 protein was found only in 
PEA whereas 2 only in PMA  and glass (Figure 4.17). In order to extract 
quantitative information about the abundance of FA proteins, the emPAI was 
used for plotting.  
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Figure 4.16. Logged emPAI of FA-associated genes shared between PMA and 
glass (left) and between PEA and PMA (right). (n=5 per sample, 1 biological 
replicate). 
 
Figure 4.17. Logged emPAI of FA-associated genes unique in PEA (left) and 
glass (right). (n=5 per sample, 1 biological replicate). 
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To assess whether the proteins matches were significant, FA proteins were 
analysed based on the P.  
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Figure 4.19. Probability score (P) of FA-associated genes shared between on 
PMA and glass (left graph) and between PEA and PMA (right graph). (n=5 per 
sample, 1 biological replicate). 
  
Figure 4.20. Probability score (P) of FA-associated genes unique on PEA, 
PMA and glass. (n=5 per sample, 1 biological replicate). 
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Gene    material emPAI score (P) 
ACTB  
actin beta 
PEA 4.43 1188 
PMA 7.53 1808 
glass 15.79 1929 
ACTN1  
actinin alpha 1 
PEA 0.51 857 
PMA 0.63 926 
glass 0.9 932 
ARF1  
ADP ribosylation factor 1 
PEA - - 
PMA 0.8 99 
glass 0.8 95 
CALR  
calreticulin 
PEA - - 
PMA - - 
glass 0.34 283 
CAPN2  
calpain 2 
PEA - - 
PMA - - 
glass 0.13 62 
CAV1  
caveolin 1 
PEA - - 
PMA 0.99 67 
glass 0.58 91 
CSRP1  
cysteine and glycine rich protein 1 
PEA - - 
PMA 0.26 90 
glass 0.26 107 
FLNA  
filamin A 
PEA - - 
PMA 0.1 2800 
glass 0.34 2609 
HSPB1  
heat shock protein family B (small) 
member 1 
PEA 1.28 272 
PMA 1.8 477 
glass 3.22 536 
ITGB1  
integrin subunit beta 1 
PEA 0.11 224 
PMA 0.24 335 
glass 0.24 283 
LASP1  
LIM and SH3 protein 1 
PEA 0.48 189 
PMA - - 
glass - - 
MARCKS  
myristoylated alanine rich protein 
kinase C substrate 
PEA 0.56 152 
PMA 0.34 252 
glass 0.56 107 
MSN  
moesin 
PEA 0.52 285 
PMA 1.31 907 
glass 1.15 722 
MYH9  
myosin heavy chain 9 
PEA 0.8 2024 
PMA 1.26 3692 
glass 1.36 3170 
PABPC1 
poly(A) binding protein cytoplasmic 1 
PEA - - 
PMA 0.07 86 
glass 0.22 178 
PFN1  
profilin 1 
PEA 2.43 234 
PMA 3.67 703 
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glass 2.43 443 
PLEC  
plectin 
PEA 0.07 451 
PMA 0.19 1232 
glass 0.11 791 
RACK1  
receptor for activated C kinase 1 
PEA - - 
PMA 0.31 283 
glass 0.14 152 
RDX  
radixin 
PEA - - 
PMA - - 
glass 0.32 259 
SLC16A3  
solute carrier family 16 member 3 
PEA 0.1 35 
PMA 0.1 89 
glass - - 
SLC3A2  
solute carrier family 3 member 2 
PEA - - 
PMA - - 
glass 0.08 68 
TLN1  
talin 1 
PEA 0.19 636 
PMA 0.37 1177 
glass 0.37 1180 
TUBA1B  
tubulin alpha 1b 
PEA 2.39 886 
PMA 2.73 1226 
glass 2.39 1188 
VCL  
vinculin 
PEA 0.28 263 
PMA 0.18 389 
glass 0.22 310 
VIM  
vimentin 
PEA 32.73 3579 
PMA 32.73 32.74 
glass 61.43 5110 
ZYX  
zyxin 
PEA 0.23 56 
PMA 0.36 148 
glass 0.09 95 
Table 4.1. The table shows the FA-associated genes together the emPAI and 
P in each material (PEA. PMA and glass).  
 
Protein Function 
ACTB 
Highly conserved proteins involved in cell motility, 
structure and intercellular signalling. Major 
component of the contractile apparatus.  
ACTN1 
Represents cytoskeletal proteins. Actin-binding with 
diverse functions dependent on the cell type.  
ARF1 
Expresses small guanine nucleotide-binding. 
Involved in protein trafficking among different 
compartments.   
CALR 
Major Ca2+-binding protein in endoplasmatic 
reticulum.  
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CAPN2 Intracellular cysteine proteases.  
CAV1 
Scaffolding protein. Main component of the caveolae 
plasma membranes found in most cell types. Involved in 
the interactions of  integrins to the tyrosine kinase FYN, 
an initiating step in coupling integrins to the Ras-ERK 
pathway. 
CSRP1 
Involved in processes important for differentiation 
and development.  
FLNA 
Non-muscle F-actin-binding protein. Contributes to 
the elastic properties of F-actin networks and to the 
recruitment of F-actin into extended networks.  
HSPB1 
Translocates to the nucleus from the cytoplasm in 
response to stress. Acts as a molecular chaperone 
that promotes the correct folding of other proteins.  
ITGB1 
Receptor of ECM proteins, such as FN and 
collagen.  
LASP1 
Plays a role in the function of cytoskeleton. 
Localised to multiple sites of dynamic actin 
assembly, such as FAs and lamellipodia membrane.  
MARCKS 
Actin filament crosslinking protein localised to the 
plasma membrane.  
MSN 
Belongs to the ERM family. Mediates interactions 
between cytoskeletal structures and plasma 
membrane,  
MYH9 
Non-muscle myosin. Involved in multiple functions, 
including cytokinesis, cell motility and maintenance 
of cell shape.  
PABPC1 
Binds to poly(A) tail of mRNA. Shuttles between 
cytoplasm and nucleus. Binding of PABPC1 to 
poly(A) promotes ribosome recruitment and initiates 
translation.  
PFN1 
Actin-binding protein. Involved in the structure  of 
the cytoskeleton by regulating actin polymerisation.  
PLEC 
interlinks intermediate filaments with microtubules 
and microfilaments.  
RACK1 
Guanine nucleotide-binding protein. Acts as a 
scaffolding/anchoring protein, regulates diverse cell 
activities and the expression of binding proteins.  
RDX 
Cytoskeletal protein that belongs to the ERM family. 
Involved in the interaction between membrane 
proteins and cytoskeleton.  
SLC16A3 
Mediated lactic acid and pyruvate transport across 
plasma membrane. 
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SLC3A2 
Cell surface, transmembrane protein. Involved in 
the regulation of intracellular Ca2+ and transports of 
L-type amino acids.  
TLN1 
Contributes to connecting cytoskeletal structures to 
the plasma membrane.  
TUBA1B Major components of microtubules. Binds to GTP. 
VCL 
Cytoplasmic actin-binding protein found in FAs. 
Involved in protein-protein interactions and 
regulates cell-ECM interactions.  
VIM 
Intermediate filament protein. Together with actin 
microfilaments, they are involved in cytoskeleton 
structure. Contributes to cell morphology and 
integrity.  
ZYX 
FA protein. Binds to ACTN1. Involved in the 
formation of actin-rich structures and contributes to 
cell adhesion to the ECM.  
Table 4.2. Summury of the function of the identified FA proteins.  
 
The intermediate filament vimentin had the higher emPAI followed by actin and 
profilin on the three substrates. Other proteins with high emPAI were tubulin 
and heat shock protein family B (small) member 1 (Table 4.1). It should be 
noted though that a high emPAI does not always corresponds to a high score. 
For example, the emPAI of plectin is 0.19 on PMA and the score is 1232. This 
might be because peptides are scored so that they best match the data rather 
than by their absolute intensities.   
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4.3.4.3 Gene ontology analysis  
The next step was to connect these FA proteins with its associated GO terms 
using PANTHER. The proteins identified in isolated FAs were classified 
according to their protein class, biological process and molecular function using 
the PANTHER classification system.  
 
 
Figure 4.21. Classification of FA proteins based on their protein class. 
The pie charts describe the protein class of the FA proteins identified in PEA, 
PMA and glass and the percentage of genes involved in each protein class. 
(n=5 per sample, 1 biological replicate). 
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Figure 4.22. Classification of FA proteins based on their biological 
process. The pie charts describe the biological process of the FA proteins 
identified in PEA, PMA and glass and the percentage of genes involved in each 
biological process. (n=5 per sample, 1 biological replicate). 
 
Figure 4.23. Classification of FA proteins based on their molecular 
function. The pie charts describe the molecular functions of the FA-associated 
genes identified in PEA, PMA and glass and the percentage of genes involved 
in each molecular process. (n=5 per sample, 1 biological replicate). 
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According to classification, most of the identified proteins are cytoskeletal 
proteins, such as actin, and intermediate filament proteins such as plectin, 
moesin, filamin-A, vimentin (Figure 4.21). They are mainly involved in cellular 
component organization (Figure 4.22) and they have structural activity as well 
as binding activity, for example Ca2+ ion binding activity (e.g. calreticulin) and 
protein binding (e.g. zyzin and myosin-9) (Figure 4.23).  
 
4.3.4.4 Gene enrichment analysis 
Next, a gene enrichment analysis was carried out using DAVID. Gene 
enrichment analysis is a computational method which compares the abundance 
of specific GO-terms in a dataset. Statistical significance is determined by 
calculating a modified Fisher P-value exact test. The threshold of P-value was 
set at 0.05 and a smaller P-value shows more enrichment. The fold enrichment 
was estimated as well and is a measure of the magnitude of enrichment. The 
majority of genes in PEA, PMA and glass encode phosphoproteins (e.g. 
vinculin, talin, zyxin, vimentin). Moreover, they are post-translationally modified 
by the attachment of at least one acetyl group. They are found in the plasma 
membrane and in cytoplasm and are mainly cytoskeletal-related and actin-
binding proteins. The group with the highest gene enrichment are cytoskeletal-
related protein and FA proteins (Table 4.3, Table 4.4,Table 4.5).  
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PEA 
Term % P Value Fold Enrichment 
phosphoprotein 92.3 2.24E-08 2.44 
acetylation 80.7 1.35E-13 5.89 
plasma membrane 76.9 6.98E-07 2.7 
cytoplasm 65.3 2.66E-07 3.77 
non-membrane-bounded organelle 61.5 7.94E-06 3.15 
cytoskeleton 50 5.41E-12 15.12 
plasma membrane part 46.1 0.001074 2.78 
cytoskeletal protein binding 46.1 7.37E-10 11.88 
cytosol 42.3 7.17E-05 4.22 
actin binding 42.3 2.03E-10 16.84 
cytoskeleton organization 38.4 7.20E-09 14.1 
cell membrane 38.4 0.00119 3.37 
focal adhesion 34.6 9.29E-08 12.64 
Table 4.3. Gene enrichment analysis of FA proteins found on PEA. The 
table describes enriched terms associated with the gene list, the percentage of 
involved genes/total genes, the P-value and the fold enrichment.  
PMA 
Term % P Value Fold Enrichment 
phosphoprotein 100 3.42E-09 2.64 
acetylation 80.9 4.14E-11 5.9 
plasma membrane 71.4 8.91E-05 2.53 
non-membrane-bounded organelle 66.6 7.64E-06 3.44 
cytoplasm 61.9 2.27E-05 3.57 
cytoskeleton 52.3 2.00E-10 15.84 
cytosol 47.6 4.88E-05 4.8 
actin binding 42.8 1.41E-08 17.06 
cytoskeletal protein binding 42.8 4.07E-07 11.03 
plasma membrane part 42.8 0.00963 2.61 
cytoskeleton organization 38.1 3.06E-07 14.6 
focal adhesion 38.1 3.69E-07 13.49 
cell motion 38.1 5.47E-07 13.4 
structural molecule activity 38.1 2.84E-05 7.8 
Table 4.4. Gene enrichment analysis of FA proteins found on PMA. The 
table describes enriched terms associated with the gene list, the percentage of 
involved genes/total genes, the P-value and the fold enrichment.  
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glass 
Term % P Value Fold Enrichment 
phosphoprotein 91.6 1.34E-07 2.42 
acetylation 83.3 1.90E-13 6.08 
plasma membrane 75 5.04E-06 2.64 
cytoplasm 66.6 4.43E-07 3.84 
non-membrane-bounded organelle 62.5 1.19E-05 3.21 
cytoskeleton 50 4.47E-11 15.12 
cytoskeletal protein binding 45.8 5.16E-09 11.8 
cytosol 45.8 2.87E-05 4.59 
actin binding 41.6 2.13E-09 16.59 
plasma membrane part 41.6 0.007632199 2.52 
cytoskeleton organization 37.5 6.04E-08 13.96 
focal adhesion 37.5 9.29E-08 12.64 
cell membrane 37.5 0.002858998 3.28 
actin-binding 33.3 1.09E-08 25.95 
cell motion 33.3 2.20E-06 11.39 
regulation of actin cytoskeleton 33.3 2.97E-06 10.51 
structural molecule activity 33.3 7.91E-05 6.82 
cell projection 33.3 1.15E-04 6.37 
disease mutation 33.3 0.001961124 4.02 
Table 4.5. Gene enrichment analysis of FA proteins found on glass. The 
table describes enriched terms associated with the gene list, the percentage of 
involved genes/total genes, the P-value and the fold enrichment. 
 
The FA pathway (generated by Kyoto Encyclopedia of Genes and Genomes 
(KEGG)289. It represented the interactions of the identified proteins and how 
they are involved in the regulation of cell motility, regulation and survival 
(Figure 4.24).  
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Figure 4.25. Complete list of symbols in KEGG pathway. 
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4.3.4.5 Analysis of non FA proteins 
The remaining proteins detected in the solubilised mixture have not been 
previously associated with the regulation and function of FAs. In order to get 
insights into their function and the processes they are involved in, all the 
proteins found on PEA, PMA and glass were classified according to their 
protein class, molecular function and biological process using PANTHER.  
 
 
Figure 4.26. Classification of non-FA associated proteins based on their 
protein class. (n=5 per sample, 1 biological replicate). 
 
 
Figure 4.27. Classification of non-FA associated proteins based on their 
biological process. (n=5 per sample, 1 biological replicate). 
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Figure 4.28. Classification of non-FAs associated proteins based on their 
molecular function. (n=5 per sample, 1 biological replicate). 
 
Based on the protein class, the majority of the proteins are nucleic acid binding 
protein such as histones, nuclear ribonucleoproteins, and ribosomal proteins. 
Enzyme modulators such as G-proteins as well as cytoskeletal proteins were 
also identified (Figure 4.26). The proteins have mainly binding activity (protein, 
lipid and nucleic acid binding), catalytic activity (hydrolase and transferase 
activity) and structural activity (Figure 4.28). As expected, the majority of 
proteins are involved in a wide range of biological processes such as cell cycle 
and communication as well as in metabolic processes (Figure 4.27). The wide 
variety of proteins detected indicate that some cells remained intact thus 
proteins in cell body and nucleus were contained in the solubilised mixture.
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4.4 Discussion 
FAs are multiprotein adhesion structures involved in cell fate by incorporating 
external cues to signaling pathways. In order to underastand how the 
underlying layer of FN guides the formation of FA structures, it is essential to 
investigate the FA protein compostion. Previous studies have described 
methods for isolating FAs and cells were bound to FN-coated magnetic 
beads290, 291 or FN-coated dishes278. This chapter focuses in the development 
of a method for the isolation of FAs from hMSCs seeded on PEA and PMA. 
After the protocol was optimised, protein composition of isolated FAs were 
characterised by proteomic analysis.  
 
To optimise the protocol, C2C12 cells and hMSCs were seeded on FN-coated 
PEA, PMA and glass. Following a mehod developed by Kuo et al281, cells were 
incubated with TEA solution to weaken the cell body and next they were 
removed with PBS using a waterpik dental jet. A vinculin, actin and nuclei 
staining was then performed to evaluate the efficiency of the method. In a first 
attempt, the waterpik tip was moved manually over the surfaces and the PBS 
pressure was adjusted at three settings (high, intermediate, low). It was found 
that the efficiency of the flow in isolating FAs depends on the substrate. More 
specifically, higher flow is required to wash off the cell body and nuclei from 
cells attached on PEA (Figure 4.3) whereas intermediate flow was required for 
PMA and glass (Figure 4.4, Figure 4.5). Although FAs remained attached on 
the surfaces while cell body and nuclei were removed, it was challenging to 
keep all conditions consistent (e.g. distance of the tip from the surface) leading 
to variable results. In addition, PBS flow often resulted in breaking the samples.  
 
To improve the process, a mask with one hole in the middle was used and was 
placed on top of the surfaces. In this case, hMSCs were seeded onto FN-
coated PEA, PMA and glass. Results were more consistent, however this 
method was not sufficient enough since intact cells, particulary at the edge of 
the surface, were observed (Figure 4.9, Figure 4.10, Figure 4.11). Another 
mask having two holes was used next. Cell body and nuclei were sufficiently 
removed from the surfaces. Similarly, better results were observed at high PBS 
flow in PEA and at intermediate flow in PMA and glass (Figure 4.12). After the 
protocol was optimised, FAs attached on the FN-coated surfaces were 
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solubilised using an SDS solution and a cell scraper. Peptide mixture was 
digested with FASP and analysed by ESI. It should be mentioned that FA 
fractions contain actin. However, this is unavoidable since FAs and actin 
cytoskeleton are interdependent structurers. 
  
A wide variety of proteins were identified including FA proteins as well as 
cytoskeletal and nuclear proteins. ECM proteins were identified too, including 
fibronectin, laminin, collagen and tenascin. A literature-based list containing 
FA-related protein was obtained from the adhesome network and was used to 
identify a subset of proteins which have been previously described as FA 
components279. The identified protein were characterised based on the emPAI 
which provides a way to obtain quantitative information about protein 
abundance, and the probability score. Two lists of identified proteins were used 
for analysis: a list containing the FA proteins and a list with the remained 
identified proteins. Analysing both lists by PCA based on the emPAI showed 
the three different protein mixtures are variable (Figure 4.13, Figure 4.14).  
Comparing the adhesome network list and the identified proteins, it was found 
that 26 proteins were shared. As expected, most of the proteins were common 
in PEA, PMA and glass (Figure 4.15). In addition, LASP1 was uninque on PEA, 
and RDX and SLC3A2 were only detected in glass (Figure 4.17). LASP1 is a 
signaling molecule292 and can bind to actin293 and zyxin294. The expression of 
LASP1 have been associated with changes in FAs, migration and 
proliferation295, 296. RDX belongs to the ezrin/radixin/moesin (ERM) protein 
family and facilitates the interactions between actin filaments and focal 
adhesion proteins297. RDX is also involved in integrin activation298. SLC3A2 is a 
type II transmembrane glyocoprotein and it has been found to associate with β 
1 integrin299, 300.  
 
Based on the protein class classification (Figure 4.21), the percentage of 
cytoskeletal proteins is similar on PMA and glass (36.70% and 38.70%), 
whereas it is higher on PEA (47.60%). The same trend is observed on most of 
protein class subcategories, such as cell adhesion molecule and cell junction 
protein. In line with this, the classification based on the molecular functon 
(Figure 4.23) reveales more similarities between PMA and glass. For example, 
similar percentag of proteins with binding and catalytic/receptor binding activity 
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are found on PMA and glass. It can thus be postulated that PEA triggers a 
distinct cell behaviour in terms of substrate adhesion, whereas cells on PMA 
and glass exhibit a similar behaviour. These results might explain the 
differences observed on cell area and circularity, with cells being more well 
spread with increased EA concentration (Figure 3.13, Figure 3.14). It should be 
noted though that these results might not be representative due to the lack of 
replicates. 
  
The output of the proteomic analysis is a long list of identified proteins 
characterised by a probability score and the quantitative value emPAI. In order 
to interpret these data and understand the proteome function, a Gene Ontology 
analysis was carried out using the PANTHER classifier and the DAVID 
bioinformatics resources. PANTHER and DAVID facilitates the high-throughput 
analysis by combining gene function, ontology, pathways and statistical 
analysis tools and aim at extracting biological meaning from large data set. 
Classification according to the protein class, molecular function and biological 
process showed that the identified FA proteins are mainly cytoskeletal and 
actin-binding proteins. Gene enrichment analysis showed that this group 
together with FA proteins have the highest enrichment.  
 
Based on the emPAI and P, vimentin was the most abudant protein identified in 
the solubilised solution extracted from PEA, PMA and glass. Vimentin is a one 
of the most widely expressed intermidiate filament proteins and is mainly found 
in cells of mesenchymal origin301, 302. Generally, vimentin plays a functional and 
structural role in regulatin the cytoskeleton. There is also evidence that it 
associates with integrins. For example, vimentin interacts with α2β1-eriched 
FAs303, with α6β4 integrin when cells were attached to either laminin 5 or FN304 
and with α5β1 integrin305. The second most abundant protein was actin. Actin is 
central in FA regulation and mechanotransduction. It interacts with numerous 
proteins such as talin306, filamin307, and actinin308. Other proteins were 
identidied and can provide a direct link to actin cytoskeleton. For example, 
plectin can provide a direct link to vimentin309, 310.  
 
Ovarall, this chapter describes the optimisation of a method to isolate MSC 
FAs. Regarding the mass spectrometry data, further replicates are required in 
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order to statistically determine whether there are differences in protein 
compostion depending on the material interface. Furthermore, well known FA 
proteins were not identified or they were characterised by low abundance. This 
may be due to the presence of significant amounts of actin and FN in FA 
fractions. Subsequently, further steps are required in order to remove actin, for 
example by immunodepletion311. 
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5. Cell migration 
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5.1 Introduction 
Cell migration is a highly integrated process and plays an important role in both 
physiological and pathological cell processes, for example morphogenesis 
during development, immune response, wound repair and tumour 
metastasis312. There are different modes of cell migration, such as single-cell 
migration (amoeboid or mesenchymal) or collective migration, and they depend 
on the cell type313. For example, epithelial cells move along a basement 
membrane314 whereas leukocytes migrate along and through any membrane in 
the body315. Cells exerting mesenchymal migration are characterised by high 
levels of adhesion to the ECM and cytoskeleton contractility. Contrary, 
amoeboid migration describes the migration of highly motile, rounded or 
ellipsoidal cells which do not form FAs and exert weak traction forces on the 
surrounding environment316. Collective cell migration is involved in tissue 
formation, organ development and wound healing and refers to the coordinated 
migration of a group of cells in the same direction at a similar speed 317.  
 
Cell migration is tightly controlled and requires rapid changes in cell adhesion 
and actomyosin cytoskeleton. Generally, during cell migration cells appear 
polarised having a leading edge which points in the cell direction and a trailing 
edge (Figure 5.1). Dynamic control of intracellular signals including GFs and 
ECM interactions is essential for the maintenance of cell polarity318. The 
leading edge is characterised by actin polymerisation followed by the formation 
of protrusions and membrane extension which mediates cell attachment and 
traction forces to the substrate. Stronger cell attachment caused by the 
contraction of the cytoskeleton filaments is observed at the cell front and the 
cell body is being pulled towards the leading edge. In contrast, adhesions are 
disassembled and released at the cell rear to allow the tail to retract. All these 
steps result in coordinated cell translocation270, 319.  
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Figure 5.1. Polarity in migrating cell. Polarisation requires dynamic 
reorganisation of actin cytoskeleton and is characterised by  the development 
of a protruding front which is closer to the direction of migration, and a 
retracting rear319. 
 
Diverse physical and chemical signals coming from the ECM strongly affect cell 
migration. For example, it has been demonstrated that stiffer and more rigid 
matrices support enhanced cell migration320-323. Furthermore, cell adhesion to 
the ECM, mainly via integrins, is fundamental in migratory behaviour. As 
previously described, integrins link the cell to the substratum and regulate 
signalling pathways, such as FAK324, 325, essential for cell migration. Different 
integrins have distinct roles in cell migration. For example, α5β1 has been 
shown to assemble nascent adhesions and promote cell protrusions whereas 
αvβ3 reinforces the development of large FAs and accumulates in areas 
subjected to high tension326. In addition, β1 promotes random migration while β3 
induces persistent migration327. During migration FAs undergo repeated cycles 
of assembly and disassembly followed by a change in their protein 
composition319, 328. Their role in cell migration is well documented. For example, 
it has been shown that nascent FAs transmit sufficient forces to pull the cell 
forward329. In addition, varying the size of FAs using nanopatterned surfaces 
correlates with a specific cell migratory behaviour330.  
 
It is well established that cell motility is influenced by the ligand density 
presented on the substrate, the integrin expression levels of the cells and the 
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integrin-ligand affinity331, 332. Changes in cell migration on protein coated 
surfaces can be also  due to changes in the protein conformation which result 
in changes in protein bioactivity332. It has become evident that cell speed 
exhibits a biphasic behaviour and maximum cell speed occurs at intermediate 
levels of cell-substratum adhesiveness where both adhesion formation and 
release are efficient 331-334.  
 
Studying cell migration behaviour in the presence of physichochemical cues is 
of great importance in order to design instructive biomaterials. This chapter 
focuses on the characterising the migratory behaviour of human fibroblasts and 
hMSCs on PEA and PMA coated with FN. Particularly, this work explores 
whether the differential conformation of adsorbed FN on PEA and PMA affects 
cell motility. To do so, migration assays were carried out over the course of 24 
h and cell speed was characterised. FA morphology was analysed as well to 
explore whether there is a functional relationship with FN conformation. Matrix 
secretion and matrix reorganisation were studied as well.  
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5.2 Materials and methods 
5.2.1 Materials 
List of reagents 
Dulbecco’s modified eagle’s medium…………… Sigma 
Glutamax……………………………………………… Invitrogen 
Penicillin/streptomycin………………………………… Biochrom 
Dulbecco’s phosphate buffered saline…………… Life Technologies 
Foetal bovine serum………………………………… Biochrom/ Life Technologies 
Human plasma fibronectin…………………………… Sigma-Aldrich 
Trypsin/EDTA………………………………………….. Sigma 
Hoechst® 33342……………………………………… ThermoFisher Scientific 
Formalheyde…………………………………............. Fischer Chemicals 
Tween20®………………………………………………. Sigma-Aldrich 
Bovine serum albumin………………………………… Roche/Sigma 
Mouse monoclonal anti-vinculin antibody………… Sigma 
Mouse monoclonal anti-cellular FN antibody............ Abcam 
Cy-3 anti-mouse antibody……………………............ Jackson ImmunoResearch 
Alexa fluor 660 phalloidin……………………............. Invitrogen 
Alexa fluor 350 phalloidin Invitrogen 
Rhodamine phalloidin………………………………… Life Technologies 
Vectashield with DAPI………………………………... Vector Laboratories 
FluoroTag FITC conjugation kit……………............... Sigma-Aldrich 
 
5.2.2 Cell culture 
Primary human dermal fibroblasts (from a 25-year old male) and hMSCs (from 
a 77-year old female) were used. Fibroblasts and hMSCs were maintained at 
37°C and 5% CO2 in DMEM (with glucose, 1% v/v P/S, and 10% v/v FBS) and 
in DMEM (low glucose, 1% v/v P/S, 10% v/v FBS and 1% v/v Glutamax) 
respectively. Media change was carried out every 3 days. For splitting or cell 
seeding, cells were rinsed twice with warm PBS followed by 2.5 ml of 
trypsin/EDTA. Cells were incubated at 37°C for 60 to 120 sec until the cells 
were detached from the tissue culture flask. Next, 7.5 ml of complete medium 
(supplemented with 10% v/v FBS) was added to the flask, cell suspension was 
transferred to a falcon tube and cell density was measured using a cell counter 
(CASY model TT system).  Next, cell solution was centrifuged at (fibroblasts: 
1500 rpm for 6 min or for 8 min, hMSCs: 1300 rpm for 8 min). Afterwards, the 
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supernatant was removed and the cell pellet was suspended in 1 ml of 
medium. Primary fibroblasts and MSCs were used at passages P0 to P5. 
 
5.2.3 Optimisation of migration assay  
TCP was coated with FN at 20 µg/ml for 1 h. Human fibroblasts were 
harvested, cell solution was diluted in medium at a density of 5000 cells/cm2 
and cells were seeded on the samples. For diluting the cell solution, medium 
containing 10% v/v FBS or FBS-free was used. Cell cultured was maintained at 
37°C, 5% CO2 for 3 h. In order to assess the effect of nuclear staining on cell 
migration, cells were incubated with Hoechst® 33342 nucleic acid dye for 10-
15 min at 37 °C. Next, medium was replaced by fresh cell culture medium. For 
this optimisation, cells without nuclear staining were included too. The plate 
was mounted in the motorised staged of a Leica DMI6000 time-lapse 
microscope to record cell migration. Four ROIs in each sample were selected 
and images were recorded every 15 min for 24 h. Four time-lapse videos were 
analysed per condition. To characterise cell velocity, automatic tracking the 
nucleus was carried out, whereas manual tracking of nucleus was carried out 
for cells without nuclear staining. The software Volocity was used to quantify 
cell velocity. 
Conditions:   
1. without FN-coating, without FBS, without DNA staining  
2. with FN-coating, without FBS, without DNA staining 
3. without FN-coating, with FBS, without DNA staining 
4. with FN-coating, with FBS, without DNA staining 
5. without FN-coating, without FBS, with DNA staining 
6. with FN-coating, without FBS, with DNA staining 
7. without FN-coating, with FBS, with DNA staining 
8. with FN-coating, with FBS, with DNA staining 
 
5.2.4 Cell seeding on surfaces  
UV sterilised PEA and PMA cover slips were coated with FN at 20 μg/ml for 1 
h. After cells were harvested by trypsinisation, they were seeded at a density of 
5000 cells/cm2. Medium supplemented with 10% v/v FBS was used. Cells were 
maintained at 37 °C for 3 h. Next, nuclear staining was carried out by 
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incubating the cells with Hoechst® 33342 nucleic acid dye for 10-15 min at 
37°C. Next, the medium was replaced by fresh cell culture medium and the 
plate was mounted in the motorised staged of a Leica DMI6000 time-lapse 
microscope to record cell migration. Four ROIs in each sample were selected 
and images were recorded every 10 min for 24 h. Four time-lapse videos were 
analysed per condition and velocity was assessed by automatically tracking the 
cell nucleus using the software Volocity. To characterise FA formation, FN 
secretion and FN remodelling, PMA and PEA cover slips were coated with FN 
at 20 μg/ml for 1 h. Human fibroblasts and hMSCs were seeded at a density of 
5000 cells/cm2 and incubated at 37°C for 6 h and 22 h. Medium supplemented 
with 10% v/v FBS was used. Next, samples were fixed (3.7% v/v 
formaldehyde/PBS) at 4°C and washed with PBS.  
 
5.2.5 FITC-labelled FN 
FN solution was prepared at 1 mg/ml in milliQ water. Next, two solutions of 
sodium carbonate were prepared: (1) 1 M sodium carbonate in milliQ water and 
(2) 0.1 M sodium carbonate in milliQ water. Next, solution (1) was added to FN 
solution (1:10). Next, one vial of FITC was reconstituted with 2 ml of solution (2) 
until all FICT was dissolved. Next FITC solution was mixed with FN solution 
(1:25). The tube was covered with aluminium foil to protect from light and it was 
incubated for 2 h at room temperature. Next, the cap of a Sephadex G-25M 
column was removed and the lower tip was cut to let excess of liquid flow 
through. After the column was equilibrated with PBS, the FITC-mixture was 
added to the top to separate labelled FN from unconjugated molecules. Next, 
PBS was used to elute the column and 0.25 ml fractions were collected. The 
absorbance of each fraction was measured at 280 nm and at 495 nm using a 
nanodrop (Nanodrop100 spectrophotometer, ThermoScientific) to calculate the 
FITC/Protein molar ratio (F/P) according to the equation:   
 
𝑀𝑊
389
 × 
𝐴495 195⁄
𝐴280 − [(0.35 × 𝐴495) 𝐸280
0.1%⁄
 =  
𝐴495 ×𝐶
𝐴280 − [(0.35 ×𝐴495)
 
 
Where: 𝐶 =
𝑀𝑊 × 𝐸280
0.1%
389 ×195
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MW is the molecular weight of the protein and 389 is the molecular weight of 
FITC. 195 is the absorption 𝐸280
0.1% of bound FITC at 490 nm at pH 13.0. 𝐸280
0.1% is 
the absorption at 280 nm of a protein at 1.0 mg/ml. 0.35 × 𝐴495  is the 
correction factor due to the absorbanve of FITC at 280 nm. C is a constant 
value for FITC conjugation of a given protein.  
 
5.2.6 Immunohistochemistry 
5.2.7 Focal adhesions 
The protocol for vinculin, actin and nuclei staining is described in section 4.2.7. 
 
5.2.8 Fibronectin secretion  
Fixed cells were incubated with permeabilisation buffer for 5 min followed by 
blocking (1% v/v BSA/PBS) for 30 min. Next, samples were incubated with 
mouse monoclonal anti-cellular FN antibody (1:400) in blocking solution for 1h. 
After they were washed twice (0.5% v/v Tween20/PBS), they were incubated 
with secondary Cy-3 anti-mouse antibody (1:200) and Alexa fluor 488 phalloidin 
(1:100) in blocking solution for 1 h. Next, samples were washed again and they 
were mounted using Vectashield with DAPI. For analysis, fluorescent images of 
endogenous FN were exported ImageJ and the integrated density was 
measured.   
  
5.2.9 Fibronectin reorganisation 
Fixed cells were incubated with permeabilisation buffer for 5 min followed by 
blocking (1% v/v BSA/PBS) for 30 min. Next, fibroblasts were incubated with 
mouse monoclonal anti-cellular FN antibody (1:400) in blocking solution for 1h. 
After samples were washed (0.5 % v/v Tween20/PBS), they were incubated 
with secondary Cy-3 anti-mouse antibody for 1h and Alexa fluor 350 phalloidin 
(1:100) in blocking solution for 1 h. MSCs were incubated with rhodamine 
phalloidin (1:100) in blocking solution for 1 h.  Finally, fibroblasts and MSCs 
were mounted with Vectashield without DAPI and with DAPI respectively. To 
quantify FN reorganisation, images were exported to ImageJ and actin was 
used as a mask for FITC-FN reorganisation. The mean intensity of FITC-FN 
underneath each cell as measured and normalised to the mean intensity of 
area outside the cell.  
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5.2.10 Cell imaging 
Fluorescent pictures were taken using an epifluorescence microscope (Zeiss 
AXIO Observer Z1, Jena, Germany). 
 
5.2.11 Statistical analysis 
Data are represented are mean ± SD and were analysed using GraphPad 
Prism 6. Statistically significant differences were assessed by two-way ANOVA 
using a Bonferroni post hoc test at a 0.05 significance level, with *p < 0.05, **p 
< 0.01, ***p < 0.0001.  
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5.3 Results 
5.3.1 Optimisation 
In order to characterise the effect of FBS and DNA staining on cell migration, 
human fibroblasts were initially cultured on TCP coated with FN. Culture media 
was either FBS-free or contained 10% v/v FBS. Culture was maintained for 3 h 
and a live-cell fluorescent staining of nuclei was carried out. Cells without DNA 
staining were included too. For cells without DNA staining, velocity was 
characterised by manually tracking of nucleus. For cells with DNA staining, 
velocity was characterised by automatic tracking.   
 
Cell speed was higher when complete medium was used and cells were not 
DNA-stained (black bars). Cell speed however decreased when DNA staining 
was carried out (blue bars).  FBS also played a role in velocity. When media 
was not supplemented with FBS and cells were not DNA stained, cell speed 
decreased over time (white bars). Velocity decreased more when DNA staining 
was carried out (light blue bars) (Figure 5.2). Based on these observations, the 
following migrations assays were carried out in complete medium since it was 
more favourable to the cells. In addition, although DNA staining compromised 
cell migration, it was carried out in order the cell tracking to be possible.  
 
Figure 5.2. Migration of human fibroblasts on FN-coated TCP over 24 h. 
Graphs shows the velocity of human fibroblasts and demonstrates how FBS 
and nucleus staining affects cell speed. (n=3 per sample, 1 biological replicate). 
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5.3.2 Velocity 
PEA and PMA are chemically similar with PEA containing one more methyl 
group than PMA. However, while similar, a different conformation of FN is 
adopted upon adsorption on PEA and PMA. To study whether such changes in 
organisation affect cell migration, a 24 h migration assay was carried out. 
Fibroblasts and hMSCs were seeded on FN-coated PEA and PMA and 
maintained at 37°C for 3 h to allow for initial attachment. Cell velocity (µm/h) 
was characterised over the course of 24 h.  
 
Figure 5.3 Migration of human fibroblasts on fibronectin-coated PEA and 
PMA over the course of 24h. (a) Phase contrast pictures of human fibroblasts 
on PEA and PMA 0h, 12h, 24h after attachment. Red arrows indicate the 
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migration of single cells over time. (b) Velocity (μm/h) of human fibroblasts. 
(n=3 per sample, 3 biological replicates). 
 
Human fibroblasts moved rapidly on PEA for the first 12 h and after this cell 
speed decreased. In contrast, no such initial rapid cell movement was observed 
on PMA, on which fibroblasts only slightly increased their speed over time. 
Fibroblast speed was highly significantly (p<0.001) greater on PEA than on 
PMA during the first 12 h, achieving up to ~ 25 µm/hour on PEA compared to 
~10 µm/hour on PMA (Figure 5.3).  
 
Figure 5.4. Migration of hMSCs on fibronectin-coated PEA and PMA over 
the course of 24h. (a) Phase contrast pictures of hMSCs on PEA and PMA 0h, 
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12h, 24h after attachment. Red arrows indicate the migration of single cells 
over time. (b) Velocity (μm/h) of hMSCs. (n=3 per sample, 3 biological 
replicates). 
 
For MSCs, cell velocity followed a similar trend on both polymers. As shown in 
the graph (Figure 5.4, b), cells increased their speed within the first 6 h and 
then it slowed down reaching an average speed of ~4.2 µm/h  
 
5.3.3 Focal adhesion analysis 
The morphology of FAs was characterised on the material interface in order to 
elucidate whether there is a functional relationship between cell motility and FA 
morphology. Cells were seeded on FN coated PEA and PMA and a vinculin 
staining was carried out after 6 h and 22 h. Area and length distribution of FAs 
were analysed by quantifying the fluorescent pictures (Figure 5.5, Figure 5.6).  
 
Figure 5.5. Immunofluorescence images of human fibroblasts on FN-
coated PEA and PMA 6 h and 22 h after seeding. Fluorescent staining of 
vinculin (green), F-actin (red) and nuclei (blue). Scale bar is 50 µm. (n=3 per 
sample, 1 biological replicate). 
 
Figure 5.6. Immunofluorescent images of hMSCs on FN-coated PEA and 
PMA 6 h and 22 h after seeding. Fluorescent staining of vinculin (green), F-
actin (red) and nuclei (blue). Scale bar is 50 µm. (n=3 per sample, 1 biological 
replicate). 
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Gross cell morphological differences were not observed between PEA and 
PMA. Cells looked similarly well spread and well-formed FAs were observed 
(Figure 5.5, Figure 5.6). For quantitative analysis of FAs, they were classified 
by area as immature (0-1 µm2), intermediate (1-2 µm2) and mature (>2 µm2) 
and further sub-classifed by length as short (1-2 µm), intermediate (2-3 µm) 
and long (>3 µm). Analysis of the adhesions revealed skewed distribution 
(towards smaller adhesion as expected) on both PEA and PMA. For human 
fibroblasts, the fraction of mature FAs (≥ 2µm2) remained constant with time on 
PEA (from 14% to 16%) and PMA (from 15% to 14%) (Figure 5.7). Similarly, no 
differences were found in the fraction of mature FA over time for hMSCs 
(Figure 5.8). 
 
 
Figure 5.7. Area amd length distribution of FAs of human fibroblasts on FN-
coated PEA and PMA 6 h and 22 h after seeding. (20 images per condition 
were analysed, n=3 per sample, 1 biological replicate). 
 
 
 144 
 
 
Figure 5.8. Area amd length distribution of FAs of hMSCs on FN-coated PEA 
and PMA 6 h and 22 h after seeding. (20 images per condition were analysed, 
n=3 per sample, 1 biological replicate). 
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5.3.4 Endogenous FN 
The effect of FN conformation on PEA and PMA on cell secreted, endogenous 
FN was explored. Cells were seeded on FN coated PEA and PMA and staining 
of endogenous FN was performed 6 h and 22 h after seeding. 
Immunofluorescent staining of fibroblasts and hMSCs showed an increase of 
deposited endogenous FN over time confirmed by quantification of the images 
(Figure 5.9, Figure 5.10). 
 
 
Figure 5.9. Endogenous FN. Immunofluorescent images of human fibroblasts 
on FN-coated PEA and PMA 6h and 22h after seeding. Staining of endogenous 
FN (red), actin (green) and nuclei (blue). Scale bar is 100 µm (top). 
Quantification of FN secreted by human fibroblasts on PEA and PMA (white 
 146 
 
and black bars respectively) 6h and 22h after seeding (bottom). (20 images per 
condition were analysed, n=3 per sample, 1 biological replicate). 
 
 
Figure 5.10. Endogenous FN. Immunofluorescent images of hMSCs on FN-
coated PEA and PMA 6h and 22h after seeding. Staining of endogenous FN 
(red), actin (green) and nuclei (blue). Scale bar is 100 µm (top). Quantification 
of FN secreted by human fibroblasts on PEA and PMA (white and black bars 
respectively) 6h and 22h after seeding (bottom). (20 images per condition were 
analysed, n=3 per sample, 1 biological replicate). 
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5.3.5 Fibronectin remodelling 
In order to study how cells reorganise the pre-adsorbed layer of FN on PEA 
and PMA, FITC-labelled FN was used. FN reorganisation appears as dark 
areas against the fluorescent background surrounded by brighter fibrils. Human 
fibroblasts appeared to reorganise FN more effectively on PMA over time 
whereas poor reorganisation was found on PEA (Figure 5.11). Contrary, no 
differences in FN reorganisation by hMSCs were observed over time on both 
polymers (Figure 5.12). 
 
 
Figure 5.11. FN reorganisation by human fibroblasts. (a) Fluorescence 
pictures of FITC-labelled FN on PEA and PMA reorganised by human 
fibroblasts at 6h and 22h after seeding. Scale bar is 30 µm. (b) Normalised 
fluorescence intensity of FN within the cell compared with the intensity outside 
the cell area. (10 images per condition were analysed, n=3 per sample, 1 
biological replicate). 
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Figure 5.12. FN reorganisation by hMSCs. (a) Fluorescence pictures of 
FITC-labelled FN on PEA and PMA reorganised by hMSCs at 6h and 22h after 
seeding. Staining of actin (red) and nucleus (blue) Scale bar is 30 µm. (b) 
Normalised fluorescence intensity of FN within the cell compared with the 
intensity outside the cell area. (10 images per condition were analysed, n=3 per 
sample, 1 biological replicate). 
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5.4 Discussion  
This chapter focuses on characterising the migratory characteristics of human 
fibroblasts and hMSCs on FN-coated PEA and PMA. These polymers have 
similar chemical properties and, when coated with FN, similar amount of the 
adsorbed protein have been measured (Figure 2.9). However, FN undergoes 
different structural changes upon passive adsorption on PEA and PMA 
triggered by the chemical properties of the substrate resulting in changes in 
protein and the availability of important binding domains (Figure 2.10, Figure 
2.11, Figure 2.12)196, 335, 336.  
 
It is well established that cell migration is highly controlled by the ligand density, 
the ligand-integrin binding affinity and the integrin level337. With this in mind, FN 
conformation and its effect on cell migration was explored. Migration assays 
revealed that the initial speed of fibroblasts was higher the first 6 h on the FN 
network adopted on PEA followed by a decrease. Contrary, cells maintained 
their speed on globular FN on PMA over time (Figure 5.3). In the case of 
hMSCs, cell speed followed a similar trend on both surfaces; it increased within 
the first 6 h and then it decreased. However, higher speed was found on the FN 
networks on PEA over the 6th to 18th hours of migration, similarly to the higher 
speed of fibroblasts on this surface (Figure 5.4). Such biphasic behaviour in cell 
migration speed has been extensively described in previous studies which have 
cited that intermediate levels of cell adhesion were required for this enhanced 
migration to be seen331, 332, 338. It is also known that multiple domains of FN 
contribute to cell migration e.g. RGD and PHSRN synergy sequence339-341, thus 
different structural patterns might result in changes in cell motility. The 
availability of the PHSRN site located in a loop region of FNIII9 was found 
higher on PEA than on PMA (Figure 2.12). In addition, other studies have 
associated the PHSRN with enhanced cell migration in vitro and accelerated 
wound healing in vivo342, 343. We thus postulate that the network-like 
conformation of FN on PEA provides a sufficient level of adhesiveness for 
enhanced fibroblasts motility. In contrast, the globular organisation on PMA 
might alter the extent to which important binding domains are displayed, 
resulting in decreased cell motility compared to PEA. 
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FAs formation was examined in order to gain further insights into cell migration. 
Previous work has correlated FA size and cell speed344. However, in this study 
FA distribution was not dramatically different in fibroblasts or hMSCs on either 
PEA or PMA (Figure 5.5, Figure 5.6, Figure 5.7, Figure 5.8). Thus, it appears 
that size, per se, was not responsible for cell migration on the substrates and 
that other cell functions, such as the secretion or cell driven re-organisation of 
ECM proteins might affect and regulate cellular migration beside the initial 
microenvironment available to cells. 
 
ECM synthesised and secreted by cells can have an impact on cell 
migration345. To further explore migratory characteristics, we investigated 
whether cell migration was associated with cell-mediated FN remodelling, 
including its reorganisation and deposition. An increase in FN secreted by both 
fibroblasts and hMSCs was found over the course of 24 hours. However, no 
significant changes were observed between substrates (Figure 5.9, Figure 
5.10). Interestingly, MSCs were shown to secrete more FN compared to 
fibroblasts on both PEA and PMA. We thus postulate that a more abundant 
matrix secretion might affect cell migration, hindering a differential migratory 
response of hMSCs to FN conformation.  
 
Remodelling of the ECM induced by cell-generated traction forces is a highly 
regulated process and is essential for important cellular functions including cell 
migration. Previous work using 3D collagen matrices has, for example, reported 
that higher invasiveness of breast cancer cells on areas that were not 
reorganised346. Similarly, enhanced invasion and migration of breast cancer 
cells was found when ECM acquired a specific alignment347. In order to gain 
further insights into this process, the reorganisation of adsorbed FN by 
fibroblasts and hMSCs was assessed. FN remodelling by fibroblasts was 
higher on PMA over time whereas no changes were seen on PEA (Figure 
5.11). It can be suggested that cells might have to reorganise the layer of FN to 
be able to use the RGD and PHSRN groups efficiently on PMA, while on PEA 
the FN is presented to the cells in a more immediately usable conformation. 
This lack of having to reorganise the adsorbed FN might lead to the higher 
speed of fibroblasts observed on PEA. It could be further postulated that, as 
cells tend to modify their surrounding environment before they secrete their 
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own matrix212, 348, the strong interaction of FN with PEA inhibits this matrix 
remodelling, resulting in a decrease in cell speed after the initial rapid migration 
phase. On the other hand, FN reorganisation by hMSCs was similar on both 
PEA and PMA over time (Figure 5.12); cell speed was similar on both PEA and 
PMA (it was higher on PEA only from the 6th to 18th h of the migration assay). It 
can be postulated that, due to the high matrix secretion, the layer of adsorbed 
FN on both PEA and PMA might not be easily available for the cells to 
reorganise it. Therefore, cell binding domains might not become available and 
subsequently efficient cell attachment might be hindered. It can be 
hypothesized that this might be associated with the similar trend of cell speed 
exhibited on PEA and PMA by hMSCs.  
 
 
 
Figure 5.13. Summary of results obtained for PEA and PMA. Schematic 
summarises the main results in terms of domain availability, BMP2 binding, cell 
adhesion, osteogenic differentiation and migration. 
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6. Discussion and Conclusions 
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6.1 Discussion 
Stem cells hold a position of great importance for maintaining proper tissue 
function and replacing damaged cells after injury. They reside in a multipotent 
and quiescent state in a specialised microenvironment, the niche, which is 
found in most adult issues. This niche provides spatial and temporal exogenous 
cues which promote quiescence or coordinate stem cell activation for example 
in response to injury349. Due to their diverse differentiation potential, stem cells 
represent a promising source for TE and therapeutic strategies. Among adult 
stem cells, MSCs can be isolated from several adult tissues including bone 
marrow, adipose tissues, liver and pancreas, and can differentiate into diverse 
lineages. Because of their properties, they show great potential in clinical 
applications. For example, Horwitz et al. demonstrated the potential of 
mesenchymal progenitors in transplanted marrow in treating children with 
osteogenic imperfecta350. However, the development of cell-based approaches 
is hindered by the inability to manipulate stem cells while maintaining their 
potency in vitro351.  
 
Stem cells are in constant and dynamic interactions with the ECM, which is 
required for the regulation of cell processes. Deciphering the mechanisms that 
control cellular processes has therefore become an area of great interest. TE 
thus aims at engineering novel biomaterials which not only provide a scaffold 
for cells, but also sustain their function by providing physicochemical signals in 
a controlled environment. A plethora of biomaterials has been used over the 
years attempting to recapitulate the physiological ECM. Numerous studies have 
identified important parameters for a controlled cell response; it is now well 
established that surface topography, chemistry, stiffness and dimensionality are 
of critical significance64, 193, 352, 353. Among the biomaterials, polymers have 
been extensively used due to their diversity and their advantages in terms of 
their manufacturing process and reproducibility354. However, biomaterials might 
fail to efficiently mimic the cell native environment. This can be due to the lack 
of fine cues which cells can recognise and respond to. Surface modification, 
such as coating of polymeric surfaces with protein components or peptides, is a 
common approach to address this issue and ensure surface functionality and 
activity185.  
 
 154 
 
As already described, the ECM is a natural 3D network composed of fibre-
forming proteins, such as laminin, collagen, FN, and other proteins such as 
glycosaminoglycans and soluble factors3. It is a reservoir of biochemical signals 
and it constantly remodelled through cell-mediated forces. Several studies have 
used ECM proteins for surface coating in order to generate interfaces which 
cells can interact with64, 196, 244. In addition to the physical properties of the 
ECM, biochemical components, such as growth factors, can regulate cell 
behaviour. For example, attempts have been made to incorporate growth 
factors into polymeric substrates in order to induce stem cell differentiation260. 
More specifically, BMP-2 has been associated with osteogenic differentiation 
and bone formation and recombinant BMP-2 is approved by the U.S. Food and 
Drug Administration and already used for certain clinical applications355. 
However, a supraphysiologic dose of BMP-2 (1.5 mg/ml) is required and can 
induce adverse clinical effects such as inflammation and extopic bone 
formation356.  
 
Among the ECM proteins, FN has been used in several TE studies. FN is a 
large glycoprotein and contains multiple domains for cell adhesion, protein 
interactions and growth factor binding. It has attracted significant attention 
because it undergoes fibrillogenesis in vivo via integrin binding and application 
of mechanical forces which eventually results in the formation of a fibrillar 
meshwork. This in turn can alter FN bioactivity though the exposure of binding 
domains. A number of studies have demonstrated that FNIII12-14 strongly 
interacts with growth factors70, while FNIII9-10 favours integrin engagement and 
cell binding66. It is now also known that fibrillogenesis can occur in cell-free 
systems for example by using chemical agents such as polyamines357.  These 
systems that induce a specific FN organisation can be used to get better 
insights into the regulatory role of the ECM in cell behaviour.  
 
The effect of intrinsic polymer properties with respect to FN organisation has 
been investigated in several studies. Two synthetic polymers, poly(ethyl 
acrylate), PEA and poly(methyl acrylate), PMA have been shown to trigger two 
distinct FN conformations upon adsorption353. A network-like conformation is 
observed on PEA whereas FN is maintained in a globular state on PMA. 
Several studies have demonstrated the effect of these two material interfaces 
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in cell response. For example, the network organised on PEA enhances 
myoblast differentiation via cell contractility353. It is also shown that PEA favours 
the synergistic interactions of growth factor receptors and integrins244, 358.  
 
The overall aim of this work was to investigate whether polymeric surfaces with 
defined chemistries of EA/MA can trigger distinct FN conformations and to 
characterize the effect of the material interface in MSC behaviour in terms of 
adhesion and osteogenic differentiation. Moreover, a method was developed in 
order to isolate focal adhesions from MSCs cultured on PEA and PMA. The 
adhesive structures were further characterised by proteomic analysis in order 
to investigate how the network-like and globular FN might affect their protein 
composition. Finally, the effect of FN organisation on cell migration was studied 
too.  
 
6.2 Thesis conclusions 
• FN conformation depends on the EA/MA ratio. 
A well connected and extended network is formed on PEA. The network 
becomes less connected when MA is introduced and FN globular 
aggregates are formed on PMA. 
 
• Differential FN conformation affects domain availability and BMP-2 
adsorption. 
The availability of the FNIII8, FNIII9-10 and FNIII12-14 domains is higher 
with increased EA concentration. Also, more BMP-2 particles are 
adsorbed on PEA100 and PEA70. Consequently, the integrin binding 
domain of FN is presented in synergy with BMP-2 on the surfaces where 
FN forms a more extended network. 
 
• Cell morphology and osteogenic differentiation are affected by the 
underlying surfaces.  
hMSC size is higher and spreading is better with increased EA 
concentration. When the surfaces are coated with FN/BMP-2, higher 
expression of RUNX2 and OCN is induced on PEA. In contrast, higher 
expression of ALP is induced on PMA. It is important to note that low 
dosed of BMP-2 drive the osteogenic differentiation of cells.   
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• FA protein composition is different on FN coated PEA and PMA. 
Proteomic analysis of the FAs isolated on PEA and PMA followed by 
PCA shows that their protein composition differs on PEA and PMA.  
 
• FN organization on PEA and PMA causes cell to migrate differently. 
Human fibroblast have to reorganise FN adsorbed on PMA before they 
can fully exploit it and by the time they have reorganised it they have 
changed from migratory/proliferative activity to a more matrix-secreting, 
differentiating activity; thus their speed is always slow. On PEA, 
however, they can immediately exploit the networks for movement and 
growth causing an initial speedy migration followed by a slow migration.  
 
6.3 Further work 
The potential of the copolymers to drive the osteogenic differentiation of MSCs 
was investigated by characterising the expression of osteogenic markers. As 
part of this work, it was intended that signaling pathways triggered by BMP-2 
were studied. Previous work showed enhanced FAK phosphorylation in C2C12 
cells with increased EA concentration359.  It is therefore particularly interesting 
to study whether the degree of FN fibrillogenesis affect FAK signaling and other 
important pathways for osteogenic differentiation, including Smad and ERK 
signaling. Besides investigating signaling pathways, it is also essential to 
explore how BMP-2 receptors interact with integrins. Previous studies suggest 
that colocalisation and synergistic interaction of growth factors and integrins 
influence cell response. For example, integrin αv has been found to colocalise 
with VEGFR-2 on the extended FN network on PEA358, and 
coimmunoprecipitation of integrin β1 and BMPRI occurred on this surface244. 
Exploring whether gradual loss in network connection influences signaling 
events and receptor-integrin interactions will give better insights into the 
molecular mechanisms guiding MSC response to the external environment. 
Elucidating these mechanisms is critical in order to use stem cells as 
therapeutic tools.  
 
In terms of proteomics, attempts were made to develop and establish a 
protocol to isolate FAs from MSCs grown on PEA and PMA. Analysis and 
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classification of the proteins previously associated with the integrin adhesome 
gave interesting results. However, more replicates are needed in order to 
efficiently characterise FA formation and composition.  It should be noted that 
in this study PEA and PMA were included. In addition to these surfaces, 
examining whether the different degrees of FN fibrillogenesis adopted on the 
copolymers induce changes in the adhesome is interesting. This will allow us to 
further understand the role of FN conformation in cell response. Proteomic 
analysis can be also performed to assess whether BMP-2 binding on FN 
triggers changes in the protein composition. Given that the protein interactions 
within FAs are transient and are characterised by a continuous ‘on’ and ‘off’ 
state, it is also important to evaluate changes over time. Moreover, it is 
interesting to evaluate changes in FA composition when cell contractility is 
inhibited. Regarding cell migration, further experiments could be performed to 
analyse the different cell speed exhibited on PEA and PMA. For example, 
analysis of cell directionality and persistence could further elucidate migratory 
behaviour. Investigating whether there are differences in the type of integrins 
required for cell migration on the two materials could also be an important 
aspect.  
 
Overall, materials that modulate FN conformation upon simple adsorption can 
be incorporated into novel approaches to study the response of other cell 
types. These series of copolymers can also be used to coat other type of 
scaffolds, such as 3D scaffolds, and create mimic more efficiently the natural 
ECM in order to gain further insights into how ECM interacts with cells.  
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